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General Abstract 
 
The principle aims of this thesis involved the development of methods to measure enzymes 
that determine nitric oxide (NO) production (eNOS) and quenching (NAD(P)Hoxidase) 
within the microvasculature of skeletal muscle, and the use of these techniques to investigate 
metabolic syndrome and various training modes. Chapter 2 describes the development of 
reliable methods to analyse enzymes responsible for NO bioavailability within the 
endothelium of skeletal muscle microvessels. Chapter 3 suggests that impaired eNOS ser1176 
phosphorylation is instrumental to the reductions in insulin sensitivity of obese Zucker rats. 
Chapter 4 reveals that 6 weeks endurance training (ET) and sprint interval training (SIT) in 
sedentary males induce similar increases in capillary density, and that SIT is more effective 
than ET at increasing eNOS content. Chapter 5 fails to observe a change in any measure of 
microvascular structure or function following 6 weeks resistance training in sedentary males. 
Chapter 6 suggests that 4 weeks of constant-load SIT is an effective intervention to improve 
the content of endothelial enzymes controlling NO bioavailability in obesity. In conclusion 
this thesis describes novel techniques which will be valuable tools for future research into 
microvascular function, and suggests that SIT may be an effective time efficient strategy to 
improve microvascular function.  
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Introduction 
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1.1 Defining a control  
The genetic makeup of Homo sapiens has changed little during the past 10,000 years (53). 
Therefore, modern humans are genetically adapted to a pre-agricultural hunter-gatherer life 
style (58), entailing the obligatory and integral performance of regular physical activity (42). 
As a consequence our ancestor’s physical activity patterns likely resembled what today would 
be classified as a combination of aerobic, sprint and strength training (52). We therefore 
believe that the sedentary, food abundant state of modern living is creating an abnormal 
phenotype, as our current genes evolved from physically active humans. As a result, and as 
suggested by Booth et al. (23) the following introduction will present a physically active 
trained phenotype as the control or optimal state for humans.  
 
1.1.1 Aerobic capacity and insulin sensitivity 
Two key adaptations to this physically active trained state are a high aerobic capacity and 
insulin sensitivity, leading to an optimal healthy phenotype. The importance of aerobic 
capacity is demonstrated by its effectiveness as a predictor of mortality, having been shown to 
be a more powerful predictor than clinical variables or established risk factors such as 
hypertension, smoking, and diabetes, as well as other exercise-test variables, including ST-
segment depression, the peak heart rate, or the development of arrhythmias during exercise 
(133). The importance of insulin sensitivity for maintenance of an optimal healthy phenotype 
during the lifespan is also demonstrated by its association with age related clinical events 
(56). 
 
Both aerobic capacity and insulin sensitivity are positively correlated to each other, with 
trained individuals participating in high levels of physical activity showing high aerobic 
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capacity and high insulin sensitivity (75). As a result a number of the mechanisms by which 
regular physical activity leads to a high aerobic capacity and insulin sensitivity are common. 
Of these, elevations in skeletal muscle mitochondrial density and improvements in lipid 
metabolism seem to be part of the key shared mechanisms (for a previous review see (84). 
Another adaptation responsible for optimal aerobic capacity and insulin sensitivity in the 
physically active state is an ability to effectively match perfusion of tissues with metabolic 
demand. Of particular importance is the perfusion of skeletal muscle as it constitutes 40% of 
body mass and is a principle determinant of aerobic exercise capacity (94) and peripheral 
insulin sensitivity (30).       
 
1.2 Insulin’s hemodynamic effects  
The following sections will discuss the role of insulin on hemodynamic changes affecting 
delivery of insulin and glucose to the muscle and the mechanisms that lead to an increased 
delivery in the optimal trained state. 
 
1.2.1 Effect of insulin on limb blood flow 
The earliest interest in the hemodynamic actions of insulin was provoked by the work of 
Baron and colleagues (12, 109), showing that insulin could regulate its own delivery to the 
muscle by increasing total leg blood flow, measured using a thermal dilution method. In this 
work they showed a strong positive correlation between increase in leg blood flow and whole 
body insulin mediated glucose uptake (12, 109) measured during hyperinsulinemic-
euglycemic clamps. Following this a number of other laboratories investigated the regulatory 
role of insulin on its own delivery, with the majority of studies supporting the role of elevated 
limb blood flow in response to insulin mediating an increase in glucose uptake (145, 146, 177, 
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191). The most direct evidence for the role of total limb blood flow in regulation of insulin 
stimulated muscle glucose uptake comes from studies where the vasodilatory action of 
insulin, a Nitric Oxide (NO) dependent action (discussed subsequently), are blocked using the 
NO synthase inhibitor  L-NG-monomethyl arginine (L-NMMA). Such studies show that 
inhibiting insulin dependent increases in total limb blood flow result in diminished glucose 
uptake.     
 
However, physiological levels of insulin have not uniformly been shown to lead to increases 
in limb blood flow in humans (20, 36, 134, 145, 146, 191), leading to controversy over the 
significance of insulin’s action on limb blood flow, when physiologically relevant conditions 
are used. Adding to this controversy are the findings that pharmacological elevation of limb 
blood flow through infusion of nitropusside or bradykinin did not elevate glucose uptake in 
insulin resistant individuals during a hyperinsulinemic-euglycemic clamp (110, 135, 139). 
Finally the time course of insulin mediated increases in limb blood flow do not reconcile with 
a significant metabolic effect in regulating delivery of insulin to the muscle. Studies using 
physiological insulin report approximately 2 hours or more are required before insulin’s effect 
on limb blood flow are observed, which significantly lags behind the insulin mediated 
increase in skeletal muscle glucose uptake (208). Consequently, it is difficult to assess the role 
that limb blood flow plays in insulin mediated glucose uptake and therefore insulin 
sensitivity. 
 
1.2.2 Insulin’s actions on the microvasculature 
The discrepancy between the time course of the insulin induced dilation of feed arteries and 
increases in muscle glucose uptake (from A-V measurements across leg and/or forearm) has 
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led to further work on the role of the skeletal muscle microvasculature in regulating insulin 
induced muscle glucose uptake. This work has led to the suggestion that low physiological 
increases in insulin lead to increases in microvascular blood volume, thus increasing the 
capillary surface area available for the transport of insulin and glucose, while larger increases 
in insulin as occur during hyperinsulinemic-euglycemic clamps also increase microvascular 
blood flow. The latter could be the consequence of the late increase in feeding artery blood 
flow seen with pharmacological doses of insulin. Barrett and collaborators specifically 
proposed a mechanism in which dilation of terminal arterioles leading to the recruitment of 
previously underperfused capillaries may actually be the key regulatory site of insulin’s action 
on skeletal muscle glucose uptake (13, 14, 150). The importance of capillary recruitment for 
glucose uptake in man has also been shown under physiologically relevant conditions through 
the direct measurement of the capillary permeability surface area product. In this study 
Gudsbjorndottir et al. (77) showed that an increase in capillary permeability surface area 
product was essential for increases in skeletal muscle glucose uptake during an oral glucose 
tolerance test. 
 
Progression in evaluating the role of insulin mediated skeletal muscle microvascular 
recruitment as the key step in the control of muscle glucose uptake has been limited by the 
lack of methods available to directly quantify skeletal muscle microvascular perfusion (34). 
Two methods have been developed to assess the effect of stimuli on skeletal muscle 
microvascular blood flow. These are 1-methylxanthine (1-MX) extraction (an index of 
endothelial surface area available), and contrast-enhanced ultrasound (CEU, a method to 
measure muscle microvascular blood volume and muscle microvascular blood flow velocity). 
Details of both methods can be found in the review of Clark, 2008 (34). 
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Use of these methods has generated data in rats and humans which suggest that insulin 
recruits previously underperfused skeletal muscle capillaries through dilation of terminal 
arterioles increasing the delivery of insulin, glucose and other nutrients in healthy active 
individuals (40, 151, 188, 189, 210).  Using these techniques it has been shown that the time 
course of insulin induced increases in muscle microvascular blood volume is much faster than 
of the dilation of feeding arteries and total leg blood flow, with the earliest measurable 
increases being apparent within 5-10 minutes. The increases in microvascular blood volume 
also precede the activation of key intermediates of the insulin signalling cascade and glucose 
uptake in skeletal muscle (186, 188). Finally it has been demonstrated that recruitment of the 
skeletal microvasculature occurs at considerably lower insulin infusion rates (1 mU .min-1. kg-
1) than required to enhance total limb blood flow (210). Therefore studies conducted using 1-
MX and CEU give compelling evidence that insulin mediated dilation of terminal arterioles is 
important in insulin sensitivity within healthy active individuals.  
 
1.3 Molecular mechanisms of insulin’s action on the vasculature 
1.3.1 Lessons from primary cell cultures 
As a result of the interest in the vasodilatory actions of insulin several studies have attempted 
to find the mechanisms leading to vasodilatation following insulin stimulation. As a result an 
endothelial biochemical insulin signalling cascade has been identified, in first instance in 
endothelial cell cultures, which as end product generates NO, a powerful vasodilator of 
vascular smooth muscle cells.  
 
The rate limiting enzyme in the synthesis of NO is endothelial nitric oxide synthase (eNOS) 
(131). eNOS converts the substrate L-arginine to the products NO and L-citrulline. Insulin 
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activates a signalling cascade similar to that within myocytes resulting in phosphorylation and 
activation of Akt, which directly phosphorylates eNOS at the serine1177 residue leading to 
activation of eNOS and subsequent production of NO (131)(Fig. 1).  
 
1.3.2 In vivo insulin signalling 
Although as discussed above insulin’s vasodilatory effect on the macrovasculature only plays 
a role in the maintenance of the arterial glucose supply to the skeletal muscle in the >120 min 
period after the start of an hyperinsulinemic euglycemic clamp, the interest in the vasodilatory 
role of eNOS within the macrovasculature has lead too much of our current knowledge on the 
mechanisms leading to vasodilatation. An important early in vivo observation was that 
infusion of the nitric oxide synthase (NOS) inhibitor L-NMMA into the femoral artery of 
human volunteers 3 h after the start of a hyperinsulinemic euglycemic clamp acutely reduced 
the late increase in limb blood flow and the accompanying increase in glucose uptake (171). 
This observation clearly illustrates the NO dependency of insulin induced arterial dilation. 
Other studies have shown that the total content of eNOS and insulin-induced phosphorylation 
of eNOS at ser1177 collectively determine endothelial NO production and the late vasodilatory 
response of the macrovasculature to insulin in animals (156, 174). Studies using cultured 
endothelial cells have also shown that incubation with insulin leads to ser1177 phosphorylation 
of eNOS, and that ser1177 is the main activation site (126, 154). Vincent et al. (187) have pre-
treated rats with the NOS inhibitor L-NAME (N-nitro-L-arginine-methyl ester) and observed 
that it both prevented the insulin induced increase in microvascular blood volume and 
increase in skeletal muscle glucose uptake which normally occur 5-10 min after the start of a 
hyperinsulinemic euglycemic clamp (187). To date no studies have investigated the specific 
role of eNOS content and insulin induced ser1177 phosphorylation of eNOS in the mechanism 
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leading to the early insulin induced increase in microvascular dilation in skeletal muscle of rat 
and man.   
 
 
Figure 1.1.  Scheme of the insulin signalling cascade within the vascular endothelium 
leading to NO production.  
Abbreviations: IR, Insulin receptor; IRS, insulin receptor substrate; PI3-K, 
phosphatidylinositol-3-kinase; PIP2, phosphatidylinositol-3,4-biphosphate; PIP3, 
phosphatidylinositol-3,4,5-triphosphate; PDK, phosphoinositide-dependent kinase 1 ;eNOS, 
endothelial nitric oxide synthase.   
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1.4 Exercise-induced changes in perfusion 
A key determinant of the aerobic exercise capacity is adequate perfusion of skeletal muscle, 
so that the fuel and oxygen needs of the exercising muscle are covered, while metabolites 
accumulating during contraction and playing a role in fatigue development are efficiently 
removed from skeletal muscle. 
 
The initiation of exercise provokes an increase in blood flow to the active skeletal muscle, 
which is maintained during sustained exercise (160). As observed during insulin stimulation, 
exercise also recruits previously underperfused muscle capillaries leading to an increase in the 
capillary endothelial surface area available for exchange of blood borne fuels and oxygen (96, 
189). This capillary recruitment observed with exercise has been shown to be very sensitive, 
with workloads that do not affect total limb blood flow increasing microvascular volume by 
2-3 fold (189). Therefore it appears that delivery of nutrients to the active skeletal muscle can 
be exquisitely controlled by this staged vascular response allowing oxygen and nutrient 
delivery to match the metabolic needs of the exercising tissue. 
 
1.4.1 Mechanisms of exercise hyperemia 
A number of mechanisms have been reported to increase blood flow to skeletal muscle during 
exercise (48).  A comprehensive review of all these mechanisms is beyond the scope of this 
introduction. Therefore, we will focus on the potential role of NO and eNOS activation in the 
regulation of the arterial and muscle microvascular blood flow during exercise. 
 
The role of NO in exercise hyperaemia is controversial. Studies using eNOS inhibitors have 
produced equivocal results with some suggesting a role for NO (25, 89, 100, 129, 161) and 
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others excluding a role in exercise hyperaemia (59, 144, 164). However simultaneous 
inhibition of NO and prostaglandins produce a ~ 30% reduction in blood flow to exercising 
limbs (25, 89, 100, 129, 161). A matter which makes it difficult to draw hard conclusions 
from these studies is the number of complementary mechanisms, with other mechanisms 
potentially taking over when NO production is reduced with eNOS inhibitors (48). We, 
therefore, believe that today it is impossible to conclude whether the production of endothelial 
NO plays a role in exercise hyperaemia both at the arterial and skeletal muscle microvascular 
level.  
 
Evidence in support for a potential role of NO in exercise hyperaemia comes from the finding 
that treadmill exercise increases eNOS ser1177 phosphorylation in arteries of active mice (211). 
It is proposed that this phosphorylation of eNOS is the result of shear stress mediated 
activation of AMPK and Akt (latter via the same signalling cascade as insulin) (211). 
 
Hester et al. (87) have shown that inhibition of NO using the NOS inhibitor L-NAME reduces 
functional dilation in response to electrical stimulation of both first and second order 
arterioles within the superperfused hamster cremaster muscle, but had no effect on third order 
arterioles. However studies investigating microvascular blood flow in humans and rats have 
produced conflicting results regarding the role of NO in exercise hyperaemia. Inhibition of 
NOS does not appear to reduce microvascular blood volume or flow measured using CEU 
(86, 158), however combined NOS and cyclooxygenase inhibition reduces microvascular 
blood flow (86).  Also in the case of the muscle microvasculature, it is therefore not clear 
today whether increases in eNOS activation and microvascular endothelial NO production 
play a role in the increased perfusion of the muscle capillary bed during exercise. 
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It has been observed in several studies that there are substantial reductions in exercise 
hyperemia and muscle perfusion in sedentary, obese and elderly individuals with and without 
the metabolic syndrome, while it has also been reported that the vascular eNOS content is 
reduced in these conditions (118). It, therefore, is important that future studies investigating 
the potential role of eNOS and NO in the mechanisms leading to exercise hyperemia will also 
include these groups with known exercise limitations. 
 
1.5 Microvascular density 
In addition to the ability of terminal arterioles to dilate in response to insulin and exercise,  
microvascular density also plays a role in determining insulin sensitivity and aerobic capacity 
as it determines the maximal capillary surface area that is available for exchange of insulin, 
oxygen and nutrients (61). In active individuals capillary density has been shown to be much 
higher than in sedentary individuals (19) and there is strong positive correlation of muscle 
capillary density with both aerobic capacity (19) and insulin sensitivity (114).  
 
1.6 Physical inactivity and obesity 
1.6.1 Epidemiology: inactivity 
As discussed earlier, throughout history daily physical activity has been a necessity for 
survival of homo sapiens (33). However, in the second half of the 20th century substantial 
changes have occurred in the need to be physically active, the most important changes being a 
reduction in professional workload requirements (more office jobs) and the introduction of 
automobiles, television and computer games. This has resulted in rapid increases in the 
proportion of adults and children leading a sedentary lifestyle. In the US 70% of the adult 
population is classed as sedentary (<30 min exercise 5 days/week) (33), while in the UK only 
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40% of males and 28% of females attain these guidelines (3). These trends for reduced 
physical activity are not only apparent in developed nations. Recent studies from India show 
high rapidly increasing levels of physical inactivity in men and women (169) and physical 
activity is documented to already dramatically decline during adolescence (105). 
 
 The landmark study of Morris et al. (128) was the first to show detrimental effects of 
physical inactivity on health, through the observation that the more active bus conductors had 
reduced risk of myocardial infarction than their more sedentary bus driver colleagues. 
Subsequently physical inactivity has been shown to affect at least 20 chronic health 
conditions (23), with reduced exercise capacity and energy expenditure from weekly activity 
more powerful predictors of all-cause mortality than clinical variables (132, 133). In addition 
to the direct health implication of sedentary lifestyles the economic cost of the prevention and 
treatment of chronic diseases resulting from physical inactivity in the UK has been estimated 
at £8.2 billion a year, involving both direct (treatment of lifestyle related disease) and indirect 
(sick absence) costs (1). This estimate excludes the contribution that physical inactivity makes 
to the direct and indirect costs of obesity (see next subsection). 
 
1.6.2 Epidemiology: obesity 
The latter half of the 20th century has also seen a massive increase in the availability 
(abundance) of food, variety of food products and marketing of food products via modern 
communication means. Although difficult to quantify, the combination of a life-style related 
reduction in energy expenditure with an increased energy intake or unhealthy nutritional 
choices and habits, has led to the dramatic increase in the prevalence of obesity in recent 
decades.  The World Health Organisation (WHO) defines obesity as the excess accumulation 
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of adipose tissue to an extent which presents a health risk to the individual (4) and it is 
crudely defined using body mass index (BMI), with a BMI >30 defining an individual as 
obese. 
  
Obesity has become a global epidemic with 396 million adults worldwide classified as obese 
(BMI > 30kg.m-2) (103). If recent trends continue this figure is expected to grow to 1.12 
billion by 2030 (103). In the UK ~24% of adults are obese with an additional ~44% of men 
and 35% of women classified as overweight (BMI > 25kg.m-2) (3). As with physical inactivity 
obesity is not confined to developed nations with obesity rates increasing at dramatic rates in 
developing countries (205). Of particular concern is the increase in childhood obesity, which 
has increased in all countries for which data is available (195), as the negative health 
consequences of obesity are expected to appear at earlier ages and lead to more severe obesity 
related pathologies in future generations of the rapidly growing elderly population.  
 
Obesity has been shown to double the risk of all-cause mortality (1), with the development of 
obesity being associated with the progression of a number of additional pathologies including 
cardiovascular disease, type II diabetes, and hypertension (170). When a number of these risk 
factors appear in conjunction with each other, in addition to obesity, the combination leads to 
“metabolic syndrome”, a condition which can dramatically increase the risk of negative health 
outcomes (64). The economic costs of obesity are also staggering with an estimated £2 billion 
spent on the treatment of obesity and its consequences by the NHS annually and the impact on 
employment predicted to be as much as £10 billion per annum (2).   
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Where possible in the subsequent discussion of vascular impairment, the negative 
consequences of inactivity and obesity will be separated, however in many cases there is a 
lack of experimental data on the role of inactivity alone.  
 
1.7 Critical role of endothelial derived nitric oxide bioavailability 
In the first part of this chapter the crucial role of increases in endothelial NO production in 
achieving insulin- and exercise-induced increases in skeletal muscle perfusion were 
explained. In the following subsections the mechanisms that impair NO production in 
sedentary and obese individuals will be reviewed and the functional consequences will be 
explained for insulin- and exercise-induced increases in arterial dilation and blood flow and 
muscle microvascular blood volume and blood flow in sedentary and obese individuals. 
 
1.7.1 Impaired nitric oxide bioavailability in inactivity and obesity; lessons from the 
macrovasculature 
NO dependent dilation following intra-arterial infusion of Acetylcholine (ACh) is reduced in 
obese individuals in comparison to lean controls (141). Further evidence of impaired NO 
production or bioavailability in obesity comes from studies measuring flow mediated dilation 
(FMD). FMD is measured as described by Thijssen et al. (178), and is the increase in vessel 
diameter (dilation) observed in an artery in response to a predefined period of 5 minutes 
occlusion and has been shown to be an NO-dependent process. FMD is the gold standard test 
used to measure whether NO production or bioavailability is reduced in certain individuals or 
populations. A reduced FMD has been observed in the brachial artery of individuals with 
obesity and the metabolic syndrome (51) and this has led to the suggestion that reduced NO 
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bioavailability leading to endothelial dysfunction may play a key role in a number of the 
developing pathologies in these groups (29). 
 
The evidence that supports  a reduction in NO bioavailability leads to endothelial dysfunction 
and impairments in vasodilatation of arteries has been supported by a number of studies in 
animal models of obesity, among others in studies of obese Zucker rats (OZR), which is the 
best known rat model of the metabolic syndrome  (64).  
 
The  FMD response of conduit arteries of sedentary individuals has been observed to be larger 
than in trained individuals (181). This counter-intuitive result was explained by the fact that 
structural remodelling occurs in response to training which leads to a larger lumen size in 
trained individuals and which, therefore, will reduce the FMD in trained individuals in 
comparison to sedentary individuals (142). Periods of inactivity lead to reductions in the size 
of the lumen of  conduit arteries, (17, 18, 45, 172) and are therefore expected to increase the 
shear stress response to FMD (181). Another mechanism which may contribute to the increase 
in FMD in sedentary individuals is that thickening of the artery wall in response to inactivity 
may increase responsiveness to vasoactive substances resulting in a positive correlation 
between wall thickness and FMD (143, 165, 166, 179). Finally an increased sensitivity to NO 
of the smooth muscle in arteries of sedentary individuals has been reported to be responsible 
for the elevated FMD (181). Although many of the studies show this increase in FMD in 
sedentary individuals, a short term bed rest study found reduced FMD which was not 
accompanied by a change in baseline lumen diameter (21), suggesting a possible role of 
reduced NO bioavailability.  
 
16 
 
Suvorava et al. (173) have shown that dilation in response to ACh is impaired in aortic rings 
of sedentary mice, suggesting that insulin induced activation of eNOS and increases in NO 
production may well be reduced in the sedentary state, similar to the observation made in 
obese individuals. 
 
1.7.2 Impaired nitric oxide bioavailability within the microvasculature of sedentary and 
obese individuals 
Obese individuals display a marked reduction in the dilation of the cutaneous 
microvasculature in response to iontophoresis of ACh, suggesting an impaired endothelial 
mediated response to this classical vasodilator (121). However use of ACh to demonstrate NO 
mediated vasodilatation in the cutaneous microcirculation has been questioned as inhibition of 
NOS does not or only partially inhibits ACh mediated cutaneous dilation (26, 92). 
 
Studies in animal models of obesity suggest that NO production or bioavailability is reduced 
within the muscle microvasculature. Frisbee & Stepp (67) have shown that the NO mediated 
dilation in response to ACh and elevated shear stress is severely impaired in situ in arterioles 
of the cremaster muscle of OZR  in comparison to LZR. In addition studies using isolated 
skeletal muscle 1a arterioles have also shown an impaired vasodilator effect to various NO 
mediated dilators in arterioles obtained from OZR in comparison to arterioles from LZR (64). 
However to the author’s knowledge the effect of obesity on the ability of terminal arterioles in 
skeletal muscle to dilate in response to ACh has not been investigated in rat or man in vivo. 
 
The effect of inactivity has also only been investigated in the cutaneous microvasculature in 
humans and the results obtained are not necessarily the same as in the skeletal muscle 
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microvasculature. In the cutaneous microvasculature ACh induced vasodilation was impaired 
following bed rest (50, 136). The cutaneous response to heating (which also is NO mediated) 
was also reduced following bed rest (44).  
 
Evidence that inactivity leads to reduced NO production or NO bioavailability in skeletal 
muscle comes from a hind limb unloading study in rats. In these animals endothelium 
dependent dilation in response to ACh is impaired in both the soleus feed artery and 1a 
arterioles (47), suggesting that the NO bioavailability is reduced in both the macrovasculature 
and the skeletal muscle microvasculature.  
 
1.7.3 Insulin mediated vasodilation 
Hyperinsulinemic-euglycemic clamps in obese individuals have shown that late (>120 min) 
insulin mediated increases in leg blood flow are attenuated suggesting an impaired response 
of the leg macrovasculature to insulin (12, 109). However, as was discussed earlier the role of 
this late increase may be less important under more physiological conditions, such as in the 
period after ingestion of a mixed meal.  
 
Insulin mediated microvascular recruitment in skeletal muscle has been studied in obese 
individuals in comparison to lean humans using the CEU method and was shown to be 
substantially impaired both during a hyperinsulinemic euglycemic clamp (38) and following 
mixed meal ingestion (37, 104). Insulin mediated microvascular recruitment, assessed with 
the 1-methylxanthine method, and skeletal muscle glucose uptake were also severely  
impaired in OZR  in comparison to LZR (193). This impairment in insulin mediated 
microvascular recruitment in skeletal muscle is likely to contribute to the reduced insulin 
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mediated glucose disposal in obesity, as the impaired microvascular recruitment will 
significantly reduce the muscle capillary surface area available for diffusion of insulin and 
glucose, thereby severely limiting delivery of insulin and glucose to the muscle fibres (13, 14, 
150).  
 
To the author’s knowledge there are no studies regarding the effect of inactivity on insulin 
mediated vasodilation in either feeding or resistance arteries or the muscle microvasculature. 
However physical inactivity through bed rest is associated with the development of insulin 
resistance and vascular dysfunction suggesting a possible role of impaired vasodilation in the 
insulin resistance developed through inactivity (79).  Inactivity also has been reported to lead 
to decreases in eNOS gene expression and protein content in the macrovasculature of humans 
and animal models (118). 
 
1.7.4 Functional hyperaemia 
In comparison to lean individuals vascular resistance is increased and exercise-induced 
increases in forearm blood flow in obese humans are impaired (137, 153). Unfortunately no 
data is available on differences in the exposed skeletal muscle capillary surface area in obese 
humans compared to lean healthy humans during exercise. However it has been shown that 
exercise induced microvascular recruitment is impaired in patients with type II diabetes 
displaying microvascular complications (198). In animal models of obesity muscle blood flow 
during contraction has been shown to be impaired in the OZR, due to attenuated functional 
hyperaemia in skeletal muscle arterioles in OZR compared to lean controls (60, 203, 204).   
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To the authors knowledge no studies have investigated the effect of bed rest on the 
microvascular blood flow of skeletal muscle during exercise in humans. Therefore evidence 
of impaired functional hyperaemia following inactivity must come from animal models 
particularly hind limb unloading models,  in which a reduced limb blood flow has been 
observed during exercise (201).  
 
It appears that obesity and inactivity reduce the maximal microvascular blood flow of skeletal 
muscle during exercise. However as discussed above mechanisms of functional hyperaemia 
are complex and currently not completely understood, therefore the possible role of NO in the 
attenuated perfusion exhibited in obesity and inactivity currently is not known. However, 
there is evidence that NO production and bioavailability are reduced by inactivity and obesity 
and that this, therefore, is one of the candidate mechanisms for the reduction in maximal 
microvascular blood flow in skeletal muscle in response to exercise in these groups (90, 192). 
Of support for this theory is data showing that improved endothelial function following the 
removal of oxidative stress and vascular sources of prostaglandinH2/thromboxane A2 
(combined treatment with Tempol and SQ-29548, respectively) is likely responsible for the 
increase in hemodynamics in response to electrical stimulation in the distal microcirculation 
of OZR to the level seen in LZR (65).  
 
1.8 Potential mechanisms of impaired NO bioavailability 
NO bioavailability is determined by the balance between NO production and NO removal. 
NO production is dependent on the activity of the rate limiting enzyme eNOS (156, 157, 174), 
which depends both on its protein content and phosphorylation state (156, 157, 174). In 
contrast NO removal is partly dependent on scavenging by ROS. The following sections will 
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focus on the effect of obesity and inactivity on eNOS gene expression, protein content and 
phosphorylation state and the main reactions that lead to ROS production in the vasculature. 
 
1.8.1 Obesity: eNOS content 
Hickner et al. (88) have shown that skeletal muscle eNOS content measured using the 
quantitative sandwich enzyme immunoassay technique in whole muscle homogenates from 
the m. vastus lateralis is negatively associated with body fat percentage, and that overweight 
women have lower eNOS content than lean women.  
 
A number of animal models have investigated the effect of obesity on eNOS content. OZR 
and rats fed a high fat diet display reduced eNOS protein content in the aorta (24, 155, 156). 
In resistance arteries isolated from rat cremaster m. eNOS content is also markedly reduced in 
obese compared to LZR (55). Although the findings of reduced eNOS content are relatively 
consistent in the macrovasculature, analysis of eNOS content in skeletal muscle homogenates 
in models of obesity are less clear. eNOS content in gastrocnemius muscle homogenates of 
high fat fed rats is reduced in comparison to lean controls (24). OZR have the same eNOS 
content as their lean littermates in hind limb skeletal muscle homogenates (69). It should be 
noted though that the interpretation of these results is confounded by the fact that eNOS is not 
only present in the muscle microvascular endothelium, but also in the muscle fibres (39). 
 
1.8.2 Obesity: eNOS phosphorylation 
Phosphorylation of eNOS has been shown to acutely regulate its activity in cultured 
endothelial cells (130). eNOS is phosphorylated on multiple phosphorylation sites with ser1177 
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regarded as the main activation site (154). However eNOS ser1177 phosphorylation has not 
been assessed in arteries and the skeletal muscle microvasculature of obese humans. 
 
In aorta of high fat fed rats basal eNOS ser1177 phosphorylation has been shown to be reduced 
(174). In addition the increase in ser1177 phosphorylation of eNOS induced by insulin infusion 
was also reduced in rats on the high fat compared to the control diet (174) and was, therefore, 
proposed to explain the reduced arterial vasodilation observed in the rats on the high fat diet. 
 
The effect of obesity on basal and insulin stimulated eNOS ser1177 phosphorylation has not 
been investigated within skeletal muscle of rats and man. The only available information is 
that eNOS ser1177 phosphorylation was increased in cardiac muscle homogenates of obese 
compared to LZR (69), but the meaning of this observation is not clear, and could also 
involve a compensation mechanism required to protect the heart in metabolic syndrome from 
fatal microvascular underperfusion.   
 
1.8.3 Obesity: ROS 
In obese humans elevated levels of oxidative stress have been demonstrated by increased 
nitrotyrosine levels in endothelial cells harvested via a scraping technique from the 
antecubital vein (167). This observation indicates that the endothelial cells in obese 
individuals not only generate NO, but also superoxide anions (.O2
-). As both of these 
molecules are free radicals they react with each other when they meet under the formation of 
peroxynitrite, which itself is a free radical and therefore remains a highly reactive molecule. 
Peroxynitrite among others can lead to nitration of the tyrosine residues in nearby endothelial 
proteins. Nitration of endothelial proteins, therefore, is a marker of local .O2
- production, 
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which in turn will lead to formation of peroxynitrite and many other secondary free radical 
molecules, collectively named Reactive Oxygen Species (ROS). Indications of increases in 
oxidative stress have also been found in the aorta and femoral artery of OZR, a model of the 
metabolic syndrome. In comparison to their lean littermates there was an increase in the aorta 
and femoral artery of OZR in dihydroethidium fluorescence, which is a histochemical staining 
technique to identify sites of .O2
- production (67, 202).  
 
Elevations in .O2
- production within the vasculature as explained above will reduce NO 
bioavailability through the scavenging of NO and subsequent formation of peroxynitrite. .O2
- 
is generated within the vasculature by redox enzymes. Two main oxidant systems exist within 
the human vascular system, NAD(P)Hoxidase (NAD(P)Hox) and xanthine oxidase. Studies in 
human obesity suggest that endothelial protein expression of NAD(P)Hox is up regulated in 
venous endothelial cells (167) while no change was seen in xanthine oxidase, suggesting that 
elevated NAD(P)Hox is primarily responsible for the elevated oxidative stress associated with 
obesity. This finding of elevated NAD(P)Hox is supported by high fat feeding studies in rats 
which also show elevation in NAD(P)Hox content within the aorta (157). In addition to 
elevated NAD(P)Hox protein content its activity has also been shown to be elevated in the 
aorta of OZR (202). 
 
NAD(P)Hox is a multi-enzyme complex, requiring the assembly of at least 6 components for 
its activation. Firstly NOX2 (Also known as gp91phox) is a transmembrane protein which 
transports electrons across cell membranes to reduce oxygen to .O2
- (15). NOX2 is activated 
by a complex series of protein/protein interactions. P22phox is a membrane bound protein 
constitutively associated with NOX2 which helps stabilise the NOX2 protein and dock 
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cytosolic proteins. For NOX2 to be activated the cytosolic subunits P47phox, p67phox, Rac 
and p40phox need to translocate to the plasma membrane, thus allowing complex formation 
and activation of the NOX2 enzyme.  
 
NAD(P)Hox protein expression has not been directly measured in the skeletal muscle 
microvasculature or in muscle homogenates of obese individuals. However treatment of 
cremaster muscle arterioles isolated from OZR with the .O2
- scavengers polyethylene glycol-
superoxide dismutase and catalase has been shown to improve ACh-induced dilation of 
arterioles (67). This suggests a potential role for elevated .O2
- production in the impaired 
vasodilatory responses to insulin and exercise observed in obesity and the metabolic 
syndrome in the skeletal muscle microcirculation.   
 
In addition to NAD(P)Hox, the enzyme eNOS itself may be a potential source of .O2
- 
production through eNOS uncoupling, a phenomenon that is observed in obesity, metabolic 
syndrome and hypertension. Production of NO by eNOS requires several cofactors, the most 
important one is tetrahydrobiopterin (BH4) which stabilises the eNOS dimmer (11). Oxidation 
of BH4 leads to loss of the interaction between BH4 and eNOS and results in the production of 
.O2
- rather than NO as eNOS transfers its electron to oxygen rather than to L-arginine (98, 
138).  Although eNOS uncoupling remains largely uninvestigated in obesity it has been 
shown that peroxynitrite is a potent oxidiser of BH4 (111, 131, 140) and secondly 
peroxynitrite may oxidise the zinc thiolate core of eNOS causing enzymatic uncoupling (140, 
212, 213).    
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1.8.3 Inactivity: eNOS content 
To the authors knowledge there are no studies investigating bed rest or inactivity on eNOS 
protein expression in arteries and the skeletal muscle microvasculature in humans. Hindlimb 
unloading studies in rats have generated a wealth of relevant data though. Hindlimb unloading 
in rats reduced the eNOS mRNA and protein content both in feed arteries and class 1a 
arterioles of the soleus m., which experienced an impaired vasodilator response to exercise 
(162, 200). Of interest eNOS expression and protein content did not change in the feed artery 
and class 1a arterioles of the gastrocnemius m., which did not experience impairment in the 
endothelium dependent vasodilatory ability. These data collectively suggest that a reduction 
in total eNOS content in response to a reduction in physical activity may reduce both resting 
muscle blood flow and insulin and exercise-induced vasodilation both at the level of the 
muscle feed arteries and arterioles. The discrepancy between muscle groups also suggests a 
possible role for chronic reductions in blood flow in the reduced eNOS expression, as resting 
muscle blood flow was reduced in the soleus m. during hind limb unloading and maintained in 
the gastrocnemius m. As it has been shown that eNOS expression is regulated by fluid flow in 
monolayer’s of cultured endothelial cells, this supports the role attributed to shear stress as 
one of the main signals controlling eNOS expression (22).   
 
1.8.4 Inactivity: eNOS activation 
There is no published data regarding the effects of inactivity on eNOS ser1177 phosphorylation 
in the basal state or in response to stimulation by insulin and exercise.  
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1.8.5 Inactivity: ROS 
In inactive rats vascular lipid peroxidation has been shown to be elevated in addition to 
elevated .O2
- release assessed by L-012 chemiluminescence and by the superoxide dismutase-
inhibitable cytochrome C reduction assay (113). NAD(P)Hox activity and protein expression 
were both elevated in homogenates of the aorta (113). This suggests a possible role for 
NAD(P)Hox in the impaired NO-dependent vasodilatory ability of feed arteries. However 
studies investigating whether physical activity or bed rest increase biochemical markers of 
oxidative stress and NAD(P)Hox protein expression or activity have not been conducted at the 
level of the skeletal muscle microvasculature.   
 
1.9 Microvascular rarefaction 
Alterations in microvascular structure and density may also play a role in obesity and 
inactivity induced reductions in skeletal muscle blood perfusion. Obesity has been 
consistently shown to cause capillary rarefaction in both humans and animal models (63, 71). 
Although inactivity has not been directly studied, detraining causes a significant reduction in 
skeletal muscle capillary and microvascular density (106). This will significantly reduce the 
capillary surface area available for transport of insulin, glucose and other nutrients thus 
limiting their delivery and uptake by the muscle fibres (61).     
 
1.9.1 Mechanisms of angiogenesis and microvascular rarefaction 
Vascular endothelial growth factor (VEGF) has previously been shown to stimulate 
endothelial cell division and migration (209) and increases in VEGF mRNA and protein 
content and VEGF receptors (VEGFR-1 and VEGFR-2) have been shown to be an essential 
prerequisite for exercise induced angiogenesis (6, 70, 72). However, increased capillary 
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proliferation through the up regulation of VEGF and VEGFR-2 in the early stages of 
electrical stimulation has been shown to be NO dependent (122), as it did not occur following 
NOS inhibition with L-NMMA. In addition the effects of longer term electrical stimulation 
appear to be fully NO dependent as inhibition of NOS suppresses capillary growth without a 
concomitant reduction in VEGF or VEGFR-2 (122).   As a result of the critical role of NO in 
exercise induced angiogenesis, much of the work on mechanisms of microvascular rarefaction 
in obesity has focused on the role played by the observed reduction in NO bioavailability 
(97). The clearest illustration that a reduced NO bioavailability leads to capillary rarefaction 
has been shown by Frisbee et al. (62) in OZR. In this study treatment of OZR with the 
antioxidant TEMPOL reduces microvascular rarefaction (62).  The importance of reduced NO 
bioavailability to this process was further illustrated when these animals were treated with L-
NAME and TEMPOL, in this situation the lower oxidative stress had no effect on 
microvascular rarefaction suggesting that it is the reduced NO bioavailability resulting from 
NO quenching by ROS and not the oxidative stress per se which caused the microvascular 
rarefaction. The mechanism by which the sedentary state (inactivity) leads to capillary 
rarefaction has not been investigated in great detail, however, it would appear likely that the 
lack of regular exercise bouts leading to regular increases in blood shear stress takes away the 
stimulus that is needed for VEGF production and angiogenesis, while the total eNOS content 
will also drop in prolonged periods of inactivity, thus leading to a new reduced set point for 
capillary density.  
 
1.10 Endurance training to regain optimal function 
As discussed earlier we believe that inactivity and obesity create an abnormal phenotype 
which increases the risk of ill health, in particular reduced aerobic capacity and insulin 
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sensitivity. However it has regularly been shown that endurance training (ET) is an effective 
way of improving health and regaining the optimal phenotype which occurs in trained 
individuals. In particular ET is shown to increase aerobic capacity (106) and insulin 
sensitivity (84) in previously sedentary or obese individuals. As a result of the beneficial 
effects of exercise on health the guidelines of the American College of Sports Medicine and 
the American Heart Association suggest that individuals between 18 and 65 should participate 
in moderate-intensity aerobic (endurance) physical activity for a minimum of 30 min five 
days a week or vigorous-intensity aerobic physical activity for a minimum of 20 min three 
days a week (82). Part of the beneficial effects of ET on aerobic capacity and insulin 
sensitivity in obesity are likely to occur via insulin and exercise-induced increases in the local 
perfusion (microvascular blood volume and blood flow) of skeletal muscle. In the next 
subsection of the introduction the vascular adaptations and mechanisms leading to this 
increase in local muscle perfusion will be discussed.  
 
1.10.1 Endurance training (ET) to improve nitric oxide bioavailability in inactivity and 
obesity; lessons from the macrovasculature 
Only one study has investigated the effects of  traditional endurance-type exercise training in 
obese adults (190). Another study (163) has investigated the effect of a combined diet and 
physical activity intervention in obese adults, while other studies have been performed in 
obese adolescents and/or children following circuit training (combined aerobic training and 
resistance training). All of these studies show that aerobic exercise training is an effective 
method to increase FMD (120, 196, 199), suggesting that aerobic training increases NO 
bioavailability in the macrovasculature of obese individuals. One study has also shown that 
aortic stiffness measured by pulse wave velocity is reduced (8). A reduction in aortic stiffness 
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is the result of structural and functional improvements, which most likely will involve an 
improved vasodilatory function as a result of an improved NO bioavailability.    
 
Animal studies also consistently show that ET is an effective method for improving NO 
bioavailability. Studies in a number of rat models of obesity have shown that ACh mediated 
dilation of the macrovasculature is improved by training in obese rats (9, 184). The 
improvements in endothelium dependent vasodilatory function observed in these studies were 
abolished following administration of the eNOS inhibitor L-NAME further suggesting that an 
increase in NO bioavailability is responsible for the improvement in the vascular dilatory 
function following training. 
 
The effect of ET on macrovascular NO dependent dilation in previously sedentary individuals 
has produced contrasting results making it difficult to draw firm conclusions on the role of ET 
increasing NO bioavailability in this group. In conduit arteries several studies have shown an 
increased FMD response in previously sedentary individuals (35, 149). However not all 
studies investigating FMD have found this increase (127, 180). It is possible that the disparate 
results are due to the different durations of the interventions, with only a single functional 
assessment being made at the end of the studies. Recent evidence suggests that functional 
adaptations (such as improved FMD) in conduit arteries may precede arterial remodelling 
leading to increases in lumen diameter. Therefore, multiple time point assessments in future 
studies are required to gain a more comprehensive understanding of the time course of 
conduit artery adaptations to training in previously sedentary individuals (182). As in conduit 
arteries, studies in resistance vessels have also produced conflicting results (182).  
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Animal studies have also produced mixed findings into the role of ET in previously sedentary 
animals with results dependent on the species, vascular bed and duration of the intervention. 
As in the human studies initial increases in endothelium dependent vasodilation are abolished 
after long term training (99). However studies in aortic rings of sedentary rats have shown an 
increased response to ACh following training and that this response was abolished following 
L-NAME suggesting that improvements are primarily mediated by an  increased NO 
dependent vasodilatory function (49).  
 
1.10.2 Endurance training to improve nitric oxide bioavailability within the 
microvasculature in inactivity and obesity 
There is no data on the effect of ET on muscle microvascular vasodilatory capacity in 
humans. However 2 studies in animals have suggested that ACh induced vasodilation of 
skeletal muscle arterioles is improved following ET in OZR (204). Frisbee et al. (66) have 
shown that 10wk of ET improved reactivity of arterioles to ACh and that this improvement 
was due to an elevated NO bioavailability in response to stimuli.    
 
One study has investigated the effect of ET on the cutaneous microvasculature and observed 
that ET increased ACh mediated microvascular perfusion in previously sedentary humans 
(194). More compelling evidence for a role of elevated cutaneous microvascular NO 
bioavailability following training in previously sedentary older adults comes from Black et al. 
(16). In this study cutaneous heating was used as the stimulus and the contribution of NO to 
the improved cutaneous perfusion following ET was directly assessed by blocking the NO 
production with L-NAME. The results suggest that ET reversed the impaired microvascular 
NO bioavailability in the previously sedentary older adults. Future research should confirm 
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that this effect of ET can be extrapolated to insulin and exercise induced dilation in the 
muscle microvasculature. 
 
It is difficult to draw a firm conclusion on the effect of ET in previously sedentary animals 
due to a large variation in responses of different order arterioles and different vascular beds. 
However, most of the studies investigating skeletal muscle arterioles have shown that the 
vasodilatory response to ACh and FMD is increased, suggesting that endothelial function can 
be improved within the microvasculature of previously sedentary animals (99). Spier et al 
(168) have suggested that the enhanced response of gastrocnemius m. arterioles to FMD 
following ET in rats is mediated exclusively through upregulation of NO mediated dilation, as 
the increased response to FMD was abolished by L-NAME administration (168).  
 
1.10.3 Insulin mediated vasodilation 
To the authors knowledge there is only one study investigating the effect of training on 
insulin mediated vasodilation. This study investigated the effect of 14 d of ET on limb blood 
flow and skeletal muscle microvascular recruitment during a hyperinsulinemic euglycemic 
clamp in previously sedentary rats (152). This study found that, although total limb blood 
flow in response to insulin was unchanged following training, hindleg 1-MX disappearance 
was increased indicating that there was an increase in skeletal muscle microvascular 
recruitment.  These observations imply that the so-called 'nutrient blood' flow to skeletal 
muscle fibres was increased and that the insulin-induced dilation of terminal arterioles is 
improved following training, likely through increased NO bioavailability as the insulin 
induced microvascular recruitment  is NO dependent (188). This increase in skeletal muscle 
microvascular recruitment was accompanied by an increase in whole body insulin sensitivity 
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suggesting an increased uptake of the glucose infused during the clamps by the skeletal 
muscle fibres. 
 
1.10.4 Exercise induced hyperemia and arteriolar vasodilation 
Information regarding the effects of ET on exercise induced hyperaemia in humans is 
unavailable for both obesity and inactivity. However two studies using OZR have investigated 
the effect of ET on femoral artery blood flow and the vasodilatory response of skeletal muscle 
arterioles to electrically induced muscle contractions (66, 204). Both studies observed an 
increased femoral artery blood flow and an increased vasodilatory response of the arterioles 
after training in the OZR, suggesting that both the response of feeding arteries and the skeletal 
muscle microvasculature to exercise-induced increases in shear stress is elevated following 
ET in the OZR model of the metabolic syndrome. 
 
In sedentary rats exercise induced vasodilation was increased in the femoral artery and class 
1a and 2a arterioles following 8 weeks of ET.  This effect, however, was lost following 16 
weeks of ET in all but the femoral artery, suggesting a time and order effect of training in 
previously sedentary animals, with increases in microvascular structure and density eventually 
leading to a reduction in the shear stress experienced by individual arterioles  during exercise 
(112).  
 
1.11 Mechanisms of improved vasodilation following training of sedentary 
and obese individuals 
The increased availability of NO appears to play a key role in the augmented vascular 
vasodilatory function observed following ET. Therefore the following subsection will focus 
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on the potential mechanisms that lead to an increase in NO bioavailability. These theoretically 
could involve increases in eNOS content and ser1177 phosphorylation leading to eNOS 
activation and increased endothelial NO production. A reduced production of .O2
- and other 
ROS could also lead to a reduction in NO scavenging.  
 
1.11.1 Human studies 
Hoeir et al (91) is the only study to investigate eNOS content in humans following ET. In this 
study skeletal muscle eNOS content measured in whole muscle homogenates was increased 
following 4 weeks of training in previously sedentary men. However, no human studies are 
available investigating the effects of exercise training of sedentary or obese individuals on 
eNOS ser1177 phosphorylation, NAD(P)Hox protein expression, or local vascular ROS 
production, and therefore the following subsections will focus on animal work alone. The 
only human studies to investigate the effect of ET on eNOS content and phosphorylation or 
NAD(P)Hox content in humans were conducted in coronary artery disease patients and 
showed that both eNOS content and ser1177 phosphorylation were increased (78), while NOX2 
content (5) was reduced in the left internal mammary artery following ET .  
 
1.11.2 Animal studies 
1.11.2.1 eNOS content and phosphorylation 
Only 2 studies have investigated the effect of ET on eNOS content and phosphorylation in 
obesity and both of these investigated the effect in the aorta. One study investigated eNOS 
content and phosphorylation in aortic homogenates of high fat fed rats (184) and the other 
aortic endothelial cells of Otsuka Long-Evans Tokushima fatty rats (displaying obesity and 
TIID) (27) before and after ET. In both studies there was an increase in eNOS ser1177 
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phosphorylation under basal (unstimulated) conditions and no change in eNOS content 
following ET. This may suggest that ET in obese individuals increases the bioavailability of 
NO via an increase in ser1177 phosphorylation and therefore via activation of eNOS rather than 
via an increase in eNOS protein content. However no studies have investigated the effect of 
ET on insulin or exercise induced eNOS phosphorylation, which would be the most important 
variable to understand the mechanism behind improvements in the vasodilatory response to 
insulin and exercise.  
 
A study in previously sedentary rats has shown that aortic endothelial cell eNOS protein 
content and mRNA are increased following training (49, 206). This suggests that elevated 
eNOS content may play a role in the improved macrovascular vasodilatory function following 
ET. In rats eNOS content is elevated in isolated arterioles assessed by Western blotting of the 
red portion of the gastrocnemius in response to ET (117). Although eNOS content appears to 
increase in both the skeletal muscle microvasculature and in feed arteries following ET, 
vascular eNOS phosphorylation following ET has never been assessed. 
 
1.11.2.2 ROS  
One of the most important effects of ET is an upregulation of antioxidant enzymes. These 
systems convert .O2
- and ROS into other molecules that are not free radicals. They therefore 
protect against quenching of NO by .O2
- and ROS and thus help to improve the vasodilatory 
response to insulin and exercise. The predominant antioxidant systems within the vasculature 
are superoxide dismutase (SOD), catalase and glutathione peroxidase. Of these systems SOD 
has received most attention following exercise training, as total SOD activity is shown to be 
elevated in skeletal muscle following training (176). SOD rapidly converts .O2
- to hydrogen 
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peroxide. SOD has three different isoforms, Cu/Zn dependent isoforms SOD-1 and 3 and Mn 
dependent SOD-2. SOD-1 is the primary isoform of SOD within blood vessels and is 
primarily localised within the cytosol of endothelial cells and vascular smooth muscle cells 
(57). SOD-2 and 3 are also present in blood vessels but less abundantly, and are localised to 
the mitochondria (57) and cell membrane (68), respectively of endothelial cells  and vascular 
smooth muscle cells.   
 
The effect of ET on antioxidant systems in obesity is understudied, as to our knowledge only 
one study has investigated the effect of training. In this study, high calorie fed rats had higher 
levels of the antioxidant SOD-1 in aorta and mesenteric arteries following training than the 
sedentary litter mates, which was associated with elevated endothelial function (46). No 
information is available on the effect of ET on the expression of antioxidant enzymes in the 
microvasculature of skeletal muscle in obese individuals. 
 
In previously sedentary pigs long term ET increase aortic SOD-1 protein content and activity 
(159). However there was no increase in protein content of other antioxidant enzymes (Mn-
SOD and catalase). These adaptations to oxidant enzymes were accompanied by a reduction 
in lipid peroxidation a marker of oxidative stress. Unlike this study in porcine aorta 
McAllister et al. (117) showed no difference in SOD-1 protein content from a number of 
conductance vessels following ET in previously sedentary rats(117). In addition SOD-1 was 
not up regulated in most orders of arterioles (1a-5a) in both red and white portions of the 
gastrocnemius. Although the gastrocnemius feed artery SOD-1 content was increased. The 
differences in these studies may be due to differences in species (rat vs. pigs) used and 
training duration (8-12 wks Rush et al. (159), vs. 16-18wk McAlister et al.(117)). The results 
do seem to suggest that reduction in oxidative stress through upregulation of antioxidant 
35 
 
enzymes may contribute to elevated endothelial function, but more studies should investigate 
its role, particularly in humans.     
 
In addition to the up regulation of antioxidant defence proteins, the content of NAD(P)Hox 
subunit p67phox has been shown to be reduced following training in previously sedentary 
pigs (159). Suggesting that in addition to the upregulatation of antioxidant defences 
production of .O2
- is reduced following ET training. This observation is waiting for 
confirmation in rat and man. 
 
1.11.3 Angiogenesis  
Whether ET can reverse the negative impact of obesity on skeletal muscle angiogenesis has 
not been investigated in human obesity and only one study has investigated the effects in 
animal models of obesity. In this study Frisbee et al. (66) demonstrated that ET reversed the 
microvascular rarefaction observed in OZR. They suggested that the increase in microvessel 
density was a result of the ability of ET to increase the low NO bioavailability in the OZR at 
the start of the training. 
 
Both studies in humans and rodents have shown that ET leads to substantial increases in 
muscle capillarization in previously sedentary  groups (7). The angiogenic response of 
skeletal muscle to exercise  training is mediated by a combination of signals which include 
contractile activity, increased shear stress and metabolic activity (54). Of these stimuli, 
increased shear stress through elevated blood flow is the most studied. As with functional 
vasodilation NO is proposed to have a significant influence on the angiogenic response to 
exercise, likely through a synergistic/ complementary association with VEGF. It has been 
shown that the initial effect of elevated blood shear stress by electrical stimulation causes an 
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increase in the release of NO which is followed by an increase in capillary proliferation 
through up regulation of VEGF and VEGF receptor2 proteins (122). The exact roles of NO 
and VEGF in capillary growth are not clear, but as long term inhibition of NOS during 
electrical stimulation had no effect on the increase in the VEGF protein but still reduced 
capillary growth it is likely that NO is instrumental for VEGF to increase capillary 
proliferation.  
 
1.12 HIT a time efficient training strategy to mirror the effects of ET 
Recently various forms of high intensity interval training (HIT) have received much attention 
as alternative training strategies due to their ability to mirror or even surpass the effects of 
traditional ET (73). As a result of this interest a number of different protocols have been 
developed varying greatly in mode, intensity and time commitment of training. The main 
protocols are aerobic interval training (AIT) developed by Wisloff and colleagues (197) and 
low volume, sprint interval training (SIT) and constant load high intensity interval training 
(HIT) developed by Gibala and colleagues (107).  The typical training session using AIT 
involves 4x4 minute intervals of treadmill exercise at 90-95% heart rate max interspersed by 
rest periods of 4 minutes at 50-70% heart rate max. SIT sessions have been developed using 
the Wingate test, which involves 30s of “all out” cycling against a high resistance. The typical 
training protocol involves 4-6 repeated Wingate tests separated by 4 or 4.5 minutes of 
recovery. The SIT method of training therefore provides a very time efficient training 
stimulus as exercise is limited to 2-3 minutes per 30 min session and total time commitment is 
~90 minutes per week for 3 sessions. The SIT protocol has subsequently been translated in 
constant workload HIT protocols which involve 1 min cycling at a constant workload of 
approximately 100% of maximal workload predefined following a maximal exercise test to 
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exhaustion and lead to reductions in training intensity and total time commitment making it a 
more practical training method (116).  
 
Despite the overwhelming evidence for the beneficial effects of ET on health and prevention 
of disease many adults fail to meet guidelines for physical activity. The most commonly cited 
reason for this failure to meet physical activity guidelines is a lack of time (185).  Given that 
lack of time is such an important barrier to chronically increase physical activity levels we 
believe that exercise prescriptions which limit time commitment may be beneficial in 
increasing public health. As a result of this belief the following section will focus on studies 
investigating the effects low volume SIT and constant workload HIT rather than AIT as we 
believe these are modes of training, which have the ability to best reduce time commitment, 
and thus increase adherence and a widespread participation in the community.    
 
Much of the current information on SIT and/or HIT has focused on the metabolic adaptations. 
Burgomaster et al., (28) were the first to investigate SIT in comparison to ET and observed  
that 6 weeks SIT 3x per week produced similar improvements in aerobic exercise capacity as 
6 weeks ET (5x per week, 40-60 minutes at 65% VO2peak) (28). Subsequent studies have 
consistently shown that this increase in aerobic exercise capacity is associated with an 
increase in activity and content of mitochondrial enzymes which mirror those of ET (74). In 
addition to these changes in skeletal muscle oxidative capacity SIT has been shown to induce 
similar changes in whole body lipid oxidation (28). SIT has also been shown to have 
beneficial effects on insulin sensitivity. In previously sedentary individuals 2 weeks of SIT 
has been shown to increase insulin sensitivity (10). Further studies in type II diabetics have 
shown that an adapted HIT (10x 60s constant workload cycling at 90% maximal heart rate 
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interspersed with 60s rest, 3x per week for 2 weeks) can reduce the 24 hour blood glucose 
concentration profile (115).  
 
Despite the growing body of information for the beneficial metabolic and health related 
effects of SIT and HIT there is very little research into the vascular effects of these potentially 
important training modes. To the author’s knowledge Rakobowchuck et al. (149) is the only 
study to investigate the effect of SIT on vascular function. In this study 6 weeks of SIT (3x 
per week, 4-6 Wingate’s interspersed by 4.5 minutes recovery) produced similar changes in 
FMD and peripheral artery stiffness as ET (5x per week, 40-60 minutes at 65% VO2peak). We 
therefore believe that considerably more work is needed into the vascular effects of this 
training mode, especially given the beneficial vascular effects of AIT shown in a number of 
different groups (80, 183).      
 
1.13 Resistance training 
Resistance training (RT) has recently been added to the guidelines of the American College of 
Sports Medicine and the American Heart Association for physical activity and public health, 
because of its well-known effects on muscular strength, which help to promote and maintain 
health and independence (82). In addition to its effects on strength RT has also been shown to 
have a beneficial effect on insulin sensitivity (95, 123). The benefits of RT on insulin 
sensitivity have previously been attributed to the increase in muscle mass which accompanies 
RT (123, 175) (as skeletal muscle is the site primarily responsible for glucose uptake), but 
studies where differences in fat mass are taken into account or no differences in body 
composition are observed still produce increases in insulin sensitivity following RT (207). 
Studies have suggested that as well as changes in muscle mass, RT causes qualitative changes 
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in skeletal muscle such as increases in the content of the glucose transporter GLUT4 and 
components of the insulin signalling cascade within skeletal muscle (93, 108).    
  
1.13.1 Effects of resistance exercise on vascular function 
Although RT has been shown to have beneficial effects on skeletal muscle its effects on the 
vasculature are less known with many studies into a variety of vascular adaptations 
suggesting it has no impact or may even cause negative or harmful effects.  
 
Early theories suggested that RT may cause an elevation in resting blood pressure; however a 
number of meta-analyses of the effect of RT have now suggested that RT may be an effective 
intervention to decrease resting systolic and diastolic blood pressure (43, 101, 102). Although 
small, these reductions could have an important impact on cardiovascular complications, as 
small reductions in BP decrease stroke and coronary heart disease risk.  
 
Another RT induced adaptation which may bring negative effects on health is through its 
reported effect on arterial stiffness. A cross-sectional study has suggested that RT may elevate 
aortic stiffness (124). The potential for RT to elevate aortic stiffness is of importance as aortic 
stiffness is highly predictive of cardiovascular events (32). The potential for RT to elevate 
arterial stiffness has also been found following an RT intervention (41, 125), however not all 
studies suggest that RT increases arterial stiffness (31, 85, 147).  
 
Studies investigating endothelial dependent dilation of conduit arteries in previously 
sedentary individuals have suggested that RT has no effect of NO bioavailability as FMD of 
the brachial artery does not change (148). This finding of unchanged endothelial function in 
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previously sedentary humans is supported by the observation in previously sedentary young 
animals that ACh mediated dilation of the femoral artery was unchanged by RT (81). In this 
study RT also did not lead to a change in eNOS content and ser1177 phosphorylation of the 
femoral artery. There are no studies in humans or animals investigating the effect of RT on 
skeletal muscle microvascular function.    
 
Capillary density has been investigated following RT. Studies suggest that RT increases 
capillarization in proportion to fibre growth (76, 83, 119). Therefore although RT may 
stimulate angiogenesis (more capillaries will be needed for the larger muscle cells and total 
muscle mass) it does not have an effect on capillary density and as a result is unlikely to play 
a role in functional adaptations such as the increase in insulin sensitivity observed following 
RT.   
 
1.14 Importance of measuring skeletal muscle microvascular enzyme 
contents 
In the preceding sections a key role has become apparent for impairments in NO production 
within the microvasculature of skeletal muscle in the progression of microvascular 
dysfunction as it occurs in the sedentary state (inactivity) and obesity. It has also been 
explained that the ability of ET to improve the capacity to produce NO under basal and 
stimulated conditions may also play a key role in the improvements of the insulin and 
exercise induced microvascular vasodilatory capacity following ET. Knowledge of the 
adaptations to the enzymes that produce or quench NO, such as eNOS and NAD(P)Hox, 
would greatly add to our understanding of the mechanisms by which the sedentary state and 
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obesity lead to microvascular function loss and the mechanisms by which exercise training 
interventions restore the microvascular vasodilatory capacity.  
 
Previous estimates of these enzymes have been made with Western Blot methodology applied 
to homogenates of human and rat muscle samples.  Although Western blot methodology is 
useful, it does not reveal the relative distribution of these enzymes between muscle fibres and 
the microvasculature when applied to muscle homogenates. Western blots also do not provide 
information on whether changes in protein content in chronic disease or as a result of exercise 
training interventions are the result of changes in endothelial protein content or the result of 
changes in microvascular density.  
 
There currently is no data on the eNOS content, eNOS ser1177 phosphorylation state, and 
NAD(P)Hox protein content in the endothelial layer of terminal arterioles and capillaries as 
they occur in rat and human muscles in situ. As changes in protein content and activity of 
these enzymes determine the vasodilatory capacity of the skeletal muscle microvasculature 
and the size of the capillary permeability surface area product for insulin, glucose, other 
nutrients and oxygen, it was clear that there was a need for the development of assays to 
specifically determine the protein content and phosphorylation state of the mentioned 
endothelial enzymes in the endothelial layer of the skeletal muscle microvasculature. This 
assay will then subsequently be used in the experimental chapters of this thesis to reveal the 
mechanisms behind the blunting of insulin and exercise induced vasodilation in the skeletal 
muscle microvasculature of sedentary and obese humans and rats with metabolic syndrome 
and also to investigate the beneficial effects of exercise training interventions.  
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1.15 Overview of the thesis 
The studies in this thesis were either designed to investigate the effects of inactivity and 
obesity on skeletal muscle microvascular density and the protein content and phosphorylation 
state of microvascular endothelial enzymes that lead to NO production (eNOS) and NO 
quenching (NAD(P)Hox) or to investigate the effect of various training methods on the 
indicated variables and relate the results obtained to whole body insulin sensitivity and 
VO2max.  
 
Current methods to investigate microvascular enzymes controlling NO availability have a 
number of weaknesses which are explained in earlier subsections of chapter 1. Therefore in 
Chapter 2 we describe the development of a new method to assess the enzymes controlling 
NO production and quenching. We present evidence that this novel immunofluorescence 
microscopy method can reliably and reproducibly quantify skeletal muscle eNOS content and 
ser1177 phosphorylation and NOX2 content. In addition the ability of the technique to 
investigate physiological changes is investigated by measuring eNOS content and eNOS 
ser1177 phosphorylation following 1 h of acute endurance-type exercise.  
 
The OZR is a model of extreme obesity leading to the metabolic syndrome. Skeletal muscle 
insulin resistance in OZR is accompanied by an impaired hemodynamic response to insulin, 
which is proposed to contribute to the decreased glucose uptake observed in earlier studies 
during a hyperinsulinemic-euglycemic clamp. In chapter 3 we aimed to use the 
immunofluorescence methods developed in chapter 2 to investigate skeletal muscle 
microvascular eNOS content and eNOS ser1177 phosphorylation in response to a 
hyperinsulinemic euglycemic clamp in OZR to see if impairments in the content or 
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phosphorylation of eNOS contribute to the impaired glucose uptake. It was hypothesised that 
reduced microvascular eNOS content in the basal state and reduced eNOS phosphorylation 
during the clamp would contribute to the reduced glucose clearance seen in OZR. These 
changes are related to the time course of glucose clearance rates during hyperinsulinemic 
euglycemic clamps in the same rats from which the muscles are dissected at the end of clamp.   
 
Sprint interval training (SIT) has received much attention recently as a time efficient exercise 
strategy which appears to mirror the metabolic adaptations observed during moderate 
intensity endurance training. However, SIT’s effect on the skeletal muscle microvasculature 
has not been studied.  Therefore in chapter 4 we firstly aimed to make comparisons of the 
structural and endothelial enzymatic changes in skeletal muscle microvessels in response to 
ET and SIT in previously sedentary young males. Secondly, we aimed to investigate the effect 
of 1 h cycling on eNOS ser1177 phosphorylation both in the untrained state and after the two 
training interventions. Finally, the effects of SIT and ET on arterial stiffness and blood 
pressure were considered to investigate earlier claims of SIT’s effectiveness within the 
macrovasculature. It was hypothesised that SIT and ET would produce similar changes in 
eNOS content and microvascular density.  
 
Resistance training has recently been added to physical activity guidelines due to its effects on 
muscular strength and insulin sensitivity. It is suggested that qualitative changes within the 
skeletal muscle are responsible for the improvements in insulin sensitivity observed with RT. 
However, it is unknown whether changes in microvascular structure and/ or function play a 
role in the increased insulin sensitivity observed following RT. As such in chapter 5 we 
aimed to investigate whether RT improved microvascular structure and endothelial enzymes 
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responsible for NO bioavailability, to investigate if changes in these factors parallel 
improvements in whole body insulin sensitivity. We hypothesised that RT would not or only 
minimally increase microvascular density and eNOS content in response to 6 weeks training, 
suggesting that these factors are not the primary drivers for the expected elevations in insulin 
sensitivity observed following 6 weeks of RT in young previously sedentary males. 
 
In chapter 4 it was shown that SIT was an effective method of improving microvascular 
density and eNOS content in lean sedentary participants. In the final chapter (Chapter 6) we 
conducted a pilot study to investigate the effects of a new more practical, time efficient 
constant workload SIT strategy. We investigated its effect on microvascular density and 
enzymes controlling NO production and quenching, and whether these changes translated into 
improved aerobic capacity, insulin sensitivity, and cardiovascular risk profile, in a young 
healthy obese previously sedentary group.  We hypothesised that microvascular density and 
eNOS content would be increased in response to 4 weeks constant workload SIT, and that 
increases in NOX2 content in the basal state resulting from obesity would be reduced 
following training. Finally we hypothesised that the improvements in microvascular structure 
and enzymes would mirror improvements in aerobic capacity, insulin sensitivity and 
cardiovascular risk profile. 
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2.1 Abstract  
The net production of nitric oxide (NO) by the muscle microvascular endothelium is a key 
regulator of muscle microvascular blood flow. Here we describe the development of a method 
to quantify the protein content and phosphorylation of endothelial NO synthase (eNOS 
content and eNOS ser1177 phosphorylation) and NAD(P)H oxidase expression. Human muscle 
cryosections were stained using antibodies targeting eNOS, p-eNOS ser1177 and NOX2 in 
combination with markers of the endothelium and the sarcolemma. Quantitation was achieved 
by analysing fluorescence intensity within the area stained positive for the microvascular 
endothelium. Analysis was performed in duplicate and repeated 5 times to investigate 
coefficient of variation (CV). In addition, 8 healthy males (age 21±1years, BMI 
24.4±1.0kg.m-2) completed 1 hour of cycling exercise at ~65% VO2max. Muscle biopsies were 
taken from the m. vastus lateralis before and immediately after exercise and analysed using 
the new methods. The CV of all methods was between 6.5 and 9.5%. Acute exercise increased 
eNOS serine1177 phosphorylation (Fold change 1.29±0.05, P <0.05). These novel 
methodologies will allow direct investigations of the molecular mechanisms underpinning the 
microvascular responses to insulin and exercise, the impairments that occur in sedentary, 
obese and elderly individuals and the effect of lifestyle interventions.  
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2.2 Introduction 
It is well established that exercise (8) and insulin (20) cause vasodilatation of feed arteries and 
arterioles and that both events contribute to increases in skeletal muscle blood flow and 
microvascular blood volume (31, 32). This microvascular response allows for exquisite 
control of blood flow distribution, and the delivery of oxygen and nutrients. Indeed, an early 
increase in microvascular volume in response to rises in insulin concentrations has been 
shown to play an important role in insulin mediated glucose uptake (1, 25, 30), while 
microvascular blood volume has been suggested to increase during low intensity exercise in 
the absence of changes in bulk blood flow (32). 
 
As with feeding arteries, indirect evidence using NOS inhibitors suggests that the elevation in 
microvascular volume observed in response to insulin is NO-dependent (30, 31), and the 
response to exercise is at least part NO-dependent (14). As a result, impairments in 
microvascular volume in response to insulin or exercise observed in sedentary, obese and 
elderly individuals have been attributed at least in part to reductions in NO bioavailability (1, 
2, 13, 25, 28, 33). Furthermore, an experimental reduction in microvascular NO 
bioavailability following NOS inhibition prevents exercise-induced angiogenesis in rats (23) 
and, therefore, reductions in NO bioavailability have been suggested as a potential cause of 
capillary rarefaction in ageing and obesity (11, 22).  Finally, impairments in NO-dependent 
muscle microvascular function have also been suggested to precede macrovascular 
impairments. Given the importance of microvascular NO availability in the regulation of 
nutrient delivery and angiogenesis, and its importance as a target for therapeutic interventions 
(6, 18), the mechanisms regulating NO availability and microvascular perfusion are of great 
scientific and clinical importance. 
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NO bioavailability is determined by the balance between NO production and NO quenching 
by reactive oxygen species. As such reductions in both endothelial NO production (29) and/or 
increased NO quenching by reactive oxygen species (21) could explain reductions in NO 
bioavailability observed in aging, obesity and other pathologies (22, 26, 33). Current 
knowledge of the enzymes that determine endothelial NO bioavailability is primarily based on 
measurements of mRNA expression and protein content in isolated (larger) blood vessels 
from animal models (12, 17, 24).  These studies have shown that the protein content and 
phosphorylation state of eNOS collectively determine NO production. Furthermore, the 
enzyme NAD(P)Hoxidase (NAD(P)Hox) has been suggested to be the major source of 
superoxide (O2
-) anion production in obesity (27) and hypertension (5). The superoxide 
anions thus generated are responsible for reductions of NO bioavailability via quenching of 
NO in a reaction that produces peroxynitrite. Studies measuring the protein content of these 
enzymes in human skeletal muscle have previously used Western blots or sandwich enzyme 
immunoassay techniques applied to extracts of whole muscle homogenates (15, 16). 
Importantly, these methodologies are not able to assess the protein content or phosphorylation 
state of eNOS in endothelial cells without potential contributions from the muscle fibres, nor 
can they provide information on changes in microvascular density.  
 
In this study we therefore aimed to adapt immunofluorescence microscopy techniques 
previously applied to investigate endothelial protein expression in isolated blood vessels or 
isolated endothelial cells (4, 7, 9) for use on cryosections of percutaneous human muscle 
biopsies. These methods will allow measurement of the content of eNOS and 
NAD(P)Hoxidase and eNOS ser1177 phosphorylation state (main activation site; (24)) in the 
endothelial layer of the microvasculature of human skeletal muscle. We also applied this 
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method to muscle biopsies obtained before and after 1 hour of dynamic cycling exercise to 
investigate the hypothesis that exercise in man leads to eNOS ser1177 phosphorylation in the 
muscle microvascular endothelium as previously observed in mouse arteries (34). 
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2.3 Materials and Methods 
Muscle samples 
Skeletal muscle samples used for the development of the immunofluorescence microscopy 
methods were obtained from the m. vastus lateralis of one human volunteer (age, 20 years; 
body mass index (BMI) 25 kg.m-2), using the percutaneous needle biopsy technique (3). 
Samples were blotted to remove excess blood and dissected free of fat and collagen. The 
samples were then embedded in Tissue-Tek OCT compound and frozen in liquid nitrogen 
cooled isopentane. Sample preparation and embedding for immunofluorescence took ~1-2min 
before samples were frozen in isopentane. Espina et al. (10) has previously shown eNOS 
ser1177 phosphorylation to be relatively stable after tissue procurement, as a result we believe 
this freezing time is adequate to avoid significant changes in eNOS ser1177 phosphorylation. 
Samples were stored at -80oC until analysis.  
 
Skeletal muscle samples used to check the specificity and selectivity of the antibodies using 
blocking peptides and Western blotting were originally obtained from this one individual. 
However, as no band was observed on Western blots for each of the tested antibodies, we 
subsequently used a sample from the m. vastus medialis of a female obese type II diabetic 
individual (Age 60 years; body mass index 48.39 kg.m-2) undergoing total knee arthroplasty 
to successfully visualise the NOX2 protein band. The specificity of eNOS and phosphorylated 
eNOS ser1177 (p-eNOS ser1177) antibodies was tested in samples obtained from one male 
Wistar rat (Charles River, Kent, UK). The animal was housed on a controlled 12 hour light-
dark cycle and fed standard rat chow and water ad libitum. The animal was killed by 
anaesthetic overdose (Alfaxalone 10 mg.ml-1 dissolved in cyclodextrin; Vétoquinol UK 
limited, Bucks, UK) diluted 1:2 with 0.9% saline and cervical dislocation. The m. tibialis 
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anterior was then dissected free and frozen in liquid nitrogen and stored at -80oC until further 
analysis. 
 
To investigate whether endurance exercise activates muscle microvasular eNOS, 8 sedentary 
healthy males (age 21±1 years, BMI 24.4±1.0 kg.m-2, VO2max 39.6 ±3.9 ml.kg.min
-1) 
completed 1 hour of cycling exercise at ~65% VO2max . Before and immediately after exercise 
muscle biopsies were taken from the m. vastus lateralis as described above and eNOS content 
and p-eNOS ser1177 were assessed within the microvasculature.  
 
Sample collection for the study was approved by the Black Country NHS Research Ethics 
Committee and the Coventry NHS Research Ethics Committee. Experiments on animals were 
performed in accordance with the UK animal (Scientific Procedures) Act 1986,  
 
Antibodies and chemicals 
Polyclonal antibody against NOX2 (a subunit of the NAD(P)Hox complex) was from Santa 
Cruz Biotechnology (Santa Cruz, CA) (gp91-phox/NOX2 (C-15), cat No. sc-5827); 
polyclonal antibody against p-eNOS ser1177 was from Cell Signalling Technology (Beverly, 
MA) (p-eNOS ser1177, cat No. 9570L); monoclonal antibody to eNOS was from Transduction 
Laboratories (Lexington, KY, cat No. 610297). Secondary antibodies were donkey anti-goat 
IgG1 594 (NOX2), goat anti-mouse IgG1 594 (eNOS) and goat anti-rabbit IgG1 594 (p-eNOS 
ser1177) (Invitrogen, Paisley, UK). Ulex Europaeus-FITC conjugate (UEA-I-FITC; Sigma-
Aldrich, UK) was used to identify the microvascular endothelium and wheat germ agglutinin-
350 (WGA-350; Invitrogen, UK) was used to identify the plasma membrane. Phosphate 
buffered saline (PBS, 137 mM sodium chloride, 3 mM potassium chloride, 8 mM disodium 
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hydrogen phosphate and 3 mM potassium dihydrogen phosphate, pH of 7.4.) was used for the 
dilution of all antibodies, reagents and washing steps. 
 
Immunofluorescence staining  
Serial 5μm cryosections were cut and collected onto room temperature uncoated glass slides.  
Sections were left to air dry at room temperature for 1 hour before treatment. Cross–sections 
were used for all immunofluorescence staining protocols.  All subsequent 
immunofluorescence analysis was performed in duplicate (mean of 2 sections on one slide). 
Reproducibility data for eNOS, p-eNOS ser1177 and NOX2 (5 duplicate measures) was 
obtained.  
 
Sections were fixed in acetone and ethanol (3:1) at room temperature for 5 minutes. Samples 
were then incubated overnight with primary antibodies against either eNOS or p-eNOS ser1177 
or NOX2 at 4oC. Samples were further incubated for 30 minutes in appropriately labelled 
fluorescent conjugated secondary antibodies and UEA-I-FITC, which was used as an 
endothelial marker in all subsequent analyses. The cell membrane stain WGA-350 was then 
applied for 15 minutes. Following incubation, coverslips were mounted in a glycerol and 
mowiol 4-88 solution in 0.2 M Tris buffer (pH 8.5) with addition of 0.1% 1,4-diazobicyclo-
[2,2,2]-octane (DABCO) anti-fade medium. Images were captured using a Nikon E600 
Microscope with a 170W Xenon light source, coupled to a SPOT RT KE colour three shot 
camera (Diagnostic Instrument Inc., MI, USA). Images were taken at a magnification of 40x 
and a numerical aperture of 0.75. In order to capture the Alexa Fluor 594 fluorophore a Texas 
red (540-580 nm) excitation filter was used. UEA-I-FITC and WGA-350 were visualised 
using the FITC (465-495 nm) and DAPI UV (340-380 nm) excitation filters. Images were 
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captured using a semi automated filter wheel and controller. Camera settings (exposure time 
and gain) were adjusted to ensure that no pixel saturation of the fluorescent signal was present 
in either channel and identical camera settings were used throughout the image capture 
process. 
 
Image analysis 
Quantification of eNOS, p-eNOS ser1177 and NOX2 within the microvascular endothelium 
was achieved by analysing the fluorescence intensity of the signal within the area 
corresponding to the positive UEA-I-FITC staining. NOX2 fluorescence intensity was also 
quantified within the cell membrane using the area stained positive for the cell membrane 
using the corresponding WGA-350 image.  
 
All image analyses were performed using Image-Pro Plus 5.1 software (Fig. 2.1.). Firstly, 
thresholding was used to create a mask of the area stained positive for the endothelium (UEA-
I-FITC) or cell membrane (WGA-350) using routine parameter settings. Threshold levels 
were selected manually to optimise extraction of the positive signal from the background and 
then used for all images in one comparison or variation estimate. The endothelial/cell 
membrane outline was overlaid onto the corresponding eNOS, p-eNOS ser1177 or NOX2 
image and fluorescence intensity of the eNOS, p-eNOS ser1177 or NOX2 staining was 
quantified within the endothelium or cell membrane specific area. Quantification of eNOS, p-
eNOS ser1177 and NOX2 was performed on raw images, which were unaltered throughout the 
analysis. Mean fluorescent intensity of the signal within the outline was reported from 5 
images per section resulting in ~181 vessels analysed from ~50 muscle fibres. 
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Figure 2.1. Image analysis for quantitative immunofluorescence.  
Fluorescence microscopy images were captured and processed using image Pro Plus 5.1. 
Following image capture, (A) an outline of the endothelial image was created using the 
selection of a standardised signal intensity threshold tool (B). The endothelial outline was 
then transferred to the corresponding eNOS, p-eNOS ser1177 or NOX2 image (D). The staining 
intensity of the eNOS, p-eNOS ser1177 or NOX2 image was then quantified within the 
endothelial outline. The same technique was used to quantify NOX2 staining intensity within 
the cell membrane using the WGA-350 image, representing the cell membrane (bar = 5μm)   
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Antibody specificity  
Blocking peptides of the respective antibodies were used to generate evidence that the 
antibodies used in this study in the immunofluorescence microscopy assays were selective 
and specific. The antibody against p-eNOS ser1177 was incubated overnight at 4oC with gentle 
agitation in the presence or absence of a ten-fold excess of p-eNOS ser1177 blocking peptide 
(Cell Signalling technology, cat No. 1827S). The antibody against NOX2 underwent the same 
treatment in the presence or absence of a 20-fold excess of gp91-phox (C-15) blocking 
peptide (Santa Cruz Biotechnology, cat No. sc-5827 P). The eNOS antibody (BD biosciences) 
was incubated overnight at 4oC with gentle agitation with a 20-fold excess of purified human 
eNOS recombinant protein (OriGene, Rockville, US, cat, No TP309228) as there is no 
specific blocking peptide for the latter. Following the overnight preincubation of these 
antibodies with their blocking peptides or in latter case intact human protein, the blocked 
antibody mixtures were used for immunofluorescence staining of muscle cross-sections as 
discussed above. 
     
Selectivity and specificity of the used antibodies was further investigated by checking 
whether Western blots revealed a single protein band at the expected molecular weight. 
Western blotting was performed using tissue from the m. tibialis anterior of a male Wistar rat 
(eNOS and p-eNOS ser1177) or  m. vastus medialis of a female obese type II diabetic 
individual (NOX2). Freeze dried muscle was added to homogenisation buffer containing 
20mM Tris-HCL (pH7.5), 150mM NACL, 1mM Na2EDTA, 1mM EGTA, protease inhibitor 
cocktail and phosphatase inhibitor cocktail (Roche Molecular Biochemicals). Samples were 
homogenised on ice and subsequently sonicated before being centrifuged at 10 000g for 20 
min. The supernatant was collected and the protein content was determined (Pierce BCA 
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protein Assay Reagent). Cell lysates (100μg total protein for the detection of the eNOS and p-
eNOS ser1177 band; 60μg for the NOX2 band) were separated by SDS-PAGE and transferred 
to a nitrocellulose membrane. Membranes were incubated with primary antibody against 
eNOS (1:1000), p-eNOS ser1177 (1:1000) and NOX2 (1:1000). Membranes were then exposed 
to appropriate horseradish peroxidise-conjugated secondary antibodies (Anti Mouse IgG, Anti 
rabbit IgG and Anti Goat IgG) for 1h at room temperature, diluted (1:2000). Bands were 
detected by enhanced chemiluminescence method (Amersham EC PlusTM western blotting 
detection reagents; GE Healthcare).      
 
Antibody selectivity and specificity for eNOS (Transduction Laboratories) and NOX2 (Santa 
Cruz Biotechnology) were also checked using Basic Local Alignment Search tool (BLAST) 
analysis, run using UniProt.org software. Percentage alignment of the antibody sequence with 
the protein of interested is reported.    
 
eNOS and p-NOS ser1177 in pre- and post-exercise biopsies 
The fluorescence signal was calculated from the mean of 2 pre- and 2 post-exercise sections 
of the same individual mounted on 1 slide. Each comparison was performed in duplicate. The 
reader was not blinded to condition as image analysis was automated removing the potential 
effects of investigator bias. Both eNOS content and p-eNOS ser1177 are presented as raw 
values and normalised to pre-training value and expressed as arbitrary units. In addition p-
eNOS ser1177 is presented normalised to eNOS content to eliminate the potential confounding 
effects of differences in eNOS content pre and post exercise and as a ratio of p-eNOS ser1177 
to eNOS content using the raw fluorescence intensity data (p-eNOS ser1177/eNOS).   
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Statistics 
Image analysis was performed in duplicate (mean of 2 sections on 1 slide). The 
reproducibility of duplicate measures for protein content of eNOS and NOX2 and eNOS 
ser1177 phosphorylation were assessed by the range, mean percentage difference and 
coefficient of variation (CV) between duplicates. eNOS content and p-eNOS ser1177 were 
analysed using a paired t-test performed using statistical analysis software (SPSS for windows 
version 16.0 (SPSS, Chicago, IL)). Significance was set at P ≤ 0.05. Data is presented as 
means ± S.E.M. 
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2.4 Results 
Localisation of staining 
 eNOS and p-eNOS ser1177 immunofluorescence was observed in the area stained by UEA-I-
FITC, and p-eNOS ser1177 fluorescence was present at a lower intensity in the plasma 
membrane region of the muscle fibre. This demonstrates that these proteins are highly 
expressed in the microvascular endothelium (Fig. 2.2a, b.). NOX2 antibody 
immunofluorescence was observed in the areas stained by the sarcolemmal marker WGA-350 
and endothelial marker UEA-I-FITC, indicating that NOX2 is present at both locations (Fig. 
2.2c.). 
 
Antibody specificity  
Antigen specificity and selectivity of each of the used antibodies was confirmed by the 
absence of positive immunofluorescence staining when antibodies first had undergone an 
overnight preincubation with specific blocking peptides (p-eNOS ser1177 and NOX2) or the 
purified recombinant human protein (eNOS) (Fig. 2.3c, d, e.). Antigen specificity of the 
eNOS and p-eNOS ser1177 antibodies was also confirmed by the presence of a single band at 
the expected MW of approximately 140 kDa on the Western blot (Fig. 2.3a.), using tissue 
from m. tibialis anterior of a male Wistar rat. Antigen specificity of the NOX2 antibody was 
confirmed by the presence of a single band on the Western blot that migrated between 
approximately 50-60 kDa (Fig. 2.3b.), presumably representing unglycosylated NOX2 as 
previously reported (19), using tissue from the m. vastus medialis of a female obese type II 
diabetic.  
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Figure 2.2. Detection of vascular enzymes within skeletal muscle microvasculature using 
immunofluorescence. 
A, Fluorescence detection of eNOS in skeletal muscle microvascular endothelium (bars = 
50µm). Immunostaining of eNOS (red) is combined with the vascular endothelial stain UEA-
I-FITC lectin (green). Merged image shows that eNOS and UEA-I-FITC colocalise (yellow). 
B, Fluorescence detection of p-eNOS ser1177 in skeletal muscle microvascular endothelium 
(bars = 50µm). Immunostaining of p-eNOS ser1177 (red)   is combined with the vascular 
endothelial stain UEA-I-FITC (green). Merged image shows that p-eNOS ser1177 colocalises 
with UEA-I-FITC (yellow). C, Fluorescence detection of NOX2 in the plasma membrane and 
microvascular endothelium of skeletal muscle (bars = 50µm). Immunostaining of NOX2 was 
combined with staining of the vascular endothelium and cell membrane with UEA-I-FITC 
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(green) and WGA-350 (blue), respectively. Merged image shows that NOX2 staining 
colocalises with the endothelial stain and the skeletal muscle plasma membrane.  
 
 
 
Figure 2.3. Specificity of antibodies used for immunofluorescence analysis using western 
blotting and blocking peptides.  
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A, eNOS and p-eNOS ser1177 was detected in rat m. tibialis anterior muscle at the expected 
molecular weight of 140 kDa. B, NOX2 was detected in human m. vastus medialis muscle at 
the expected molecular weight between 50 and 60 kDa. C, immunofluorescence detection of 
eNOS (red) in human skeletal muscle after preincubation of the eNOS antibody in the 
presence or absence of purified eNOS recombinant protein as a blocking protein. The vascular 
endothelium is stained with UEA-I-FITC (green). D, immunofluorescence detection of p-
eNOS ser1177 (red) in human skeletal muscle after preincubation of the p-eNOS ser1177 
antibody in the presence or absence of a specific blocking peptide. The vascular endothelium 
is stained with UEA-I-FITC (green). E, immunofluorescence detection of NOX2 (red) in 
human skeletal muscle after preincubation of the NOX2 antibody in the presence or absence 
of a specific blocking peptide. The cell membrane is stained with WGA-350 (blue). Bars = 
50µm. 
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Results of BLAST analysis revealed that eNOS and NOX2 antibodies shared 100% sequence 
alignment with human eNOS and NOX2 respectively. NOX2 and eNOS antibodies also 
shared 98% and 90% sequence alignment with rat NOX2 and eNOS proteins respectively.  p-
eNOS ser1177 has been reported to share 100% sequence alignment with both human and rat 
eNOS phosphorylated at ser1177 (sequence alignment information from Cell Signalling 
Technology, Inc.).  
 
Reproducibility of quantitative immunofluorescence  
Immunofluorescence analysis of protein expression and phosphorylation was performed in 
duplicate. Reproducibility data for eNOS, p-eNOS ser1177 and NOX2 (5 duplicate measures) 
is displayed in Table 2.1. The CV for eNOS, p-eNOS ser1177 and NOX2 within the 
endothelium were 7%, 7% and 9.5%, respectively. The CV of NOX2 within the cell 
membrane was 6.5%. 
 
eNOS following exercise 
Total eNOS content within the microvasculature was unaffected by exercise (fluorescence 
intensity pre exercise 57±5 AU vs. post exercise 58±5 AU P=0.708; fold change from rest 
1.01±0.02, P=0.628). eNOS ser1177 phosphorylation increased 29% within the microvascular 
endothelium following exercise (fluorescence intensity, pre exercise 50±6 AU vs. post 
exercise 67±9 AU  P <0.05; Fold change from rest 1.29±0.05, P <0.05, Fig. 2.4.). When 
eNOS phosphorylation was presented as a ratio of p-eNOS ser1177 to eNOS content eNOS 
ser1177 phosphorylation was increased by 26% following acute exercise (P <0.05, Fig. 2.4.). 
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Table 2.1. Reproducibility of protein content and eNOS phoshorylation state using 
immunofluorescence analysis 
Variable No. of Duplicate 
measurements 
Range between 
duplicates (AU) 
Mean 
Difference, % 
Coefficient of 
variation, % 
eNOS 6 56- 66 8 7 
p-eNOS ser1177 5 48-56 9 7 
Endothelial NOX2 6 24-31 10 9.5 
Cell Membrane 
NOX2 
6 15-17 7 6.5 
 
Range between duplicates measured in arbitrary unit (AU), mean percentage difference in 
signal intensity between duplicates and the coefficient of variation of signal intensity between 
duplicates are given; eNOS, endothelial nitric oxide synthase; p-eNOS ser1177, endothelial 
nitric oxide synthase phosphorylated on serine1177; NOX2, NAD(P)H oxidase subunit NOX2.  
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Figure 2.4. Evaluation of eNOS serine1177 phosphorylation (p-eNOS ser1177) pre and 
immediately post exercise in man. 
A, representative immunofluorescence images of p-eNOS ser1177 pre- and immediately post-
exercise. Immunostaining of p-eNOS ser1177 (red) with the vascular endothelial stain UEA-I-
FITC (green). B, mean p-eNOS ser1177 within the skeletal muscle microvasculature 
significantly increases immediately post exercise. C, Mean p-eNOS ser1177 normalised to 
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eNOS protein content within the skeletal muscle microvasculature significantly increases 
immediately post exercise. * Significant difference between pre and immediately post 
exercise (P <0.05). Values are means ± S.E.M (bars = 50µm). 
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2.5 Discussion 
This study describes a novel application of immunofluorescence microscopy to quantify the 
protein content and phosphorylation state of enzymes within the endothelium of human 
skeletal muscle microvasculature, which play a crucial role in production of NO (eNOS) and 
quenching of NO via superoxide anion production (NADPHox). The overall CV between 
duplicate measurements was <9.5% for all variables demonstrating that the technique is 
reproducible and the 1.29-fold increase in eNOS phosphorylation following exercise indicates 
that the technique can reliably detect changes in eNOS phosphorylation in response to 
physiological perturbation.  
 
Measurements of vascular NOX2, eNOS and p-eNOS ser1177 have previously been made with 
Western blot methodology applied to aorta, arteries or resistance arterioles, primarily from 
animal models (12, 17). This has led to the current understanding of the mechanisms behind 
adaptations to pathologies and exercise training. However it is becoming increasingly 
apparent that the vasodilatory responsiveness of terminal arterioles and microvascular density 
in skeletal muscle is the major determinant of the supply of fuels and oxygen to the skeletal 
muscle fibres both at rest and during exercise (1, 11). In the present study, we first confirmed 
the presence of eNOS and p-eNOSser1177 in the muscle microvascular endothelium and 
NOX2 in the muscle microvascular endothelium and plasma membrane through the 
colocalisation of the enzyme with endothelial and plasma membrane markers. We then 
quantified the fluorescence intensity of each protein within the relevant locations as a measure 
of the protein content of each enzyme. The quantification method showed a good 
reproducibility as demonstrated by the CV which is lower than 10% for all analyses. This 
compares favourably with previous immunofluorescence approaches to quantify endothelial 
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enzyme expression in isolated endothelial cells (7). In addition the antibodies used in the 
development of the new assays were thoroughly tested for selectivity and specificity 
providing convincing evidence of this. However, we acknowledge that that the most reliable 
method to assess antibody specificity would have been to perform measures in muscle from 
knockout animals, but tissue from such animals was not available.    
 
Methods previously used to measure the protein content of vascular enzymes within skeletal 
muscle using whole muscle homogenates (Western blotting and sandwich enzyme 
immunoassays) do not reveal the relative distribution of these enzymes between muscle fibres 
and the microvasculature. These methods also do not provide information on whether changes 
in protein expression in chronic disease or in response to exercise training are the result of 
changes in endothelial protein content or of changes in microvascular density. The novel 
methodology described here, enables the expression and phosphorylation status of proteins to 
be analysed specifically within the endothelium of human skeletal muscle without 
confounding issues of variations in capillary density.  
 
The ability of the method to generate novel information is demonstrated by the significant 
increase in endothelial eNOS ser1177 phosphorylation observed following 1 hour of cycling 
exercise, whereas no change in total eNOS content was detected. Previous studies have 
demonstrated eNOS phosphorylation in the aorta of rats following exercise (34), but this is 
the first time that increased eNOS phosphorylation has been observed in the microvasculature 
of either animal or human skeletal muscle. Elevated NO bioavailability during exercise has 
been suggested to play a role in microvascular exercise hyperaemia (14), although the full 
extent of its involvement is difficult to speculate on due to the observed redundancy of NO 
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seen in physiological systems  (8). As such, the elevation in eNOS ser1177 phosphorylation 
observed in this study supports this suggestion with the underlying molecular mechanism. 
Furthermore, NO is also an important signalling mechanism for angiogenesis (23), and 
therefore, the increase in eNOS ser1177 phosphorylation within the microvasculature during 
exercise is likely to contribute to the angiogenic effect of endurance training.  
 
We acknowledge that the analysis of protein content and enzyme phosphorylation status using 
immunofluorescence microscopy is semi-quantitative in nature, and only allows relative 
differences between two or more conditions to be assessed simultaneously. However, Western 
blots are also semi-quantitative and the CV of the novel method in our hands is comparable to 
those of Western blots. Therefore, this analytical approach has the potential to substantially 
improve our understanding of the role played by these microvascular endothelial enzymes in 
the mechanisms by which physiological stimuli increase eNOS phosphorylation and lead to 
insulin resistance and sarcopenia in chronic age and lifestyle related metabolic diseases. 
Furthermore, the novel methods could also be used to determine whether the well-known 
improvements in insulin sensitivity, glucose homeostasis and the reduction in sarcopenia that 
results from endurance and resistance training, is mediated at least in part by mechanisms that 
operate at the level of the microvascular endothelium in skeletal muscle (1, 25, 33).  
 
Perspective 
The novel immunofluorescence microscopy approach described in this study allows for 
reproducible measurements of the protein content and activation of microvascular enzymes, 
independent of changes in muscle fibre enzyme content and microvascular density. This 
method has the potential to generate novel insight into the molecular mechanisms determining 
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microvascular function and its role in the pathophysiology resulting from physical inactivity, 
obesity and ageing. The method can also be used to investigate the effect of lifestyle (diet and 
exercise) and pharmacological interventions aiming to improve microvascular endothelial 
function and metabolic health.  
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Chapter 3 
 
Impaired Insulin-Mediated ser1176 Phosphorylation of 
Endothelial Nitric Oxide Synthase in Skeletal Muscle 
Arterioles of Obese Zucker Rats 
 
 
 
 
 
 
 
 
 
 
 
 
105 
 
3.1 Abstract  
Early studies in rat and man observed that insulin mediated NO-dependent increases in 
skeletal muscle microvascular volume precede increases in muscle glucose uptake and, 
therefore, hypothesised that insulin induced dilation of terminal arterioles leading to increased 
recruitment of capillaries is an important step in the control of skeletal muscle glucose uptake. 
Impairments in this mechanism have subsequently been seen in humans with obesity and type 
2 diabetes and in obese Zucker rats (OZR), an animal model of the metabolic syndrome. In 
cultured endothelial cells insulin has been shown to activate endothelial nitric oxide synthase 
(eNOS) via insulin mediated serine phosphorylation. The aim of this study was to investigate 
the hypothesis that an impairment in eNOS ser1176 phosphorylation is instrumental to skeletal 
muscle insulin resistance in OZR. The m. tibialis anterior was dissected from 20 week old 
lean Zucker rats (LZR) and OZR in the fasted state (n=7) and 2 h after the start of a 
hyperinsulinaemic-euglycemic clamp (n=7).  eNOS content and ser1176 phosphorylation were 
measured in the endothelial layer of skeletal muscle terminal arterioles and capillaries using 
quantitative immunofluorescence microscopy. Total eNOS content and eNOS ser1176 
phosphorylation in the fasted state was not significantly different between LZR and OZR both 
in terminal arterioles and capillaries. Insulin stimulation significantly elevated terminal 
arteriole eNOS ser1176 phosphorylation in LZR (14%; P <0.05), while causing a significant 
reduction in OZR (-28%; P <0.05). Insulin did not significantly change capillary eNOS ser1176 
phosphorylation in LZR (-7%), while reducing this variable in OZR (-31%, P <0.05). 
Capillary density and number of capillaries per muscle fibre were also significantly lower in 
OZR compared to LZR (P <0.05).  The impairments in OZR coincided with a reduced 
glucose infusion rate area under the curve during the first 21 min of the hyperinsulinemic-
euglycemic clamp and a reduced insulin sensitivity index (both P<0.05). We conclude that 
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insulin-induced eNOS ser1176 phosphorylation is impaired in skeletal muscle arterioles of 
OZR, confirming the hypothesis that this molecular event is instrumental to skeletal muscle 
insulin resistance. 
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3.2 Introduction 
The metabolic syndrome, defined as the combined presence of obesity, insulin resistance, 
hypertension and dyslipidemia affects 23.7% of American adults (31).  The obese Zucker rat 
(OZR) experiences chronic hyperphagia due to a recessive mutation in the leptin gene (22). 
As a result it develops features similar  to those observed in the human metabolic syndrome 
(12), and the OZR is therefore generally regarded as an animal model of the metabolic 
syndrome. 
 
Wallis and colleagues  (37) using hyperinsulinemic clamp conditions have previously 
observed that skeletal muscle insulin resistance in OZR is accompanied by an impaired 
hemodynamic response to insulin. This impaired hemodynamic response includes both a 
blunted increase in insulin stimulated femoral artery blood flow and recruitment of the 
skeletal muscle microvasculature (37). The latter was measured as a reduction in the 
extraction of 1-methylxanthine over the hindleg during the hyperinsulinemic clamp in the 
OZR, while the expected increase was seen in LZR. Impairments in the insulin stimulated 
recruitment of the skeletal muscle microvasculature (37) together with capillary rarefaction 
(11) have been suggested to be responsible for the large reduction in skeletal muscle glucose 
uptake observed in OZR (37) and in humans with obesity (6) and type 2 diabetes during 
hyperinsulinemic-euglycemic clamps (15). Both events contribute to a reduction in the 
capillary permeability surface area (PSA) available for delivery of insulin and glucose to the 
skeletal muscle fibres (4, 15, 16). Gudbjörnsdóttir et al (16) have shown that the capillary 
PSA is a major determinant for the increases in muscle glucose uptake that occur in man 90-
120 min after the start of an OGTT and of a hyperinsulinemic-euglycemic clamp using low 
physiological concentrations of insulin.  
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Insulin induced NO-dependent vasodilatation of the skeletal muscle microvasculature occurs 
in rat muscle as early as 5-10 min after the start of a hyperinsulinemic-euglycemic clamp (33) 
and the vasodilation subsequently remains for 120 min (34, 36). Studies with cultured 
endothelial cells have shown that insulin acutely increases the synthesis rate of NO through 
activation of endothelial nitric oxide synthase (eNOS) by means of serine phosphorylation. 
Ser1176 is the main activation site in rats and ser1177 in humans (23, 30).  Pre-treatment of rats 
with the NOS inhibitor L-NAME blocked the early microvascular recruitment in response to 
insulin infusion and partially inhibited the early increases in muscle glucose uptake (35). 
Therefore, reductions in eNOS content and/or reduced insulin induced eNOS 
phosphorylation, could be part of the mechanisms behind a reduced NO production and 
impairments in muscle microvascular vasodilatation and glucose uptake in OZR. Studies in 
isolated skeletal muscle resistance vessels of OZR have shown a decreased eNOS content (9), 
while the eNOS content of a whole muscle homogenate did not change and eNOS ser1176 
phosphorylation was surprisingly elevated in OZR in the basal fasted state in comparison to 
LZR (13). However eNOS content or ser11776 phosphorylation in response to insulin has never 
been measured locally in the terminal arterioles of skeletal muscle, which is assumed by many 
to be the main insulin-induced vasodilator site, and thus, responsible for insulin induced 
increases in capillary permeability surface area and muscle microvascular blood volume (1, 2, 
14, 28, 29, 34-36).  
 
Therefore, the aim of the current study was to measure eNOS content and eNOS ser1176 
phosphorylation in the fasted state and in response to insulin infusion in skeletal muscle 
terminal arterioles and capillaries of LZR and OZR, to investigate the hypothesis that the 
impaired glucose disposal in OZR during a hyperinsulinemic-euglycemic clamp is the result 
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of a failure of insulin to activate eNOS by ser1176 phosphorylation thus reducing capillary 
recruitment and muscle glucose uptake. This hypothesis will be investigated by measuring 
eNOS content and ser1176 phosphorylation in arterioles and capillaries in the m. tibialis 
anterior dissected from LZR and OZR before and 2 h after the start of a hyperinsulinemic-
euglycemic clamp, while making continuous measurements of whole body glucose clearance 
and in the last 20 min an estimate of whole body insulin sensitivity. As insulin induced 
vasodilatation of the muscle microvasculature has been shown to occur as early as 5-10 min 
(32, 33), comparisons of whole body glucose clearance rates between LZR and OZR will 
focus on the early response (within the first 30 minutes) with the a priori hypothesis being that 
glucose infusion rate (GIR) will be substantially reduced in OZR. 
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 3.3 Materials and Methods  
Animals 
The rat experiments were performed in the research laboratories of Astra Zeneca in Alderley 
Park (Cheshire, UK). Male 20 week old lean (Fa/?) and obese (fa/fa) Zucker rats (purchased 
from Charles River, France) were housed on a controlled 12 hour light-dark cycle and fed 
standard rat chow and water ad libitum. All experiments were performed in accordance with 
the UK animal (Scientific Procedures) Act 1986. 
 
Experimental protocol 
Rats were randomly assigned to the fasted group or insulin stimulated group (n=7 per group). 
The day before the experimental trial animals received a fixed ration of 16 or 10g (OZR and 
LZR, respectively) of rat chow at 16:00h, with the intention of ensuring animals were non-
absorptive but not starved during the experimental protocol.  Rats in the insulin stimulated 
condition underwent a hyperinsulinaemic-euglycemic clamp. Rats were anesthetised (160-190 
mg.kg-1 Inactin I.P) and surgically prepared by placing catheters and probes for subsequent 
arterial and venous sampling and intravenous infusion and assessment of femoral artery blood 
flow and blood pressure. Following surgical procedures a 60 min recovery period was 
allowed, followed by a 120 min hyperinsulinaemic-euglycemic clamp. LZR were given 10 
mU·min-1·kg -1 of insulin while OZR received 20 mU·min -1·kg -1 of insulin. The difference in 
infusion rate was chosen to achieve proportional increases in plasma insulin levels in a range 
that is normally seen by the LZR and OZR. Also for this reason euglycemia was maintained 
at 4 mM in the LZR and at 6 mM in the OZR via frequent on line measurements of the blood 
glucose concentration with an automated glucose analyser and small adjustments of the 
glucose infusion rate. Femoral artery blood flow was measured at 60 min using a perivascular 
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flowprobe (0.7 V) attached to a flow meter (T106 small animal blood flow meter; Transonic 
Systems Inc., NY, USA) placed around the animals femoral artery. Immediately following the 
hyperinsulinaemic-euglycemic clamp insulin stimulated animals were killed by anaesthetic 
overdose and cervical dislocation and the m. tibialis anterior was dissected free. Samples 
were embedded in Tissue-Tek OCT Compound (Sakura Finetek Europe, Zoeterwoude, 
Netherlands) and immediately frozen in liquid nitrogen cooled isopentane (Sigma-Aldrich, 
Dorset, UK). Samples were then stored at -80oC until analysis was performed. Control muscle 
was obtained from animals in the fasted state using the same procedures. 
 
GIR (μmol.kg lean body mass-1.min-1) was calculated, and as plasma glucose concentration 
was kept constant is assumed to be equal to the disappearance rate of glucose from the blood 
into skeletal muscle and other tissues. Insulin sensitivity was calculated as GIR (μmol.kg lean 
body mass-1.min-1)/plasma insulin (pmol.L-1) in the 60-80 min steady state period, using GIR 
and plasma insulin measurements at the corresponding time points. To investigate the early 
response of glucose uptake to insulin GIR area under the curve (calculated using the 
conventional trapezoid rule) for the first 21 minutes of the clamp procedure was measured.  
 
Femoral artery vascular conductance (FVC) was calculated as femoral artery blood flow 
(ml/min-1)/ arterial blood pressure (mmHg), in the fasted state and 60 min into the clamp in 4 
of the 7 animals.  
 
Quantitative immunofluorescence  
Serial 5μm sections of the m. tibialis anterior (TA) were cut at -30°C using a microtome and 
collected on to room temperature uncoated glass slides. Two sections from each condition 
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(lean fasted, obese fasted, lean insulin stimulated, obese insulin stimulated) were placed on 
each slide and analysis was performed in duplicate. 
 
eNOS content and ser1176 phosphorylation of eNOS were assessed using the technique 
described by Cocks et al. (7) adapted for use in rats.  The method was also modified to 
differentiate between skeletal muscle capillaries and arterioles.  In brief sections were 
incubated with antibodies against either eNOS (Transduction Laboratories, Lexington, KY) or 
p-eNOS ser1177 (Cell Signalling Technology, Beverly, MA) (reported to share 100% sequence 
alignment with rat eNOS phosphorylated at ser1176, sequence alignment information from Cell 
Signalling Technology, Inc.) in combination with anti-alpha smooth muscle actin (SMA; 
Abcam, Cambridge, UK) as a marker to differentiate between arterioles and capillaries. 
Sections were then incubated with appropriately labelled secondary antibodies (Invitrogen, 
Paisley, UK), in combination with Fluorescein Griffonia (Bandeiraea) Simplicifolia I lectin 
(BSI-I, Vector labs, Burlingame, CA) as a marker of the endothelium. Following staining 
cover slips were applied using a glycerol and mowiol 4-88 solution. 
 
Images were acquired as described in (7). Image analysis was performed as described in (7), 
but vessels were divided into capillaries and arterioles using the SMA image. Arteriole 
diameter was also determined on calibrated images using Image Pro Plus 5.1 software.  
 
NOX2 content would have been an interesting measurement, but the antibody and methods 
previously described in human muscle (7) (gp91-phox/NOX2 (C-15); Santa Cruz 
Biotechnology, Santa Cruz, CA) did not work in rat muscle. As a result this measure was not 
conducted in the present study. 
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Capillary density 
Sections were prepared as above, and then incubated with BSI-I (Vector labs, Burlingame, 
CA) and wheat germ agglutinin-350 (WGA-350; Invitrogen, UK) as markers of the 
endothelium and plasma membrane, respectively. Following staining cover slips were applied 
using a glycerol and mowiol 4-88 solution. 
 
For analysis, slides were viewed using a Nikon E600 widefield fluorescence microscope 
using a 20 x 0.4 numerical aperture objective. Images were captured as described in (7). 
 
Capillary density (caps/mm2) and number of capillaries per fibre (calculated as total number 
of capillaries/total number of muscle fibres analysed) were manually quantified using the 
BSI-I and WGA-350 images as markers. Fibre cross sectional area (units) was measured on 
calibrated images using ImagePro Plus 5.1 software.  
 
Statistics 
eNOS content and measures of capillarization and fibre area were analysed using an 
independent samples t-test. eNOS ser1176 phosphorylation was analysed using a two-way 
repeated measures ANOVA with the between group factor ‘group’ (lean versus obese) and 
within group factor ‘stimulation’ (fasted versus insulin-stimulated). Significant 
group*stimulation interactions were examined using an independent t-test due to the small 
sample size of the current study. Femoral artery blood flow and FVC was also analysed using 
a two-way repeated measures ANOVA with the between group factor ‘group’ (lean versus 
obese) and within group factor ‘stimulation’ (fasted versus insulin-stimulated). Significant 
group*stimulation interactions were examined using paired samples t-test (fasted versus 
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insulin stimulated), and independent samples t-test (lean versus obese) again due to the small 
sample size of the current study. Quantitative immunofluorescence (eNOS content and ser1176 
phosphorylation) data from one slide was more than 2 standard deviations from the mean and, 
therefore, has been excluded as an outlier. All analyses were performed using statistical 
analysis software (SPSS for windows version 16.0, SPSS, Chicago, IL).  Significance was set 
at P ≤ 0.05. Data is presented as means ± S.E.M. 
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3.4  Results 
Glucose infusion rate (GIR), insulin sensitivity index and femoral artery blood flow 
Plasma glucose and GIR during the hyperinsulinemic euglycemic clamp are given in Fig. 3.1. 
GIR area under the curve was greater in the LZR than in the OZR at 21 min (LZR 95.8±14.1, 
OZR 39.7±17.9; P<0.05). There was no significant difference for the mean GIR between the 
two groups in the 60-80 min period. The insulin sensitivity index during the last 20 min of the 
clamp was 6-fold higher for the LZR than for the OZR (Fig. 3.2; P<0.05).There was no 
significant main effect of insulin on femoral artery blood flow at 60 min (P=0.306) and no 
significant group*stimulation interaction was observed (P=0.257) (Fig. 3.3a). A near 
significant group*stimulation interaction (P=0.052) was observed in FVC at 60 min (Fig. 
3.3b). Subsequent paired samples t-tests revealed FVC at 60 min in the LZR was significantly 
higher than in the fasted state LZR during the clamp  (P<0.05).  No significant change from 
the basal fasted state was seen for FVC in the OZR (P=0.950). However FVC was not 
significantly different between groups at 60 min (P=0.306).  
 
eNOS content and ser1176 phosphorylation  
Skeletal muscle eNOS content in the endothelium did not differ significantly between LZR 
and OZR neither in skeletal muscle terminal arterioles (P=0.279) nor in capillaries (P=0.125) 
(Fig. 3.4 and 3.5). A significant group*stimulation interaction was observed in terminal 
arteriole eNOS ser1176 phosphorylation (P <0.05) (Fig. 3.6).  A subsequent independent 
samples t-test revealed that fasting eNOS ser1176 phosphorylation was not different between 
LZR and OZR (P=0.840). However, there was a significant increase in eNOS ser1176 
phosphorylation following insulin stimulation in the LZR (P <0.05), whereas insulin 
stimulation significantly reduced eNOS ser1176 phosphorylation in OZR (P <0.05). In 
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addition, following insulin stimulation eNOS ser1176 phosphorylation was significantly higher 
in the LZR than in OZR (P <0.05). A significant group*stimulation interaction was observed 
in capillary eNOS ser1176 phosphorylation (P <0.05) (Fig. 3.7).  Subsequent independent 
samples t-tests revealed that fasting capillary eNOS ser1176 phosphorylation was not different 
between lean and obese animals (P =0.662). Insulin stimulation did not change capillary 
eNOS ser1176 phosphorylation in LZR (P =0.339), while in OZR insulin stimulation 
significantly reduced eNOS ser1176 phosphorylation (P <0.05). Following insulin stimulation 
eNOS ser1176 phosphorylation in OZR was 23% of that in LZR, but the difference between the 
groups was not significant (P =0.072). Mean arteriole diameter for assessment of eNOS and 
eNOS ser1176 phosphorylation was 8.9±0.1µm and 7±0.3 arterioles were analysed for each 
condition. 
 
 
Fibre area and capillarization 
No significant difference was observed in muscle fibre area between LZR and OZR (LZR 
2377±237 µm2, OZR 2147±124 µm2; P=0.401). There was a significant reduction in capillary 
density between lean and obese animals (LZR 1246±109 capillaries/mm2, OZR 962±71 
capillaries/mm2; P<0.05). In addition the number of capillaries per fibre was significantly 
lower in OZR compared to the LZR (LZR 2.61±0.11 capillaries/fibre, OZR 1.95±0.08 
capillaries/fibre; P <0.05). 
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Figure 3.1. Blood glucose and glucose infusion rate in lean and obese Zucker rats 
Blood glucose (A) and glucose infusion rate (B) during hyperinsulinaemic-euglycemic clamp  
in lean (LZR) and obese (OZR) Zucker rats.   
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Figure 3.2. Insulin sensitivity in lean and obese Zucker rats 
Insulin sensitivity in lean (LZR) and obese (LZR) Zucker rats. Insulin sensitivity was  
calculated as glucose infusion rate (μmol/lbmkg/min) / plasma insulin (pmol/L) at 60-80 min  
(at clamp) of the hyperinsulinaemic-euglycemic clamp. + P<0.05 from LZR  
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Figure 3.3. Femoral artery blood flow and vascular conductance in lean and obese 
Zucker rats 
Change in femoral artery blood flow (A) and femoral vascular conductance (FVC) (B) from  
fasted to insulin-stimulated in lean (LZR) and obese (LZR) Zucker rats. FVC was calculated  
as femoral artery blood flow (ml.min-1)/ arterial blood pressure (mmHg). Data was collected  
at 60 min after the start hyperinsulinaemic-euglycemic clamp. # P<0.05 from LZR fasted 
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Figure 3.4. Terminal arteriole eNOS content in lean and obese Zucker rats 
A. Widefield microscopy images of m. Tibilais anterior in lean (LZR) and obese (OZR) 
Zucker rats. The skeletal muscle microvascular endothelium was revealed using Fluorescein 
Griffonia (Bandeiraea) Simplicifolia I lectin (BSI-I) (green). Arterioles and capillaries were 
identified using anti smooth muscle actin (SMA) in combination with Alexa-Fluror 350 
conjugated secondary antibody (blue). eNOS was revealed using Alexa-Fluror 594 conjugated 
secondary antibody (red). Bar = 10μm. B Mean fluorescence intensity of eNOS within 
terminal arterioles is summarized. The mean level of eNOS in LZR was assigned a value of 1, 
and the relative intensity of eNOS in OZR was calculated.  
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Figure 3.5. Capillary eNOS content in lean and obese Zucker rats 
A. Widefield microscopy images of m. Tibilais anterior in lean (LZR) and obese (OZR) 
Zucker rats. The skeletal muscle microvascular endothelium was revealed using Fluorescein 
Griffonia (Bandeiraea) Simplicifolia I lectin (BSI-I) (green). Arterioles and capillaries were 
separated using anti smooth muscle actin (SMA) in combination with Alexa-Fluror 350 
conjugated secondary antibody (blue). eNOS was revealed using Alexa-Fluror 594 conjugated 
secondary antibody (red). Bar = 50μm. B Mean fluorescence intensity of eNOS within 
capillaries is summarized. The mean level of eNOS in LZR was assigned a value of 1, and the 
relative intensity of eNOS in OZR was calculated. 
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Figure 3.6. Fasted and insulin stimulated terminal arteriole eNOS ser1176 
phosphorylation in lean and obese Zucker rats 
A. Widefield microscopy images of m. Tibilais anterior in lean (LZR) and obese (OZR) 
Zucker rats. The skeletal muscle microvascular endothelium was revealed using Fluorescein 
Griffonia (Bandeiraea) Simplicifolia I lectin (BSI-I) (green). Arterioles and capillaries were 
separated using anti smooth muscle actin (SMA) in combination with Alexa-Fluror 350 
conjugated secondary antibody (blue). eNOS ser1176 phosphorylation was revealed using 
Alexa-Fluror 594 conjugated secondary antibody (red). Bar = 10μm. B Mean fluorescence 
intensity of eNOS ser1176 phosphorylation within terminal arterioles is summarized. The mean 
level of eNOS ser1176 phosphorylation from LZR in the fasted state (LZR fasted) was assigned 
a value of 1, and the relative intensity of eNOS ser1176 phosphorylation in LZR post insulin 
(LZR insulin), OZR in the fasted state (OZR fasted) and OZR post insulin (OZR insulin) was 
calculated. # P<0.05 from LZR fasted, + P<0.05 from LZR insulin, * P<0.05 from OZR 
fasted 
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Figure 3.7.  Fasted and insulin stimulated capillary eNOS ser1176 phosphorylation in lean 
and obese Zucker rats 
A. Widefield microscopy images of m.Tibilais anterior in lean (LZR) and obese (OZR) 
Zucker rats. The skeletal muscle microvascular endothelium was revealed using Fluorescein 
Griffonia (Bandeiraea) Simplicifolia I lectin (BSI-I) (green). Arterioles and capillaries were 
separated using anti smooth muscle actin (SMA) in combination with Alexa-Fluror 350 
conjugated secondary antibody (blue). eNOS ser1176 phosphorylation was revealed using 
Alexa-Fluror 594 conjugated secondary antibody (red). Bar = 50μm. B Mean fluorescence 
intensity of eNOS ser1176 phosphorylation within capillaries is summarized. The mean level of 
eNOS ser1176 phosphorylation from LZR in the fasted state (LZR basal) was assigned a value 
of 1, and the relative intensity of eNOS ser1176 phosphorylation in LZR post insulin (LZR 
insulin), OZR in the fasted state (OZR fasted) and OZR post insulin (OZR insulin) was 
calculated. * P<0.05 from OZR fasted. 
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3.5 Discussion 
The most important novel findings of the present study are 1) skeletal muscle eNOS content 
was not different between LZR and OZR in either arterioles or capillaries, 2) fasted eNOS 
ser1176 phosphorylation was not different between LZR and OZR in arterioles or capillaries, 3) 
skeletal muscle eNOS ser1176 phosphorylation in arterioles of LZR was significantly elevated 
following insulin stimulation, but was significantly reduced in OZR, 4) capillary eNOS ser1176 
phosphorylation was unchanged in LZR, but was significantly reduced in OZR in response to 
insulin stimulation. As hypothesised these impairments in insulin stimulated eNOS ser1176 
phosphorylation were accompanied by significant reductions in glucose clearance and whole 
body insulin sensitivity during the early stages and final 20 minutes, respectively, of a 
hyperinsulinemic-euglycemic clamp. These findings add an important in vivo signalling 
perspective to existing physiological data, disclosing at least part of the molecular 
mechanisms that contribute to impaired dilation of (terminal) arterioles and reduced glucose 
uptake in skeletal muscle of OZR. 
 
The OZR in the present study were insulin resistant as shown by the substantial reduction in 
insulin sensitivity index (Fig. 3.2) compared to their lean littermates.  However no difference 
was observed in GIR between LZR and OZR at the end of the clamp, which may be explained 
by the different insulin infusion rates in LZR and OZR and preferential channelling of glucose 
to tissues other than skeletal muscle in OZR. Different insulin infusion rates were chosen to 
generate increases in insulin concentration that are in the normal physiological range both for 
the LZR and OZR, with much higher concentrations occurring in the OZR.  In the LZR a 4-
fold increase in hind limb glucose uptake has been observed during a hyperinsulinaemic-
euglycemic clamp (37). However, in OZR increases in hind limb glucose extraction were 
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minimal 2 h after the start of the hyperinsulinemic-euglycemic clamp (37) using the same 
insulin infusion rates as in our study, implying that the majority of the glucose in the OZR 
must be taken up by tissues other than skeletal muscle. Adipose tissue (26), liver (3) and skin 
(27) seem to be the major contributors to the clearance of the large increases in GIR observed 
in OZR in the 30-120 min period, with only minimal increases in glucose uptake occurring in 
skeletal muscle (37). Finally previous studies have suggested that increases in microvascular 
volume occur as early as 5 min into a hyperinsulinemic-euglycemic clamp and are therefore 
important in the early rise in glucose uptake. As such, the significant reduction in GIR in the 
OZR in the early phase (first 21 min) of the clamp seems to be due to impairment in 
microvascular recruitment. The reduced 1-methyl-xanthine extraction by the hindlimbs 
observed in the OZR in comparison to the LZR may also suggest that insulin infusion during 
the clamp in fact leads to the vasoconstriction of the muscle microvasculature in the OZR.  
 
eNOS content was not different between LZR and OZR in either terminal arterioles or 
capillaries. This is the first observation of endothelial specific eNOS content from terminal 
arterioles or capillaries of OZR, and suggests that reductions in eNOS content do not 
contribute to the  previously observed reductions in capillary surface area  that is perfused in 
the fasting and insulin stimulated state in the hindlimbs of OZR (37).  
 
Fasting eNOS ser1176 phosphorylation was also unaltered in OZR terminal arterioles and 
capillaries compared to their lean littermates. These results, therefore, suggest that reductions 
in eNOS ser1176 phosphorylation and any subsequent impairment in NO production also do 
not play a role in the previously observed reduction in capillary surface area  that is perfused 
in the fasting state (37).  
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Although fasting eNOS ser1176 phosphorylation was unchanged we observed a significant 
impairment in terminal arteriole eNOS ser1176 phosphorylation in response to insulin in OZR. 
Insulin stimulation mediated an elevation in terminal arteriole eNOS ser1176 phosphorylation 
in LZR, however in OZR insulin stimulation surprisingly resulted in reduced eNOS ser1176 
phosphorylation. The observation that insulin is able to reduce eNOS phosphorylation has 
previously been made in aortic endothelial cells isolated from ob/ob mice (19) exposed to 
high concentrations of insulin during in vitro incubations. As eNOS phosphorylation increases 
eNOS activity and subsequent NO production (23, 30) it is reasonable to assume that reduced 
eNOS ser1176 phosphorylation is instrumental in the failure of insulin to increase the capillary 
surface area that is perfused in OZR. As increases in microvascular volume and  the capillary  
permeability surface area product are important for the ability of insulin to stimulate glucose 
uptake (1, 2, 16, 35), reduced eNOS ser1176 phosphorylation is likely to be an important 
mechanism in the impaired insulin sensitivity and early glucose clearance observed in OZR in 
the current study.    
 
Similar to the observation in terminal arterioles, eNOS ser1176 phosphorylation was also 
reduced in skeletal muscle capillaries following insulin stimulation in OZR.  However, unlike 
the observation made in terminal arterioles, insulin stimulation did not increase eNOS ser1176 
phosphorylation in skeletal muscle capillaries in LZR. As muscle samples were collect 120 
min after the start of the clamp, increases at earlier time points may well have been missed. 
As previous research has provided evidence for the existence  of eNOS phosphatases (24), 
such enzymes might potentially contribute to subsequent inactivation (switching off of the 
signal) following prolonged insulin stimulation, but future research will be required to 
confirm this.  
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NO production and/ or bioavailability has been implicated in the trans-endothelial transport of 
insulin (2). Trans-endothelial transport of insulin across the endothelium of the muscle 
capillary bed has been suggested to be a second mechanism next to capillary recruitment 
exerting control on the delivery of insulin to the skeletal muscle fibres and is suggested to be 
NO-dependent (2). Therefore the reductions in the insulin induced eNOS ser1176 
phosphorylation in muscle capillaries of OZR may potentially reduce trans-endothelial 
transport of insulin and this mechanism may well be part of the reduction in the capillary 
permeability surface area product available for delivery of insulin that has been observed in 
patients with type 2 diabetes (15).  
  
NO production and/ or bioavailability has also been implicated and in the mechanisms leading 
to VEGF induced angiogenesis (9).  Therefore, Frisbee et al. (10) have suggested a role for 
chronically reduced NO bioavailability in the capillary rarefaction that is seen in OZR. The 
impaired capillary eNOS ser1176 phosphorylation in response to insulin stimulation may 
therefore play a role in the reduced capillary density in OZR observed in the current study (9). 
As previously suggested (9), the capillary rarefaction in the current study will contribute to 
the insulin resistance in OZR as it will reduce the capillary permeability surface area product 
for insulin and glucose  and thus reduce muscle glucose uptake (15).  
 
Elevated plasma tumor necrosis factor-α (TNFα) (18) and plasma free fatty acids (FFA) (21) 
in OZR may be responsible for the impaired insulin mediated eNOS signalling. Acutely 
elevated TNFα (38) and FFA (5) have been shown to impair microvascular recruitment and 
skeletal muscle glucose uptake. In vitro it has been shown that elevated exposure of 
endothelial cells to FFA increases levels of diacylglycerols, ceramide and long chain fatty 
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acyl CoA (25). These fatty acid metabolites and TNFα activate serine kinases such as PKC, 
inhibitory KB kinase (IKKβ) and Jun N-terminal kinase (JNK) inhibiting the insulin 
signalling cascade and eNOS phosphorylation (8, 25). Although the inhibitory effects of 
TNFα and FFA may explain impaired eNOS ser1176 phosphorylation in OZR they cannot 
explain the reduction observed in the present study. Vasoconstriction in response to insulin 
reducing shear stress may therefore be an additional important mechanism responsible for the 
reduction eNOS ser1176, as shear stress is one of the most important regulators of eNOS ser1176 
phosphorylation (24). Unlike the Akt dependent insulin signalling cascade the MAP-kinase 
signalling pathway which is also stimulated by insulin is intact in OZR (17). Activation of the 
MAP-kinase pathway results in production of endothelin-1 (ET-1), a vasoconstrictor peptide 
(25) and this activation especially occurs at the high insulin levels that occur in the OZR (17, 
25). Acute TNFα has been shown to inhibit insulin mediated vasodilatation but elevate 
vasoconstriction, reducing blood flow in skeletal muscle microvessels (8). In addition 
increased adrenergic activity and reactivity has been shown in OZR (12). As such, elevated 
vasoconstriction may reduce blood flow and shear stress in the OZR, and this could provide 
an explanation for the insulin induced reduction in eNOS ser1176 phosphorylation both in 
terminal arterioles and capillaries. 
 
An obvious limitation of the current study is that muscle microvascular volume was not 
measured; as a result the physiological consequences of eNOS signalling in obesity and 
following insulin stimulation have been inferred from previous studies conducted in LZR and 
OZR (37). The present study did however show impairments in insulin induced reductions in 
femoral vascular conductance (Fig. 3.3). Although the time course of insulin-mediated 
vasodilatation is different between arteries (90-120 min) and the skeletal muscle 
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microvasculature (36) (5-10 min), insulin-mediated dilation of the macrovasculature is also 
NO dependent (33), and Wallis et al (37) have previously shown that increases in femoral 
artery blood flow are impaired in the arteries of OZR during a hyperinsulinemic-euglycemic 
clamp. A further limitation is that only eNOS activation by ser1176 phosphorylation was 
investigated. A recent study by Ritchie et al. (30) has shown that ser615 is also phosphorylated 
by insulin, but phosphorylation at ser615 alone was not sufficient to activate eNOS unlike 
ser1176 phosphorylation.  
 
Finally it is well documented that NO bioavailability is not only a result of NO production by 
eNOS, but is a balance between NO production and NO quenching by superoxide anions (.O2-
) (20). Due to methodological issues discussed earlier we were not able to measure 
NAD(P)Hoxidase content of muscle terminal arterioles and capillaries. As elevations in 
NAD(P)Hoxidase have previously been observed in endothelial scrapings of the 
macrovasculature in obese humans (32), future studies should also investigate the role that 
induction of this enzyme has on the impaired microvascular response to insulin in obesity and 
type 2 diabetes,.     
 
In conclusion, the current study provides novel findings which suggest that impaired eNOS 
ser1176 phosphorylation plays a crucial role in the previously observed blunting of insulin 
mediated increases in muscle microvascular volume, and that these molecular mechanisms are 
instrumental to the reduction in insulin sensitivity and early uptake of glucose in skeletal 
muscle of OZR.   
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Chapter 4 
 
Sprint Interval and Endurance Training are Equally 
Effective in Increasing Muscle Microvascular Density and 
eNOS Content in Sedentary Males 
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4.1 Abstract  
Sprint interval training (SIT) has been proposed as a time efficient alternative to endurance 
training (ET) for increasing skeletal muscle oxidative capacity and improving certain 
cardiovascular functions. In this study we sought to make the first comparisons of the 
structural and endothelial enzymatic changes in skeletal muscle microvessels in response to 
ET and SIT. 16 Young sedentary males (age 21±0.7 yr, BMI 23.8±0.7 kg.m-2) were randomly 
assigned to 6 weeks of ET (40-60 min cycling at ~65% VO2peak, 5 times per week) or SIT (4-6 
Wingate tests, 3 times per week). Muscle biopsies were taken from the m. vastus lateralis 
before and following 60 min cycling at 65% VO2peak to measure muscle microvascular 
endothelial eNOS content, eNOS serine1177 phosphorylation, NOX2 content and 
capillarization using quantitative immunofluorescence microscopy. Whole body insulin 
sensitivity, arterial stiffness, and blood pressure were also assessed. ET and SIT increased 
skeletal muscle microvascular eNOS content (ET 14%; P<0.05, SIT 36%; P < 0.05), with a 
significantly greater increase observed following SIT (P <0.05). 60 Min of moderate intensity 
exercise increased eNOS ser1177 phosphorylation in all instances (P <0.05), however basal and 
post-exercise eNOS ser1177 phosphorylation was lower following both training modes. All 
microscopy measures of skeletal muscle capillarization (P<0.05) were increased with SIT or 
ET, while neither endothelial nor membrane NOX2 were changed. Both training modes 
reduced aortic stiffness and increased whole body insulin sensitivity (P <0.05). In conclusion, 
in sedentary males SIT and ET are effective in improving muscle microvascular density and 
eNOS protein content.  
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4.2 Introduction  
It is well established that endothelial function is dependent on nitric oxide (NO) 
bioavailability (30), which in turn is determined by the balance between NO synthesis and 
scavenging by superoxide anions and related reactive oxygen species.  As endothelial function 
plays a role in insulin sensitivity, blood pressure regulation and the molecular mechanisms 
leading to atherosclerosis (3, 4, 30, 44) an optimal balance between NO production and 
scavenging is important in the maintenance of a healthy phenotype. Experiments with isolated 
arteries and cultured endothelial cells have shown that endothelial nitric oxide synthase 
(eNOS) is the rate limiting enzyme for endothelial NO synthesis. The eNOS protein content 
and serine1177 (ser1177) phosphorylation state together determine eNOS activity and NO 
production. A major source of superoxide production and NO scavenging in the vascular wall 
is NAD(P)Hoxidase (NAD(P)Hox) (7, 39), but substantial expression of this enzyme is 
assumed to only occur in obesity, cardiovascular pathology and ageing (7, 39). However, the 
lack of a validated method means that currently there is little information on the protein 
content of these enzymes in the endothelial layer of the microvasculature of human skeletal 
muscle.  
 
There is substantial evidence in the literature that the adoption of a sedentary lifestyle, 
obesity, ageing and chronic diseases lead to an attenuation of endothelial NO production by 
reductions in eNOS expression and protein content (McAllister & Laughlin, 2006) and 
increases in NAD(P)Hox expression and protein content (Brandez and Kreuzer 2005, Silver at 
al., 2007) in the macrovasculature. Whether these adaptations also occur in the muscle 
microvasculature is currently unknown. In obese and elderly individuals and patients with 
type 2 diabetes and cardiovascular disease an attenuated NO production in the muscle 
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microvasculature has been implicated in the development of skeletal muscle insulin resistance 
(3, 4), anabolic resistance to insulin and amino acids leading to sarcopenia and reductions in 
muscle capillary density (44). An attenuated endothelial NO production has also been 
implicated in the reduction in exercise hyperemia that is known to occur in elderly humans 
(12, 38) with Spier et al. (40) providing evidence that this impairment indeed occurs in 
isolated muscle arterioles of old rats and can be restored by exercise training. Krentz et al. 
(26) have also made the observation that functional impairments in NO-dependent muscle 
microvascular function precede macrovascular impairments in humans and, therefore, 
suggested that the muscle microvasculature should be regarded as a primary target for 
therapeutic interventions. 
 
Endurance training (ET) is recognised as an efficient means to increase eNOS gene 
expression, protein content, and NO production in feeding and resistance arteries (McAllister 
& Laughlin 2006), thereby increasing the vasodilatory response to insulin (3, 37) and flow 
mediated dilation, and reducing the risk for the development of hypertension and 
atherosclerosis (30, 42). ET is also the traditional means to increase the production of vascular 
endothelial growth factor (VEGF) in skeletal muscle which generates an NO dependent signal 
stimulating angiogenesis (1, 16, 21, 31, 45). However, it is not known whether ET increases 
eNOS content in the endothelial layer of the muscle microvasculature or its phosphorylation 
at ser1177 in the basal state or in response to moderate intensity cycling exercise in man. In 
addition the effect of ET on muscle microvascular NAD(P)Hox content has not been 
investigated.  
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Recently sprint interval training (SIT) has received much attention as it elicits similar muscle 
metabolic (increases in activity of mitochondrial enzymes, aerobic capacity and insulin 
sensitivity) and macrovascular adaptations (reduced arterial stiffness and blood pressure) as 
ET, despite a marked reduction in time commitment (2, 8, 17, 36). In rodent models, SIT has 
also been shown to increase aortic eNOS content (18). However to date, no studies have made 
comparisons between the effects of SIT and ET on the microvascular enzymes controlling NO 
production and skeletal muscle microvascular density in man.  
 
The main aims of the present study were twofold. First, we sought to determine the effects of 
six weeks of traditional ET and SIT on skeletal muscle microvascular density and 
microvascular enzyme content (eNOS and NOX2) in previously sedentary men. We 
employed a novel method recently developed in our laboratory (10), to measure the protein 
content of these enzymes in the endothelial layer of the muscle microvasculature using 
quantitative immunofluorescence microscopy. Secondly, we aimed to investigate the effect of 
1 h of continuous cycling exercise at 65% VO2peak on eNOS ser
1177 phosphorylation both in 
the untrained state and after the two training interventions. eNOS ser1177 is the main activation 
site previously shown to be phosphorylated by endurance exercise in mouse arteries (48). 
Finally, the effects of SIT and ET on arterial stiffness and blood pressure were considered to 
investigate earlier claims that SIT is an effective means to improve macrovascular functions 
(24, 36). We hypothesized that microvascular density and eNOS content would increase in 
response to both modes of training, that eNOS ser1177 phosphorylation would be lower after 
training as the increase in microvascular density and metabolic training adaptations will 
reduce shear stress per microvessel and that NOX2 content would be unaltered due to the 
healthy nature of the participants.  
143 
 
4.3 Materials and Methods  
The percutaneous muscle biopsies taken in this study before and after both training modes and 
under basal conditions and after 1 h of endurance exercise have been used both for the 
measurements described in this manuscript and for measurements of the content of 
intramuscular triglycerides (IMTG), perilipin-2 and perilipin-5 and usage of total IMTG and 
IMTG associated with perilipin-2 and perilipin-5 during endurance exercise. The latter are 
reported in a parallel manuscript (Shepherd SO, Cocks M, Tipton KD, Ransinghe AM, Barker 
TA, Burniston JG, Wagenmakers AJM and Shaw CS, unpublished data). Measures such as 
insulin sensitivity and VO2peak also made in the indicated human volunteers are relevant for 
the interpretation of both studies and are presented in both manuscripts.  
 
Participants  
16 young sedentary males (defined as performing less than 1 h of organised exercise per 
week; in sports clubs, university or commercial gyms or sports classes) participated in the 
study (Table 4.1). Participants were randomly assigned to either ET or SIT groups, in a 
matched fashion based on age and VO2peak (n=8). The participants gave written informed 
consent to a protocol adhering to the Declaration of Helsinki and approved by the Black 
Country NHS Research Ethics Committee. 
 
Pre-training testing protocol 
Participants first completed an incremental exercise test to exhaustion on an 
electromagnetically braked cycle ergometer to determine maximal aerobic power output 
(Wmax) and VO2peak using an online gas collection system (Oxycon Pro, Viasys, Wuerzberg, 
Germany). Briefly, participants started cycling at 95 W for 3 min; following this the workload 
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was increased by 35 W every 3 min until volitional fatigue. VO2peak corresponds to the highest 
value achieved over a 15 second recording period. After sufficient rest, participants in the SIT 
group performed a Wingate test (30 s ‘all out’ effort against a resistance equivalent to 0.075kg 
body mass) to familiarise themselves with the SIT training protocol. 
 
3-7 Days after the incremental exercise test and following an overnight fast, macrovascular 
function was assessed (blood pressure and arterial stiffness). Following this a 2 h oral glucose 
tolerance test was completed. The next day, again following an overnight fast a muscle biopsy 
was taken at rest from the m. vastus lateralis. Participants then performed 60 min of cycling 
on an electromagnetically braked cycle ergometer at 65% of pre-training VO2peak. A second 
biopsy was taken immediately after exercise from the same leg as the pre-exercise biopsy.  
 
Post-training testing protocol 
Post-training VO2peak testing was performed the day before the final training session. 
Approximately 48 hours after the final training session the post-training testing protocol was 
conducted with procedures, methods and timings identical in all respects to the pre-training 
testing protocol. Power output of the 60 min steady state cycling exercise bout was set at the 
same absolute intensity as during the pre-training exercise bout.  
 
Arterial stiffness  
Supine brachial artery blood pressure measurements were made in triplicate using an 
automated sphygmomanometer (Omron 7051T, Omron Corporation, Kyoto, Japan) following 
15 minutes of supine rest. Central (carotid-femoral, cPWV) and peripheral (carotid-radial, 
pPWV) pulse wave velocity (PWV) were assessed using a semi automated device and 
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software (SphygmoCor, AtCor Medical, Sydney, Australia). PWV is defined as the speed of 
travel of a pulse between two sites along the arterial branch (34) and is a measure of artery 
stiffness. A single high fidelity applanation tonometer was used to obtain a proximal (carotid 
artery) and distal (radial or femoral artery) pulse, recorded sequentially over 10 waveforms. 
Simultaneously the QRS complex was measured using electrocardiography (ECG). The time 
between the R wave of the ECG and the foot of the proximal waveform is subtracted from the 
time between the R wave and the foot of the distal waveform to obtain the pulse transit time. 
To determine the distance used for PWV the distance from the proximal measurement site 
(carotid artery) to the suprasternal notch was subtracted from the distance between the distal 
(radial/ femoral artery) measurement site and the suprasternal notch using an anthropometric 
measuring tape. PWV measurements were made in triplicate. The day to day variability 
measured as co-efficient of variation for cPWV and pPWV in our laboratory was 4% and 4%, 
respectively. Radial artery pressure waveforms were acquired (SphygmoCor, AtCor Medical, 
Sydney, Australia) and the aortic waveform reconstructed using a validated transfer function 
(34). Augmentation index (AIx), an assessment of systemic wave reflection and thus arterial 
stiffness (27), was then determined using pulse wave analysis (PWA). To control for the 
potentially confounding influence of heart rate (47) AIx was normalised to a heart rate of 75 
bpm (AIx@75bpm). Resting heart rate was obtained during PWA using the SphygmoCor 
software. PWA measurements were made in triplicate. The day to day variability measured as 
co-efficient of variation in our laboratory was 8% for AIx@75bpm. 
 
Oral glucose tolerance test and Matsuda insulin sensitivity index 
Following the insertion of a cannula into an antecubital vein, a baseline 25 ml blood sample 
was taken. Participants then ingested a 25% glucose beverage containing 75g glucose made 
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up in 300 ml of water. Further blood samples (10 ml) were collected at 30, 60, 90 and 120 
minutes while participants rested, following the procedure originally proposed by Matsuda & 
DeFronzo (1999) for the assessment of whole body insulin sensitivity. Plasma was separated 
by centrifugation (10 minutes at 3000 rpm) and stored at -80oC until analysis. Plasma insulin 
concentrations were determined by enzyme linked immuno-sorbent assay (ELISA) using a 
commercially available kit (Invitrogen, UK).  Plasma glucose concentrations were analysed 
using an automated analyzer (IL ILab 650 Chemistry Analyzer, Diamond Diagnostics, USA).  
Area under the curve (AUC) for insulin and glucose during the oral glucose tolerance test was 
calculated using the conventional trapezoid rule. The Matsuda index, a variable which is 
generally accepted and widely used as a non-invasive alternative to measure whole body 
insulin sensitivity has been shown to have a high correlation with insulin sensitivity measured 
with the hyperglycemic euglycemic clamp (28), which is the gold standard method. The 
Matsuda index was calculated using the formula: 
 
 
Where FPG is fasting plasma glucose concentration (mg.dl-1), FPI is fasting plasma insulin 
concentration (µU.ml-1), and mean OGTT glucose and insulin is the mean plasma glucose 
(mg.dl-1) and insulin (µU.ml-1) concentration of all samples taken during the oral glucose 
tolerance test (0, 30, 60, 90 and 120 min).  
 
Muscle biopsy 
While participants rested a muscle biopsy was taken from the lateral portion of the m. vastus 
lateralis, approximately 25-50% of the distance from the lateral joint line and the greater 
trochanter under local anaesthesia (1% lidocaine) using the percutaneous needle biopsy 
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technique (6) as recently described (41).  Post exercise biopsies where taken from an incision 
~2 cm proximal to the first incision. Excess blood and visible collagen or fat were removed 
before samples were embedded in Tissue-Tek OCT Compound (Sakura Finetek Europe, 
Zoeterwoude, Netherlands) and immediately frozen in liquid nitrogen cooled isopentane 
(Sigma-Aldrich, Dorset, UK). Samples were then stored at -80oC until analysis was 
performed. 
 
Dietary controls 
24 Hours prior to and throughout the 2 days of the pre- and post-training testing protocol 
participant’s diets were standardised. Using commercially available diet analysis software 
(WISP) 3 day diet diaries were logged and average daily energy intake was calculated. The 
standard diet was matched to the participant’s habitual energy intake and was composed of 
50% carbohydrate, 35% fat and 15% protein.  
 
Training  
Training programs were initiated   48 hours after completion of the pre-training testing 
protocol. Training for the ET group consisted of 40-60 min continuous cycling on an 
electromagnetically braked cycle ergometer at an intensity eliciting   65% VO2peak. Participants 
trained 5 times a week. Following 3 weeks of training a second incremental exercise test was 
conducted and workload was changed accordingly. The duration of the sessions was increased 
from 40 min during the first 10 sessions, to 50 minutes for sessions 11- 20 and 60 min for 
sessions 21-30. The SIT group performed repeated Wingate tests (8), interspersed with 4.5 
min recovery (cycling at 30 W). The number of Wingate tests performed each session was 
increased from 4 for the first 6 sessions to 5 during sessions 7-12 and 6 during session 13-18. 
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All training sessions were supervised by members of the research team and significant 
encouragement was provided during the Wingate tests.  
 
Quantitative immunofluorescence  
Serial 5μm sections were cut at -30°C using a microtome and collected on to room 
temperature uncoated glass slides. Pre- and post-training sections were placed on the same 
slide for analysis of eNOS and NOX2 content. For analysis of p-eNOS ser1177 pre- and post-
training and pre- and post-exercise sections were placed on the same slide. Two sections from 
each condition (pre- or post-training and -exercise) were placed on each slide and analysis 
was performed in duplicate.  Transverse orientated samples were used for all analysis. 
Sections were left to dry for 1 hour before treatment.  
 
The procedures for immunofluorescence staining and subsequent image analysis have been 
described in detail by Cocks et al. (10). Briefly, sections were incubated with antibodies 
against eNOS (Transduction Laboratories, Lexington, KY), p-eNOS ser1177 (Cell Signalling 
Technology, Beverly, MA) and NOX2 (Santa Cruz Biotechnology, Santa Cruz, CA), which 
have been previously validated for immunofluorescence (10). Sections where then incubated 
with appropriately labelled secondary antibodies (Invitrogen, Paisley, UK), in combination 
with Ulex Europaeus-FITC conjugated (UEA-I-FITC; Sigma-Aldrich, UK) and wheat germ 
agglutinin-350 (WGA-350; Invitrogen, UK) as markers of the endothelium and plasma 
membrane, respectively. 
 
For analysis, slides were viewed using a Nikon E600 microscope using a 40x 0.75 numerical 
aperture objective. Images were captured using a SPOT RT KE colour three shot CCD camera 
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(Diagnostic Instrument Inc., MI, USA). Camera exposure time and gain was adjusted so that 
no pixel saturation was present in any channel and identical camera settings were used for all 
images within each participant. Image analysis was performed using Image Pro Plus 5.1 
software (Media Cybernetics Inc, Bethesda, MD, USA). Endothelial specific fluorescence 
was determined using the UEA-I FITC (endothelial marker) image, which was extracted and 
overlaid onto the corresponding eNOS, p-eNOS ser1177 or NOX2 image. Cell membrane 
specific fluorescence for NOX2 was determined using WGA-350 as a stain to create an 
outline of the cell membrane. The latter was extracted and overlaid onto the corresponding 
NOX2 image. Fluorescence intensity of the eNOS, p-eNOS ser1177 or NOX2 signal was 
quantified within the endothelium or cell membrane specific area. The reader was not blinded 
to condition as image analysis was automated removing the potential effects of investigator 
bias (10).  The mean fluorescence levels of pre-training and pre-training pre-exercise (p-
eNOS ser1177 only) samples were normalised to a value of 1, and the relative level of post-
training and post-exercise (p-eNOS ser1177 only) samples were calculated.  
 
Capillarization  
Capillaries were quantified manually using the UEA-I FITC and WGA-350 images as 
capillary and sarcolemmal markers, respectively. The following indexes were measured (20): 
1) number of capillaries around a fibre (capillary contacts), 2) capillary-to-fibre ratio on an 
individual-fibre basis, 3) the number of capillaries sharing a fibre (sharing factor) and 4) 
capillary density. Quantitation of capillarization was performed only on transverse fibres 
(longitudinal fibres were discounted from the analysis).  In line with previous studies 
assessing capillarization, at least 50 complete fibres (pre 52±1, post 52±1 fibres per subject) 
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were included in each analysis (35). Fibre cross sectional area and perimeter were measured 
on calibrated images using ImagePro Plus 5.1 software.  
 
Statistics  
All variables except p-eNOS ser1177 were analysed using a two-way mixed analysis of 
variance (ANOVA), with the between factor ‘group’ (ET vs. HIIT) and repeated factor 
‘training status’ (pre-training vs. post-training). p-eNOS ser1177 was analysed using a three-
way mixed ANOVA with the factors ‘group’ (ET vs. SIT), ‘training status’ (pre- vs. post-
training) and ‘exercise time’ (0 versus 60 min). All analyses were performed using statistical 
analysis software (SPSS for windows version 16.0 [SPSS, Chicago, IL]).  Significance was 
set at P ≤ 0.05. Data is presented as means ± S.E.M. All measures of arterial stiffness were 
measured in 15 participants due to an unacceptable pulse recording in one participant. Due to 
unsuccessful UEA-I FITC staining in one participant, p-eNOS ser1177 and NOX2 within the 
endothelium is presented for 15 participants. The primary aim of the study was to compare the 
effects of ET and SIT on muscle microvascular eNOS content and microvascular density.  
The study was powered to detect between group (SIT versus ET) differences in the increase in 
these variables in response to training. G*Power 3.1 software (G*Power Software Inc., Kiel, 
Germany) was used to calculate the required sample size. The study was designed to detect a 
between group effect of f=0.30, representative of a medium sized effect (11) adopting an 
alpha of 0.05 and power of 0.80. In light of the paucity of studies investigating the effects of 
training on microvascular eNOS content we deemed an f of 0.30 to be a physiologically 
relevant difference. 
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4.4 Results  
Training effect 
Training increased VO2peak (ET 15%, SIT 8%) and Wmax (ET 16%, SIT 9%) with main effect 
of training (P < 0.05; Table 4.1) and no difference between groups. Resting heart rate was 
reduced in both SIT and ET groups following training (main effect of training, P < 0.05; 
Table 4.1). Mean and diastolic blood pressures were both reduced by training, with no 
difference between groups (P < 0.05; Table 4.1). Systolic blood pressure was not altered by 
either training method (P = 0.211; Table 4.1).    
 
Insulin sensitivity  
The Matsuda insulin sensitivity index was significantly improved by ET (31%) and SIT 
(27%), respectively, with no difference between training methods (main effect of training, P < 
0.05; Table 4.1). Both glucose and insulin area under the curve (AUC) were reduced by both 
methods of training (main effect of training, P < 0.05; Table 4.1). 
 
eNOS content and eNOS ser1177 phosphorylation 
A main effect of training and group on eNOS content was observed (P<0.05), while there also 
was a significant interaction (P<0.05). When within group differences were examined both 
SIT and ET significantly increased eNOS content (36%, P<0.05, 16%, P<0.05), and when 
between group differences were probed eNOS content post SIT was significantly greater than 
eNOS content post ET (P<0.05)(Fig. 4.1). 1 h moderate intensity exercise significantly 
increased eNOS ser1177 phosphorylation both before and after training (main effect of time, P 
<0.05). Both pre- and post-exercise eNOS ser1177 phosphorylation was lower following 
training (main effect of training, P <0.05), with no difference between groups. There was no  
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Table 4.1. Subject characteristics, insulin sensitivity, hemodynamic and peak oxygen 
uptake pre and post 6 weeks of training. 
 Endurance Sprint interval 
Variable Pre training Post training Pre training Post training 
Age (yr) 21±1 - 22±1 - 
Height (cm) 177±3 - 174±2 - 
Weight (kg) 71±4 71±5 75±3 75±3 
BMI (kg.m-2) 22.6±1.6 22.6±1.2 24.8±0.8 24.8±0.9 
VO2peak (ml.kg
-1.min-1) 41.7±4.1 48.2±5.0* 41.9±1.8 45.1±2.3* 
Wmax (W) 218±11 253±16* 221±11 241±14* 
ISI Matsuda 3.7±0.5 4.7±0.7* 3.9±0.3 5.8±0.4* 
Glucose AUC 
(mmol.L-1.120min-1) 
16835±992 14783±950* 17634±710 14551±398* 
Insulin AUC 
(mmol.L-1.120min-1) 
8434±880 6813±711* 8847±1140 5792±688* 
Resting heart rate 
(bpm) 
60±2 57±2* 65±2 61±3* 
Mean arterial pressure 
(mmHg) 
78±2 76±3* 81±3 77±3* 
Systolic blood pressure 
(mmHg) 
114±4 113±5 117±3 115±3 
Diastolic blood 
pressure (mmHg) 
61±3 57±3* 62±3 59±3* 
 
Values are means ± S.E.M., n=8 per group. * P < 0.05, main effect of training 
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Figure 4.1. Effects of endurance training (ET) and sprint interval training (SIT) on 
eNOS content. 
A. Widefield microscopy images of skeletal muscle pre (left) and post (right) endurance 
training (top) and high intensity interval training (bottom). Skeletal muscle eNOS expression 
was revealed using Alexa-Fluror 594 conjugated secondary antibody (red). Bar = 50μm. B 
Mean fluorescence intensity of eNOS is summarized. The mean level of eNOS pre training 
was assigned a value of 1, and the relative intensity of eNOS post training was calculated (ET 
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n = 8, SIT n = 8). * P < 0.05, different from pre training.  + P < 0.05, different from ET post 
training 
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effect of group or training on the change in phosphorylation from pre- to post-exercise (Fig. 
4.2) meaning that the relative increase in eNOS ser1177 phosphorylation was unchanged by 
training.  
 
NOX2 content 
Microvascular and sarcolemma-associated NOX2 expression was unaltered by training, with 
no difference between groups (microvascular, P=0.805; membrane, P=0.085) (Fig. 4.3).  
 
Capillarization  
Muscle fibre cross sectional area and sharing factor were unchanged by training, with no 
difference between groups (Fibre area, P=0.202; Sharing factor, P=0.085). Capillary contacts 
increased by 20% and 21% in the ET and SIT groups, respectively, with no difference 
between groups (main effect of training, P <0.05). The capillary-to-fibre ratio on an 
individual-fibre basis was increased in both ET and SIT by 22% and 24%, respectively, with 
no difference between groups (main effect of training, P<0.05). Finally, capillary density was 
increased 32% in the ET group and 27% in the SIT group, with no difference between groups 
(main effect of training, P <0.05, Table 4.2). Representative images from pre- and post-
training in both ET and SIT groups are presented in Fig.4. 4. 
 
Arterial stiffness 
AIx@75bpm was significantly decreased following training, with no difference observed 
between training methods (main effect of training, P < 0.05; Fig. 4.5a). cPWV was decreased 
by 5% and 7% following ET and SIT, respectively (main effect of training, P <0.05; Fig. 
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4.5b), whereas pPWV was not significantly altered following either training mode (P = 0.404; 
Fig. 4.5c). 
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Figure 4.2. Effects of acute exercise and endurance training (ET) and sprint interval 
training (SIT) on eNOS serine1177 phosphorylation. 
A. Widefield microscopy images of skeletal muscle pre training pre exercise (pre, pre), post 
training pre exercise (Pre, post), pre training post exercise (Pre, post) and post training post 
exercise (Post, post) in endurance training (top) and high intensity interval training (bottom). 
Skeletal muscle eNOS serine1177 (ser1177) phosphorylation was revealed using Alexa-Fluror 
594 conjugated secondary antibody (red). Bar = 5μm. B Mean fluorescence intensity of eNOS 
ser1177 is summarized (ET n = 7, SIT n = 8). The mean level of eNOS ser1177 pre training pre 
exercise was assigned a value of 1, and the relative intensity of eNOS ser1177 post training or 
post exercise was calculated. * P < 0.05, Main effect of training. + P < 0.05, Main effect of 
time. 
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Figure 4.3. Effects of endurance training (ET) and sprint interval training (SIT) on 
NOX2 content. 
A. Widefield microscopy images of skeletal muscle pre (left) and post (right) endurance 
training (top) and high intensity interval training (bottom). Skeletal muscle NOX2 content 
was revealed using Alexa-Fluror 594 conjugated secondary antibody (red). Bar = 50μm. B 
Mean fluorescence intensity of NOX2 within the endothelium is summarized (ET n = 7, SIT n 
= 8). C Mean fluorescence intensity of NOX2 within the muscle membrane is summarized 
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(ET n = 7, SIT n = 8). The mean level of NOX2 pre training was assigned a value of 1, and 
the relative intensity of NOX2 post training was calculated.  
 
 
 
 
Figure 4.4. Effects of endurance training (ET) and sprint interval training (SIT) on 
skeletal muscle capillarization. 
Composite widefield microscopy images of skeletal muscle pre (left) and post (right) 
endurance training (top) and high intensity interval training (bottom). Skeletal muscle 
microvessels were visualised using Ulex Europaeus-FITC conjugated lectin (green) and the 
skeletal muscle membrane was revealed using wheat germ agglutinin-350 (blue). Bar = 50μm. 
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Table 4.2. Capillarization pre and post training. 
 Endurance Sprint interval 
Variable Pre training Post training Pre training Post training 
FA (mm2) 5131±525 4607±398 4437±172 4339±332 
CC 5.07±0.47 6.07±0.55* 4.53±0.23 5.50±0.35* 
C/FI 1.90±0.20 2.32±0.23* 1.66±0.10 2.07±0.15* 
SF 2.69±0.06 2.68±0.03 2.78±0.02 2.71±0.03 
CD (caps/ mm2) 663.0±26.5 872.9±33.6* 642.0±34.2 816.3±24.0* 
 
Values are means ± S.E.M. * P <0.05, main effect of training. FA, fibre cross sectional area, 
SF, sharing factor, CD, capillary density, CC, capillary contacts, C/FI, capillary-to-fibre ratio 
on an individual-fibre basis. 
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Figure 4.5. Effect of endurance training (ET) and sprint intensity interval training (SIT) 
on systemic wave reflections and central and peripheral artery stiffness. 
A. systemic wave reflections measured using Augmentation index normalized to 75 bpm 
(AIx@75bpm) following ET and RT. B. Central artery (aortic) stiffness measured using pulse 
wave velocity (PWV) following ET and SIT. C. Peripheral artery (brachial artery) stiffness 
measured using pulse wave velocity following ET and SIT. * P < 0.05, Main effect of 
training. 
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4.5 Discussion  
The most important novel findings of the present study are that: 1) 6 weeks of ET and SIT in 
young previously sedentary adult males increased skeletal muscle capillarization to a similar 
extent, 2) SIT increased the eNOS protein content of the muscle microvascular endothelium 
more than ET, 3) 1 h of moderate intensity exercise increased eNOS ser1177 phosphorylation 
irrespective of training status, but with lower pre- and post-exercise eNOS phosphorylation 
occurring following both modes of training, 4) neither intervention as expected induced a 
change in the protein expression of NOX2. Finally our results confirm previous reports 
showing that both ET and SIT significantly decrease arterial stiffness, brachial artery blood 
pressure and increase insulin sensitivity. Our integrative approach suggests that SIT is a time 
efficient alternative training mode for increasing aerobic exercise capacity and changing 
cardiovascular function in a direction consistent with health benefits in young healthy males.  
 
Aerobic capacity and capillarization 
The 6 week ET and SIT interventions both induced significant improvements in VO2peak. 
These findings are in agreement with a number of recent studies demonstrating that SIT and 
ET both induce improvements in aerobic capacity (8, 17). ET has long been known to 
improve capillarization of several leg skeletal muscles (1, 22). This study is the first to show 
that SIT improves all measures of capillarization within the m. vastus lateralis to a similar 
extent as ET in healthy sedentary young men. Future studies will be required to investigate if 
this effect also occurs in other muscles. The observation of an increased VO2peak and muscle 
capillarization is very important as they occur in the SIT group despite a marked reduction in 
total exercise duration of the training sessions and total workload of individual training 
sessions and the cumulative training intervention. Skeletal muscle angiogenesis has been 
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suggested to be the result of several stimuli including contractile activity, shear stress 
resulting from exercise hyperaemia, low O2 tension and metabolic activity (16, 45). 
 
Increases in capillarization and mitochondrial density are well described adaptations to 
endurance training and both contribute to the increases in aerobic exercise capacity (5). This 
study is the first to show that enhanced muscle capillarization is also an adaptation that 
contributes to the increase in aerobic exercise capacity with SIT, while the parallel study 
executed in the same individuals also showed similar increases in the SIT and ET group in 
mitochondrial density (Shepherd SO, Cocks M, Tipton KD, Ransinghe A, Barker T, 
Burniston JG, Wagenmakers AJM and Shaw CS, unpublished data). This implies that SIT and 
ET increase 2 of the major determinants of aerobic exercise capacity at the muscle level and 
are equally effective in the current study despite a massive difference in the nature of the 
exercise. The elevated capillarization following the 2 training modes may also contribute to 
the improved delivery of nutrients and hormones to the muscle fibres and therefore contribute 
to the improvements in insulin sensitivity.  
 
Microvascular enzyme content 
This study utilised a new quantitative immunofluorescence microscopy method recently 
developed in our laboratory (10) to study changes with ET and SIT in the protein content of 
enzymes that control NO production in the microvascular endothelium of skeletal muscle. 
Analytical methods such as Western blotting and sandwich enzyme immunoassay techniques 
which are applied to extracts of whole muscle homogenates do not reveal the relative 
distribution of these enzymes between muscle fibres and the microvessels and also do not 
provide information on whether changes in protein expression following training are the result 
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of changes in endothelial protein content or the result of changes in microvascular density. 
The method used in the present study is the first to generate important information on changes 
in the protein content and phosphorylation of eNOS and NAD(P)Hox in response to training 
interventions within the endothelial layer of the microvasculature of human skeletal muscle.  
 
eNOS content 
6 Weeks of ET and SIT significantly increased the protein content of eNOS within the 
microvascular endothelium of human skeletal muscle (Fig. 4.1) with a significantly larger 
increase occurring following SIT (36%) than following ET (16%). The effect of ET in our 
study in humans is in line with previous work in rats showing that endurance training 
increases the eNOS content, measured with Western blots applied to isolated 2nd-5th order 
arterioles isolated from the gastrocnemius muscle (29). This increase in eNOS content may 
potentially lead to increases in NO production upon stimulation by insulin, exercise induced 
shear stress and exercise induced VEGF production as previously hypothesised (21, 40, 43, 
44). However, future studies making parallel measurements of eNOS content, eNOS ser1177 
phosphorylation and muscle microvascular blood volume and flow will be required to confirm 
that higher eNOS content has functional consequences for muscle microvascular blood flow 
regulation. 
 
The larger improvement in microvascular eNOS content following SIT is in agreement with 
previous work in the macrovasculature showing that SIT increased eNOS content of the aorta 
more than ET in low aerobic capacity rats (18). Given the greater microvascular eNOS 
expression induced by SIT, it cannot be excluded that SIT is more effective than ET at 
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improving the vasodilatory response of the muscle microvasculature to increases in insulin 
(meal ingestion) and exercise induced shear stress.   
 
eNOS phosphorylation  
This is the first study to report changes in microvascular eNOS ser1177 phosphorylation 
induced by acute exercise before and after 6 weeks ET and 6 weeks SIT. We show that pre- 
and post-exercise microvascular eNOS ser1177 phosphorylation was reduced by both modes of 
training. Shear stress in cultured endothelial cells has been suggested to be one of the most 
important regulators of eNOS ser1177 phosphorylation (32). Therefore, the reduction in 
microvascular eNOS ser1177 phosphorylation following training that we observe may 
potentially be the result of a reduction of the size of the shear stress stimulus. As the absolute 
intensity of the acute cycling exercise was the same before and after training (1 h at 65% of 
pretraining VO2peak) and the muscle capillary density was higher post-training (Fig. 4.2) it is 
likely that blood flow per capillary will be reduced after training both at rest and during 
cycling exercise. Previous one leg knee extensor training studies (25) have shown that the 
femoral venous blood flow was  lower in the trained than the non-trained leg during exercise 
at 65% of the VO2peak for the knee extensors, implying that total local muscle blood flow may 
be lower as well. It should be noted that the relative increase in eNOS ser1177 phosphorylation 
in response to acute exercise was unaltered by training (Fig. 4.2). Further studies are required 
to fully understand the mechanisms behind ET and SIT induced changes in eNOS 
phosphorylation, capillary density and skeletal muscle perfusion during exercise. 
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NOX2 content  
ET and SIT did not lead to changes in the protein content of the membrane associated subunit 
of NAD(P)Hox NOX2 in the skeletal muscle microvasculature (Fig. 4.3b). As in the previous 
study (10) NOX2 was also observed to be present in the sarcolemma (Fig. 4.3c) and again SIT 
and ET did not change the protein content in the sarcolemma. Despite being sedentary, it is 
unlikely that the young healthy individuals in the present study exhibited high levels of 
NAD(P)Hox, which may explain the absence of a training effect. NAD(P)Hox is an inducible 
enzyme and its expression is increased by obesity (39), inflammation and cardiovascular 
disease (7). This suggests that any changes observed in microvascular function with training, 
at least in lean sedentary young men, is mediated by increases in eNOS protein content, rather 
than a reduction in the scavenging of NO by superoxide anions resulting from a training 
induced decrease in  NAD(P)Hox content. 
 
Arterial stiffness 
The present study is the first to show that ET and SIT induce similar changes in central artery 
stiffness in young healthy sedentary males. Traditional moderate intensity ET has previously 
been shown to improve central arterial stiffness (13, 23). However to date, SIT studies have 
failed to show any training induced improvements in central artery stiffness (36, 46). This 
discrepancy may be due to the following factors. Firstly in the study by Whyte et al. (2010) 
training duration was only 2 weeks in comparison to the 6 weeks intervention employed in the 
current study. Secondly, Rakobowchuk et al. (2008), used a different method to measure 
central stiffness than those employed in the current study (cPWV vs. carotid artery 
distensibilty) (36). A considerable variability has been observed between different 
168 
 
methodologies to measure central arterial stiffness (9, 19), and this may also contribute to the 
discrepancy between the studies. 
 
No change was observed in our study in pPWV following either ET or SIT. This is in 
agreement with an earlier study that has shown that 16 weeks of ET in middle aged men had 
no effect on stiffness of muscular peripheral arteries of the leg (19). However, in contrast to 
the current study another study investigating the effects of 6 weeks SIT in young sedentary 
males has observed reductions in stiffness of the popliteal artery stiffness (36). Differences in 
arteries used (prone to develop stiffness or not) are likely to explain the differences between 
these studies (14). 
 
Our study is the first to investigate the effect of SIT on AIx and compare the effects of 6 
weeks ET and SIT and shows that both were equally effective in improving AIx, an 
assessment of systemic wave reflection and thus arterial stiffness (33). The only other study 
that has investigated the effect of ET was a study of Edwards et al in coronary artery disease 
patients, which showed that 12 weeks of ET improved AIx (15). However, to the authors’ 
knowledge this is the first time that AIx have been measured following a period of sustained 
exercise training in a young healthy sedentary group and that a comparison has been made 
between the effects of ET and SIT.  
 
Limitations 
We decided to not include an untrained control group with repeated measurements in this 
study for comparison.  This would have strengthened the design, but reduced the feasibility of 
completing the study (e.g. due to costs, time demands and recruitment difficulties). The study 
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was powered to detect a medium effect size between groups for muscle microvascular eNOS 
content and muscle microvascular density, as a result it should be noted that the sample size 
of the study may not have been high enough to detect between group differences in other 
variables displaying a larger variability (e.g. increases in VO2peak and insulin sensitivity). 
Translational studies with a larger number of participants are required before it can be 
concluded that SIT and ET are similarly effective in inducing adaptation in all the variables 
investigated in this study. We also acknowledge that the conclusions made in this study 
should also be restricted to previously sedentary young adult males. Finally, the results of the 
current study and others (24, 36) indicate that both SIT and ET improve a number of 
cardiovascular functions, but additional larger scale and longer term studies are required 
before it can be concluded that SIT and ET are equally effective in reducing cardiovascular 
disease risk in a variety of populations. 
  
In conclusion this study generates novel information that 6 weeks of SIT is equally effective 
as 6 weeks of ET in increasing skeletal muscle microvascular density. The study also shows 
for the first time that ET and SIT both lead to significant increases in microvascular eNOS 
content, with SIT leading to a greater increase than ET. The study finally generates the novel 
information that the structural adaptations that occur in the muscle microvasculature in 
response to SIT and ET leads to a reduced eNOS ser1177 phosphorylation state both at rest and 
in response to 1 h of endurance exercise at 65% VO2peak. The increase in microvascular eNOS 
may contribute to the increases in insulin sensitivity observed following both modes of 
exercise observed in this study and several earlier studies. The SIT intervention used in this 
study involved a maximum time commitment of 1.5 h per week, while the ET involved 5 h of 
exercise per week leading to the conclusion that SIT is a time efficient alternative to achieve 
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these effects in young previously sedentary men. Together with previous reports that SIT and 
ET elicit similar muscle metabolic (increases in activity of mitochondrial enzymes and 
aerobic capacity (8, 17)), and macrovascular adaptations (24, 36) suggests that SIT is a time 
efficient alternative training mode to simulate many of the known effects of ET on fitness, the 
macrovasculature and the metabolic function of skeletal muscle and its microvasculature.  
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Chapter 5 
 
Effect of resistance training on microvascular density and 
eNOS content in skeletal muscle of sedentary men 
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5.1. Abstract 
Increases in muscle microvascular density and eNOS content are fundamental adaptations to 
traditional endurance training (ET) and are mechanistically linked to skeletal muscle insulin 
sensitivity and maximal aerobic oxygen consumption (VO2max) during exercise. Apart from 
the well known effects of resistance training (RT) on muscle mass, strength and insulin 
action, it is currently unknown whether in sedentary males RT also increases muscle 
microvascular density and eNOS content. Eight previously sedentary males (age 20±0.4y, 
BMI 24.5±0.9 kg.m-2) completed 6 weeks of whole body progressive RT 3 times per week. 
Muscle biopsies were taken from the m. vastus lateralis and microvascular density, eNOS 
content, eNOS Ser1177  phosphorylation and NOX2 content were assessed pre- and post-RT 
using quantitative immunofluorescence microscopy. Whole body insulin sensitivity 
(measured as Matsuda Index), microvascular filtration capacity (a functional measure of the 
total available endothelial surface area) and  arterial stiffness (augmentation index and central 
and peripheral pulse wave velocity) were also measured pre- and post-RT. Measures of 
microvascular density, microvascular filtration capacity, microvascular eNOS content, basal 
eNOS phosphorylation and endothelial NOX2 content did not change from pre-RT to post-
RT. RT increased insulin sensitivity (P <0.05) and reduced resting blood pressure and 
augmentation index (P <0.05), but did not change central or peripheral pulse wave velocity. 
In conclusion RT did not change any measure of microvascular structure or function, 
indicating that adaptations to the microvasculature do not make a major contribution to the 
well-known insulin sensitizing effect of RT. 
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5.2. Introduction 
Resistance training (RT) has recently been added to the guidelines for physical activity and 
public health of the American College of Sports Medicine (ACSM) and the American Heart 
Association (19). The main reasons for these recommendations are the established effects of 
RT on insulin sensitivity (whole body and muscle) and muscular strength, variables that are 
strongly related to promotion and maintenance of independence and health throughout the 
lifespan (19). 
 
The elevation in insulin-mediated glucose uptake and therefore insulin sensitivity observed 
following resistance training has been attributed to elevations in muscle mass and qualitative 
changes within the muscle (14) involving increases in GLUT 4 and key proteins in the insulin 
signalling cascade (22, 25, 45). However, it is becoming increasingly apparent that in addition 
to qualitative changes within the skeletal muscle adaptations to the muscle microvasculature 
also play important roles in determining insulin sensitivity (2, 3). It has long been known that 
traditional endurance-based training (ET) leads to increases in skeletal muscle capillary 
density (1), and recent research from our laboratory (11) has shown that increases in 
endothelial eNOS content are also part of the muscle microvascular adaptations to ET. 
Increases in microvascular eNOS content are important as eNOS is responsible for insulin 
stimulated NO production and local microvascular vasodilatation (41). These variables and 
eNOS ser1177 phosphorylation (main eNOS activation site; (31)) by insulin and exercise-
induced shear stress are therefore important determinants of the local microvascular blood 
flow and the capillary surface area available for glucose uptake (2, 3, 12, 28, 35, 42). As a 
result, these microvascular adaptations are potentially important in the increased insulin 
sensitivity (15) and aerobic exercise capacity (4) seen following endurance-training, 
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increasing local blood flow and capillary surface area available for delivery of insulin, blood 
borne fuels and oxygen to the muscle. 
 
Today no studies have investigated the effect of resistance training (RT) on muscle 
microvascular density and eNOS content in man to obtain insight into whether such 
adaptations can play a role in the RT-induced increases in insulin sensitivity. As previously 
explained (12) NO bioavailability in the microvasculature is determined by the balance 
between production of NO by eNOS (36, 37, 39), and the scavenging of NO by superoxide 
anions (.O2
-). A major source of superoxide production and NO scavenging in the vascular 
wall is NAD(P)Hoxidase (NAD(P)Hox) (6, 38), but substantial expression of this enzyme is 
assumed to only occur in obesity, cardiovascular pathology and ageing (6, 38). 
 
As there is a paucity of data on the effect of RT on the skeletal muscle microvasculature we 
first sought to determine the effects of six weeks RT on skeletal muscle microvascular density 
and microvascular enzyme contents (eNOS and NOX2) in previously sedentary men. We 
employed a novel method recently developed in our laboratory (12), to measure the protein 
content of these enzymes in the endothelial layer of the muscle microvasculature using 
quantitative immunofluorescence microscopy. Secondly, we aimed to investigate the effect of 
6 weeks RT on microvascular eNOS ser1177 phosphorylation in the resting fasted state. 
Finally, the effects of 6 weeks RT on arterial stiffness and blood pressure were considered to 
investigate earlier claims that RT may have a negative effect on arterial stiffness (30). We 
hypothesized that microvascular density and eNOS content would not or only minimally 
increase in response to 6 weeks RT, implying that different mechanisms contribute to the 
insulin sensitising effects of RT and ET. 
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5.3. Materials and Methods 
The percutaneous muscle biopsies taken in this study have been used both for the 
measurements described in this manuscript and for measurements of the content of 
intramuscular triglycerides (IMTG) and perilipin-2 and perilipin-5. The latter are reported in a 
parallel manuscript (Shepherd SO, Cocks M, Tipton KD, Ransinghe AM, Barker TA, 
Burniston JG, Wagenmakers AJM and Shaw CS, unpublished data). Measures such as insulin 
sensitivity made in the indicated human volunteers are relevant for the interpretation of both 
studies and are presented in both manuscripts. 
 
Participants 
Eight healthy sedentary males participated in the study (Table 5.1). The sedentary state was 
defined as performing less than 1 hour per week of structured physical activity (e.g. sports 
club, commercial gym or exercise class). Following recruitment all participants provided 
written informed consent, using a protocol adhering to the Declaration of Helsinki and 
approved by the Black Country NHS Research Ethics Committee. 
 
Familiarisation and 1RM 
Participants were first familiarised with all the resistance training equipment and instructed on 
correct lifting technique. Eight motion guided resistance exercise machines (Cybex 
International Inc., MA, USA) targeting both the upper and lower body were used ( leg press, 
leg extension, seated leg curls, chest press, lat pull down, shoulder press, arm curls, and arm 
extensions).  In order to determine the initial load for the training period, 1RM was 
determined on all eight machines, 1RM was determined using the method of Kraemer and Fry 
(24). Before determination of 1 RM participants completed a warm up consisting of  6 
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repetitions at an estimate of 50% 1RM, 4 repetitions at approximately 70% 1RM, and 2 
repetitions at 80% 1RM, with 2 min recovery between sets. Subsequently, each exercise was 
performed at the estimate of 1RM.  Repetitions were valid if the load was lifted through the 
full range of motion in a controlled manner without assistance. Following this first attempt the 
load was increased based on the maximum number of repetitions performed for the previous 
load, using the following equation: 
     
    
                             
 
This was continued until only 1 repetition was possible, this load was determined to be 1RM. 
Post training 1RM was completed prior to the final training session, 1RM was determined on 
the leg press, chest press, leg extension and shoulder press, as a measure of training effect. 
 
Experimental protocol 
Experimental testing took place over 2 days and included measures of vascular function, 
insulin sensitivity (day 1) and a muscle biopsy (day 2). Pre- and post-training testing was 
identical in all respects and all testing procedures were conducted at least 48 hours after the 
last exercise bout to exclude the effects of acute exercise. On all occasions testing was 
performed following 24 hours standardised diet and following an overnight fast. Standard 
diets were matched to the participant’s average daily energy intake, calculated using 3 day 
diet diaries. The composition of the standard diet was 50% carbohydrate, 35% fat and 15% 
protein. 
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Experimental procedures 
Arterial stiffness 
Supine blood pressure was measured in triplicate using an automated sphygmomanometer 
(Omron 7051T, Omron Corporation, Kyoto, Japan) following 15 minutes of supine rest. Pulse 
wave analysis was conducted using a semi-automated device and software (SphygmoCor, 
AtCor Medical, Sydney, Australia). Central (carotid- femoral, cPWV) and peripheral (carotid- 
radial, pPWV) pulse wave velocity were assessed using a semi-automated device and 
software (SphygmoCor, AtCor Medical, Sydney, Australia) using the protocol described in 
(11). Briefly, pulse transit time was calculated by concurrent measurement of the QRS 
complex obtained using electrocardiography and arterial waveforms collected using 
applanation tonometry. Distance was measure using an anthropometric measuring tape 
between specific anatomical locations. Tonometry measures were collected from the femoral 
and carotid arteries for cPWV, and radial and carotid arteries for pPWV. All measurements 
were made in triplicate. A series of arterial waveforms were collected from the radial artery 
using applanation tonometry. The brachial artery blood pressure was then used to calibrate the 
waveforms to create a complete cardiac cycle. Using a generalised transfer function (32) the 
aortic waveform was reconstructed. Augmentation index (AIx) an assessment of systemic 
wave reflection and thus arterial stiffness (26) was calculated from the resulting aortic 
waveform. To control for the influence of heart rate on AIx, AIx was normalised to a heart 
rate of 75 beats per minute (AIx@75) (43). All measurements were made in triplicate. 
 
Venous occlusion plethysmography 
Microvascular filtration capacity (Kf) was measured using venous occlusion 
plethysmography. The system and small cumulative venous congestion plethysmography 
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protocol is based on the previously established system developed by Gamble et al. (16, 17). 
The measurements were made in a quiet temperature controlled room following a supine rest 
of at least 30 minutes. Measurements were made with the left calf elevated to the level of the 
heart and a congestion pressure cuff placed around the left thigh. Changes in calf 
circumference were measured using a passive inductive transducer with an accuracy of ± 5 
μm, in response to five 10 mmHg cumulative congestion pressure steps. The maximum 
pressure never exceeded the participant’s diastolic pressure.  
 
Changes in pressure in excess of the ambient venous pressure caused a rapid volume response 
attributable to venous filling. Following this rapid volume response a slow steady state 
volume change occurred, reflecting fluid filtration (Jv). Slope of the Jv response was then 
measured over the last 2 minutes of the pressure step to ensure vascular filling had occurred. 
The slope of the regression line attained by plotting Jv at each pressure represented Kf.   
 
Oral glucose tolerance test and Matsuda insulin sensitivity index 
Following the insertion of a cannula into an antecubital vein, a baseline 25 ml blood sample 
was taken. Participants then ingested a 25% glucose beverage containing 75g glucose made 
up in 300 ml of water. Further blood samples (10 ml) were collected at 30, 60, 90 and 120 
minutes while participants rested, following the procedure originally proposed by Matsuda & 
DeFronzo (27) for the assessment of whole body insulin sensitivity. Plasma was separated by 
centrifugation (10 minutes at 3000 rpm) and stored at -80oC until analysis. Plasma insulin 
concentrations were determined by enzyme linked immuno-sorbent assay (ELISA) using a 
commercially available kit (Invitrogen, UK).  Plasma glucose concentrations were analysed 
using an automated analyzer (IL ILab 650 Chemistry Analyzer, Diamond Diagnostics, USA). 
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Area under the curve (AUC) for insulin and glucose during the oral glucose tolerance test was 
calculated using the conventional trapezoid rule. The Matsuda index, a variable which is 
generally accepted and widely used as a non-invasive alternative to measure whole body 
insulin sensitivity has been shown to have a high correlation with insulin sensitivity measured 
with the hyperglycemic euglycemic clamp (27), which is the gold standard method. The 
Matsuda index was calculated using the formula: 
 
 
Where FPG is fasting plasma glucose concentration (mg.dl-1), FPI is fasting plasma insulin 
concentration (µU.ml-1), and mean OGTT glucose and insulin is the mean plasma glucose 
(mg.dl-1) and insulin (µU.ml-1) concentration of all samples taken during the oral glucose 
tolerance test (0, 30, 60, 90 and 120 min). 
 
Muscle biopsy 
On day 2 following an overnight fast a muscle biopsy was taken from the lateral portion of 
the m. vastus lateralis, approximately 25-50% of the distance from the lateral joint line and 
the greater trochanter under local anaesthesia (1% lidocaine) using the percutaneous needle 
biopsy technique (5) as recently described (40).  Excess blood and visible collagen or fat were 
removed before samples were embedded in Tissue-Tek OCT Compound (Sakura Finetek 
Europe, Zoeterwoude, Netherlands) and immediately frozen in liquid nitrogen cooled 
isopentane (Sigma-Aldrich, Dorset, UK). Samples were then stored at -80oC until analysis 
was performed. 
 
 
)gl ucoseOGTT( m ean i nsul i n)OGTTm ean()FPIFPG(
10000
I SI Mat suda


 
187 
 
Training 
Participants trained three times per week completing a minimum of 16 sessions and maximum 
of 18 during the 6 weeks. Participants completed the training sessions in the School of Sport 
and Exercise Sciences at the University of Birmingham under the instruction of the research 
team. Eight motion guided resistance exercise machines (discussed above) targeting both the 
upper and lower body were used. During the first week participants completed 3 sets of 10-12 
repetitions at 50%, 60% and finally 70% 1RM. Following the first week participants 
completed 2 sets of 10-12 repetitions, the third set was then performed to volitional fatigue. 
Loads of 80% 1RM were used. To ensure progression, load was increased by 5 lb following 
successful completion of 3 sets of 12 lifts. 
 
Quantitative immunofluorescence  
The immunofluorescence staining protocol and quantification has been described previously 
by Cocks et al. (12). Briefly, samples orientated to provide muscle fibre cross-sections were 
cut (5μm) and placed on glass slides. Both pre- and post-training samples within an individual 
were placed on the same slide. Sections were fixed in acetone and ethanol (3:1). Following 
fixation section were incubated overnight with antibodies for the following: NOX2 (Santa 
Cruz Biotechnology, Santa Cruz, CA, gp91-phox/NOX2 (C-15), cat No. sc-5827), eNOS 
(Transduction laboratories, Lexington, KY, cat No. 610297) or p-eNOS ser1177 (Cell 
Signalling Technology Beverly, MA, p-eNOS ser1177, cat No. 9570L). Sections were then 
incubated with appropriately labelled secondary antibodies (Invitrogen, Paisley, UK) and the 
endothelial marker Ulex Europaeus-FITC conjugated (UEA-I-FITC; Sigma-Aldrich, UK). 
Finally sections were incubated with the cell membrane marker wheat germ agglutinin-350 
(WGA-350; Invitrogen, UK). 
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For image capture, muscle sections were viewed using a Nikon E600 microscope using a 40x 
0.75 numerical aperture objective, illuminated with a 170W Xenon light source. Images were 
captured using a SPOT RT KE colour three shot camera (Diagnostic Instrument Inc., MI, 
USA) coupled to the microscope. Camera exposure time and gain was adjusted so no pixel 
saturation was present in any channel and identical camera settings were used for all images 
within each participant. 
 
Once captured images were analysed using Image Pro Plus 5.1 software (Media Cybernetics 
Inc, Bethesda, MD, USA). Endothelial specific fluorescence was determined using the UEA-I 
FITC (endothelial marker) image, which was extracted and overlaid onto the corresponding 
eNOS, p-eNOS ser1177 or NOX2 image. Cell membrane specific fluorescence for NOX2 was 
determined using WGA-350 as a stain to create an outline of the cell membrane. The latter 
was extracted and overlaid onto the corresponding NOX2 image. Fluorescence intensity of the 
eNOS, p-eNOS ser1177 or NOX2 signal was quantified within the endothelium or cell 
membrane specific area. The reader was not blinded to condition as image analysis was 
automated removing the potential effects of investigator bias (12).  Values were normalised to 
pre-training values. 
 
Capillarization 
Capillaries were quantified manually using the UEA-I and WGA-350 images as markers of 
capillaries and muscle fibre membrane. The following indexes were measured as previously 
described (21): 1) number of capillaries around a fibre (capillary contacts (CC)), 2) capillary-
to-fibre ratio on an individual-fibre basis (C/FI), the number of capillaries sharing a fibre 
(sharing factor (SF)), 4) capillary density (CD) and 5) capillary-fibre-perimeter exchange 
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(CFPE) index. Fibre cross sectional area and perimeter were measured using ImagePro Plus 
5.1. 
 
Statistics 
Statistical analyses were performed using SPSS for windows version 16.0 (SPSS, Chicago, 
IL)).  All variables were analysed using paired samples t-tests for comparison. Significance 
was set at P ≤ 0.05. Data is presented as means ± S.E.M. The primary aim of the study was to 
compare the effects of RT on muscle microvascular eNOS content. G*Power 3.1 software 
(G*Power Software Inc., Kiel, Germany) was used to calculate the required sample size. The 
study was designed to detect an effect size of dz=0.98, representative of a large sized effect 
(13) adopting an alpha of 0.05 and power of 0.80. We deemed a dz of 0.98 to be a 
physiologically relevant difference as we previously observed an effect of this size following 
6 weeks of ET and sprint interval training (SIT) in sedentary individuals. 
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5.4. Results 
Training effects 
Participants as expected exhibited significant gains in strength following RT. 1RM increased 
by 43%, 33%, 32% and 38% for the leg press, leg extension, chest press and shoulder press, 
respectively (all variables P < 0.05; Table 5.1).  Resting heart rate was unchanged by training 
(P = 0.119; Table 5.1). Brachial mean arterial pressure (MAP), systolic blood pressure (SBP), 
and diastolic blood pressure (DBP) were all reduced following training (P < 0.05; Table 5.1). 
 
Insulin sensitivity 
The Matsuda insulin sensitivity index was significantly increased by 31% following RT (P < 
0.05; Table 5.1). Both glucose and insulin area under the curve (AUC) were reduced 
following training (P < 0.05; Table 5.1). 
 
Microvascular enzymes 
Skeletal muscle endothelial specific eNOS content and ser1177 phosphorylation was not 
significantly different between pre- and post-RT (eNOS content: P = 0.091, Fig. 5.1; eNOS 
ser1177 phosphorylation: P = 0.075; Fig. 5.2). Skeletal muscle endothelial specific and 
membrane specific NOX2 content also was not changed by RT (endothelial specific: P = 
0.319; membrane specific P = 0.164; Fig. 5.3). 
 
Filtration capacity and capillarization 
Kf was unaltered by training (P = 0.333; Fig. 5.4). Fibre cross sectional area and perimeter 
were not changed by RT in either type I or II fibres (fibre cross sectional area: P = 0.827; 
perimeter: P = 0.625). Sharing factor was not changed by RT (P = 0.408) and no significant 
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difference was found for capillary density (P = 0.715). Type I fibres had significantly higher 
capillary contacts, capillary-to-fibre ratio on an individual-fibre basis and capillary-fibre-
perimeter exchange than type II fibres both before and after training (P < 0.05), but no 
significant differences were found in these variables as a result of RT (CC: P = 0.716; C/FI: P 
= 0.598; CFPE, P = 0.654; Table 5.2). 
 
Arterial stiffness 
AIx@75bpm was significantly decreased following training (P < 0.05; Fig. 5.5a). However, 
neither cPWV nor pPWV were affected by training (cPWV P = 0.934, pPWV P = 0.708; Fig. 
5.5b and c). 
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Table 5.1. Subject characteristics, insulin sensitivity and hemodynamics pre and post 6 
weeks of resistance training. 
Variable Pre training Post training 
Age (yr) 20±1 - 
Height (cm) 172±3 - 
Weight (Kg) 72.6±2.4 71.1±2.2 
BMI (kg.m-2) 24.4±0.9 24.2±0.8 
ISI Matsuda 2.8±0.2 3.7±0.3* 
Glucose AUC (mmol.L-
1.120min-1) 
923.7±64.6 843.9±73.1* 
Insulin AUC 
(mmol.L-1.120min-1) 
8914.4±513.1 7308.1±652.5* 
Resting heart rate (bpm) 67±4 63±2 
Mean arterial pressure 
(mmHg) 
81±2 75±1* 
Systolic blood pressure 
(mmHg) 
115±2 109±3* 
Diastolic blood pressure 
(mmHg) 
64±2 57±2* 
 
Leg press 1RM (lb) 427 ± 21 612 ± 34* 
Chest press 1RM (lb) 119 ± 6 157 ± 7* 
Leg extension 1RM (lb) 263 ± 10 349 ± 12* 
Shoulder press 1RM (lb) 103 ± 4 142 ± 5* 
 
Values are means ± S.E.M. * P < 0.05. 1RM, 1 repetition maximum 
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Figure 5.1. Effect of resistance training (RT) on eNOS content. 
A. Widefield microscopy images of skeletal muscle pre- (left) and post-RT (right). Skeletal 
muscle eNOS expression was revealed using Alexa-Fluor 594 conjugated secondary antibody 
(red). Bar = 50μm. B Mean fluorescence intensity of eNOS is indicated. The mean level of 
eNOS pre-training was assigned a value of 1, and the relative intensity of eNOS post-training 
was calculated. 
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Figure 5.2. Effect of resistance training (RT) on basal eNOS serine1177 phosphorylation. 
A. Widefield microscopy images of skeletal muscle pre- (left) and post-RT (right). Skeletal 
muscle eNOS serine1177 phosphorylation was revealed using Alexa-Fluor 594 conjugated 
secondary antibody (red). Bar = 5μm. B Mean fluorescence intensity of eNOS serine1177 is 
indicated. The mean level of eNOS serine1177 pre-training was assigned a value of 1, and the 
relative intensity of eNOS serine1177 post training was calculated. 
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Figure 5.3. Effects of resistance training (RT) on NOX2 content. 
A. Widefield microscopy images of skeletal muscle pre- (left) and post-RT (right). Skeletal 
muscle NOX2 content was revealed using Alexa-Fluor 594 conjugated secondary antibody 
(red). Bar = 50μm. B Mean fluorescence intensity of NOX2 within the muscle membrane is 
summarized. C Mean fluorescence intensity of NOX2 within the endothelium is indicated. 
The mean level of NOX2 pre-training was assigned a value of 1, and the relative intensity of 
NOX2 post-training was calculated. 
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Figure 5.4. Effect of resistance training on calf microvascular filtration capacity (Kf). 
Calf microvascular Kf measured using venous occlusion plethysmography. Fluid filtration (Jv) 
was measured over the final 2 minutes of 5x 5 minute cumulative pressure steps (10mmHg). 
Jv was then plotted against pressure and the resulting slope of the line gave a measure of Kf. 
Kf is a measure proportional to the capillary surface area available for exchange.  
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Table 5.2. Capillarization pre and post resistance training. 
Variable Pre training Post training 
Overall FA (mm2) 3694±206 3713±258 
Type I FA (mm2) 3473±232 3674±341 
Type II FA (mm2) 3761±263 3681±253 
Overall Perimeter (mm2) 250.3±7.5 251.3±8.0 
Type I Perimeter (mm2) 243.1±7.6 253.2±11.1 
Type II Perimeter (mm2) 252.7±9.4 250.2±7.9 
Overall CC 4.21±0.29 4.27±0.19 
Type I CC 4.61±0.28 4.73±0.20 
Type II CC 4.02±0.33 4.08±0.19 
Overall C/FI 1.53±0.13 1.56±0.09 
Type I C/FI 1.68±0.13 1.77±0.10 
Type II C/FI 1.45±0.14 1.48±0.09 
Overall CFPE 6.07±0.42 6.23±0.29 
Type I CFPE 7.03±0.54 7.03±0.28 
Type II CFPE 5.66±0.43 5.92±0.26 
SF 2.82±0.05 2.80±0.03 
CD (caps/ mm2) 701.4±42.4 713.0±40.6 
 
Values are means ± S.E.M. FA, fiber cross sectional area; SF, sharing factor; CD, capillary 
density; CC, capillary contacts; C/FI, capillary-to-fibre ratio on an individual-fibre basis; 
CFPE, capillary-fibre-perimeter exchange. 
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Figure 5.5. Effect of resistance training (RT) on augmentation index and central and 
peripheral artery stiffness. 
A. systemic stiffness measured through augmentation index normalized to 75 bpm following 
RT. B. Central artery (aortic) stiffness measured using pulse wave velocity (PWV) following 
RT. C. Peripheral artery (brachial artery) stiffness measured using pulse wave velocity 
following RT. * P < 0.05. 
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5.5. Discussion 
The most important findings of the present study are that: 1) 6 weeks of RT in young 
previously sedentary males did not increase skeletal muscle capillarization, 2) RT did not 
increase eNOS protein content of the muscle microvascular endothelium, 3) Basal eNOS 
ser1177 phosphorylation was unchanged by RT, 4) As expected RT did not induce a change in 
the protein content of NOX2, 5) despite the lack of microvascular adaptations RT increased 
insulin sensitivity by 32% (P<0.05). Finally our results contrast previous suggestions that RT 
increases central arterial stiffness (30)and show that AIx a measure of systemic stiffness was 
reduced by 28% (P<0.05) following RT. Our results suggest that increases in skeletal muscle 
capillary density and/or microvascular eNOS content are not the primary drivers for the 
elevations in insulin sensitivity observed following 6 weeks RT in young previously sedentary 
males. 
 
Insulin sensitivity, capillary density and eNOS content 
Results from previous studies investigating the effect of RT on capillary density have 
produced similar results to the current study suggesting that RT is not effective at increasing 
capillary density, however unlike the present study RT has previously been shown to increase 
the number of capillaries per fibre (18, 29). This rise in number of capillaries following RT 
was suggested to be proportional to fibre growth, so that no reduction in diffusion distances 
would occur in the enlarged fibres. The lack of change in number of capillaries per fibre in the 
current study might be explained by the fact that the 6 weeks RT intervention did not lead to 
significant muscle fibre hypertrophy in the sampled muscle. Further confirmation of the 
absence of an increase in capillary density is offered by the absence of a change in 
microvascular filtration capacity, a functional measure of capillary surface area available for 
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diffusion of plasma water. Kf was previously shown to correlate with capillary density (9). 
This is the first study to investigate the effects of RT on Kf, but results support previous 
findings in strength trained athletes showing no elevation in Kf in this group compared to 
sedentary individuals (7). 
 
It has been suggested that capillary density (23) and microvascular Kf (10) are key 
determinants of insulin sensitivity due to their role in capillary surface area available for 
exchange of insulin and glucose, thus regulating insulin and glucose delivery to the muscle. 
However as neither capillary density nor Kf were increased following RT it appears that 
improvements in delivery of insulin and glucose to the muscle through increased surface area 
do not play a role in the RT induced elevation in insulin sensitivity observed in the current 
study and previous studies. 
 
Key to insulin-induced increases in microvascular blood flow is an increase in NO production 
by eNOS (41). Increases in eNOS content in response to training interventions as we 
previously observed following 6 weeks of ET in previously sedentary individuals (11), 
therefore, may contribute to the increase in insulin sensitivity that is seen after ET. However, 
RT did not lead to increases in muscle microvascular eNOS content, implying that such 
increases cannot be responsible for the increased insulin sensitivity observed following RT. It 
cannot be ruled out though that other adaptations of the microvasculature, such as increased 
insulin-induced eNOS phosphorylation or reduced NO quenching by reactive oxygen species 
may cause increases in insulin mediated NO bioavailability. 
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Previous research by our group and others has suggested that ET is effective at increasing 
microvascular density ((1, 11)) and eNOS content (11)). These results suggest that the 
mechanisms leading to improved insulin sensitivity are different between ET and RT, with 
microvascular adaptations playing a greater role in the response to ET than RT. We, therefore, 
suggest that increases in muscle mass leading to an increased capacity to clear glucose and a 
higher protein expression of intermediates of the insulin signalling cascade which has been 
observed before (22, 25, 45) contribute to increase in insulin sensitivity following RT. It is 
also possible that the ability of insulin to activate the insulin signalling cascade in skeletal 
muscle is increased via a mechanism that is not currently known. As such, a combination of 
ET and RT may prove to be the most effective training approach as it may increase muscle 
insulin sensitivity via multiple mechanisms, but also increase muscle mass and strength, 
which is particularly relevant to maintain an independent lifestyle in the rapidly growing 
ageing population.  
 
Although significance was not reached there was a trend for an increase in eNOS content (P = 
0.091). Although this may suggest that the study was underpowered a previous study 
investigating the changes in microvascular eNOS content following ET and SIT using the 
same criteria and number of individuals did produce a significant increase (11). 
 
eNOS phosphorylation 
RT did not change basal eNOS ser1177 phosphorylation, although there was a trend towards a 
decrease (P = 0.075). In chapter 4 (11) a reduction in eNOS ser1177 phosphorylation was 
observed in sedentary individuals following 6 weeks ET and SIT, which we attributed to a 
reduction in shear stress mediated by a training-induced increase in capillary density. As there 
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is no change in capillary density following RT, the absence of an effect on eNOS ser1177 
phosphorylation is as expected.   
 
NOX2 
No change was seen in the protein content of the membrane bound subunit of the 
NAD(P)Hox complex NOX2 in either the skeletal muscle sarcolemma or in the muscle 
microvascular endothelium. The lack of response of NOX2 to RT in present study either 
seems to be the result of the nature of the exercise stimulus, or a consequence of the young 
healthy nature of the participants, who despite being sedentary are unlikely to have elevated 
levels of NAD(P)Hox before the intervention. In chapter 4 (11) we also did not find a change 
in NAD(P)Hox following 6 weeks sprint interval (SIT) and ET, while 4 weeks SIT did reduce 
NAD(P)Hox in sedentary obese individuals (chapter 6).  
 
Arterial stiffness 
In contrast to a recent meta-analysis which suggested that high intensity RT is associated with 
increased central artery stiffness (30) the current study showed no change in aortic or 
peripheral artery stiffness following high intensity RT. The discrepancy between studies is 
likely the result of different RT protocols performed (concentric lifting protocols, high 
volume and high intensity RT versus eccentric lifting protocols). Studies using similar high 
intensity RT protocols to the current study also did not observe a change in arterial stiffness 
(8, 33, 34). This suggests that when ACSM guidelines for high intensity RT are followed 
arterial stiffness is not adversely affected; however, unlike exercise modes such as ET and 
HIT, RT does not have a beneficial effect on arterial stiffness. 
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Unlike local artery stiffness (aorta and brachial artery), augmentation index (AIx) was 
reduced following training. AIx is a measure of the contribution wave reflections make to the 
arterial pressure waveform (44). As such, AIx is a measure of systemic stiffness as the 
amplitude and timing of wave reflections depend on small and large arteries. Systemic 
stiffness is an important measure as it partly determines left ventricular workload, and 
therefore is of significant clinical importance (44). The current finding however is in contrast 
with two previous studies investigating RTs effect on systemic stiffness in young healthy 
participants, which suggested that RT has no effect on systemic stiffness (8, 20). An 
explanation for these differences is unclear as the current study uses the same protocol for 
measuring AIx and a similar RT protocol (8, 20). Because of the potential clinical 
implications more detailed future studies are required in young healthy adults, elderly 
individuals and patient populations to solve this discrepancy.  
 
In conclusion this study generates novel information that 6 weeks RT in previously sedentary 
young males does not increase microvascular density or eNOS content and ser1177 
phosphorylation state. Despite the lack of microvascular adaptations insulin sensitivity was 
increased by RT suggesting that microvascular adaptations are not responsible for the 
improvement in insulin sensitivity. Together with previous reports investigating the effect of 
ET (11) and RT (22, 25, 45), we suggest that the combination of both training modes may 
lead to optimal metabolic and health benefits, as different mechanisms appear to contribute to 
the increase in insulin sensitivity.  ET in addition will be a powerful means to increase muscle 
oxidative capacity, capillarity and microvascular responsiveness, while RT has unique effects 
on muscle mass and strength.  
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Muscle Microvasular Density and eNOS Content in 
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6.1 Abstract 
Previous research has shown that structural and functional impairments in the muscle 
microvasculature play an important role in the mechanisms by which obesity leads to 
endothelial function loss, characterised by reductions in NO bioavailability and insulin 
induced microvascular vasodilation. Sprint interval training (SIT) has recently been proposed 
as a time efficient alternative to traditional endurance based training, leading to similar 
increases in muscle microvascular density and larger increases in microvascular endothelial 
eNOS content in young previously sedentary individuals. In this pilot study, we aimed to 
investigate whether SIT has the same effects on the muscle microvasculature in obese males, 
and whether these changes translate into improved aerobic capacity and whole body insulin 
sensitivity as previously observed in sedentary young men. Six young obese males (age 
23±3y, BMI 35.5±1.1 kg.m-2) volunteered to participate. Participants performed 4-7 intervals 
(constant workload of 200% Wattmax with 2 minutes active recovery between intervals) 3 
times per week for 4 weeks. Biopsies were taken before and after training from the m. vastus 
lateralis for quantatitative immunofluorescence microscopy measurements of microvascular 
density and content and ser1177 phosphorylation state of eNOS and NAD(P)Hoxidase (NOX2), 
in addition to a series of relevant functional measurements.  SIT significantly (P<0.05) 
increased eNOS protein content of skeletal muscle arterioles (10%) and capillaries (13%).  
SIT also increased basal ser1177 phosphorylation (arterioles 15% and capillaries 7%, both 
P<0.05) and reduced skeletal muscle microvascular NOX2 content (15%; P<0.05). SIT did 
not change microvascular density, but led to a significant increase in microvascular filtration 
capacity (18%; P<0.05), a functional measure of the accessible capillary surface area. SIT in 
parallel significantly (P<0.05) increased maximal aerobic capacity (VO2max) (9%), whole 
body insulin sensitivity (18%) and reduced arterial stiffness (11%). Finally, SIT significantly 
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reduced fasting plasma free fatty acids. In conclusion, this pilot study in obese individuals 
shows that 4 weeks of constant workload SIT is an effective intervention to improve the 
content of endothelial enzymes controlling NO bioavailability and these molecular 
adaptations are paralleled by increases in whole body insulin sensitivity, microvascular 
filtration capacity and VO2max, while reducing cardiovascular risk factors. All these changes 
are consistent with potential long-term health benefits of SIT in this high risk group.  
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6.2 Introduction 
Obesity has become a global epidemic with 200 million men and 300 million women over 20 
(1)  classified as obese worldwide (Body mass index (BMI)> 30kg.m-2) (32). The rapid 
increase in obesity prevalence is regarded to be instrumental to the worldwide increase in the 
prevalence of cardiovascular disease and metabolic syndrome (1) and the obesity epidemic, 
therefore is currently regarded as a major economic, social and health burden. If recent trends 
continue the number of obese adults is expected to grow to 1.12 billion by 2030 (32). 
 
A growing body of literature suggests that reductions in muscle microvascular density in 
obese individuals and animal models (24) in combination with impairments in the 
vasodilatory responsiveness of the muscle microvasculature to physiological stimuli (insulin, 
VEGF and exercise-induced shear stress) are instrumental to the development of functional 
impairments and in the longer term chronic diseases in the obese population  (4-6, 15, 20, 21, 
52).  Suggestions have also been made that microvascular impairments may be an early and 
important factor in the later development of macrovascular function loss (33).  
It is well established that the insulin dependent dilation of the muscle microvasculature 
controls glucose uptake in skeletal muscle and depends on adequate increases in nitric oxide 
(NO) bioavailability (22, 39). The latter is determined by the balance between insulin induced 
increases in NO synthesis and in obesity (see next paragraph) scavenging of NO by 
superoxide anions and related reactive oxygen species.  
 
Experiments with isolated arteries and cultured endothelial cells have shown that the rate 
limiting enzyme for endothelial NO synthesis is endothelial nitric oxide synthase (eNOS). 
The protein content and serine1177 phosphorylation state together determine total eNOS 
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activity and endothelial NO production (42). A major source of superoxide anion production 
and NO scavenging in the vascular wall is NAD(P)Hoxidase (NAD(P)Hox) (9, 46), and 
substantial expression of this enzyme is assumed to occur in obesity and cardiovascular 
pathology (9, 46). Because of the lack of a method to measure the protein expression of these 
enzymes in the muscle microvascular endothelium it is currently unknown if there is an 
imbalance between eNOS protein expression and phosphorylation and NAD(P)Hox protein 
expression in obese individuals.  
 
Hard evidence exists that traditional endurance-based training (ET) delays or prevents the 
onset of obesity related chronic diseases (34).  However, the majority of the adult population 
does not meet the current recommendations to perform a minimum of 150 minutes of 
moderate intensity endurance exercise per week to thus sustain metabolic fitness and health 
(27). 'Lack of time' is cited as the major reason for the wide-spread failure to adhere to this 
exercise recommendation (50). In an earlier study (17) we showed that 6 weeks SIT using 
repeated Wingate’s (“all out” cycling for 30 seconds) was more effective than traditional ET 
to increase muscle microvascular eNOS content and equally effective at increasing muscle 
microvascular density. We, therefore, decided to perform the current pilot study to investigate 
whether SIT might also be a time efficient alternative to ET to improve microvascular enzyme 
expression and function in obese individuals and whether this leads to parallel metabolic and 
functional adaptations that in the long-term might reduce the risk for development of 
cardiovascular disease and metabolic syndrome.  
 
Previous studies (11, 17, 44) investigating SIT have used “all out” cycling, in the form of 
repeated 30s Wingate tests. However, this method of training is very demanding and requires 
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high levels of motivation to deliver maximal effort in each session and over prolonged 
intervention periods. In addition it also requires specialised cycle ergometers and may 
therefore not be a practical training method for the majority of the obese population. These 
criticisms have led others to develop high intensity interval (HIT) protocols which use 
constant loads (36, 49), as these have been suggested to remove the demanding character of 
“all out” SIT. As such, in the present study we have developed a SIT protocol designed to 
maintain the anaerobic nature of “all out” SIT whilst utilizing the benefits of constant 
workload HIT. 
 
The main aims of the current study were twofold. First, we sought to determine whether 4 
weeks constant workload SIT increased skeletal muscle microvascular density and 
microvascular filtration capacity, a functional measure of the accessible capillary surface area 
in muscle, in previously sedentary obese males. Secondly, we aim to investigate the effects of 
constant workload SIT on skeletal muscle microvascular endothelial enzyme content and 
phosphorylation (eNOS content and ser1177 phosphorylation and NOX2 content). As in 
previous chapters we hypothesise that these microvascular adaptations lead to parallel 
increases in aerobic capacity and insulin sensitivity. In addition this is the first study to 
investigate whether cardiovascular risk factors are reduced by SIT. We employed quantitative 
immunofluorescence microscopy, a recently developed technique to assess protein content 
and phosphorylation of the indicated enzymes within the endothelial layer of the skeletal 
muscle microvasculature. The method was modified from previous studies (17, 18) to allow 
for separation of arterioles and capillaries (eNOS and eNOS ser1177 phosphorylation only), 
as it is terminal arterioles that control capillary perfusion. Finally, the effects of constant 
workload SIT on arterial stiffness and blood pressure were also investigated. We hypothesise 
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that microvascular density and function would increase in response to constant workload SIT, 
that eNOS content would be increased in both arterioles and capillaries following training and 
that NOX2 content would be reduced. Finally we hypothesise that the improvements in 
microvascular function and structure would be paralleled by improvements in aerobic 
capacity and insulin sensitivity and a reduction in cardiovascular risk factors. 
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6.3 Materials and methods  
The percutaneous muscle biopsies taken in this study have been used both for the 
measurements described in this manuscript and for measurements of the content of 
intramuscular triglycerides (IMTG), perilipin-2 and perilipin-5. The latter are reported in a 
parallel thesis (Shepherd SO, University of Birmingham, 2012). Measures such as VO2peak, 
insulin sensitivity and the cardiovascular risk factors are relevant for the interpretation of both 
studies and are presented in both theses.  
 
Participants  
Six young sedentary obese males, defined by a BMI above 30 kg.m-2 and currently 
participating in less than 1 hour structured physical activity per week completed the study 
(Table 1). Participants were free of cardiovascular and metabolic disease and other 
contraindications to participate in exercise training interventions, ascertained through a 
medical screening process. All participants gave written informed consent to a protocol 
adhering to the Declaration of Helsinki and approved by the Black Country NHS Research 
Ethics Committee. 
 
Pre training testing protocol 
Participants first completed an incremental exercise test to exhaustion on an 
electromagnetically braked cycle ergometer to determine Watt max (Wmax) and VO2peak (as 
described in chapter 4). Following sufficient rest participants were familiarised to the SIT 
protocol, for this participants completed 1x30s repetition of the SIT protocol (200% Wmax).  
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3-7 days after the incremental exercise test and following an overnight fast, vascular functions 
were assessed (blood pressure, arterial stiffness, microvascular filtration capacity), these were 
followed by a resting muscle biopsy, oral glucose tolerance test (OGTT) and finally body 
composition assessment using DXA.   
 
Post training procedures 
Post-training VO2peak testing was performed the day before the final training session. 
Approximately 48 hours after the final training session the post-training testing protocol was 
conducted with procedures, methods and timings identical in all respects to the pre-training 
testing protocol. 
 
Arterial stiffness 
Supine blood pressure was measured using an automated sphygmomanometer (Omron 7051T, 
Omron Corporation, Kyoto, Japan) following 15 minutes of supine rest. Systemic wave 
reflection was then investigated using pulse wave analysis conducted using a semi automated 
device and software (SphygmoCor, AtCor Medical, Sydney, Australia), using this 
augmentation index (AIx) was calculated as described previously (Chapter 4). To control for 
the influence of heart rate on AIx, AIx was normalised to a heart rate of 75 beats per minute 
(AIx@75) (53). Central (carotid- femoral, cPWV) and peripheral (carotid- radial, pPWV) 
artery stiffness were investigated by pulse wave velocity, assessed using a semi automated 
device and software (SphygmoCor, AtCor Medical, Sydney, Australia) as previously 
described (Chapter 4). All measurements were made in triplicate.  
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Venous occlusion plethysmography  
Microvascular filtration capacity (Kf) was measured through venous occlusion 
plethysmography using the principles described previously (Chapter 4). However the method 
was adapted to use a mercury-in-silastic strain gauge and semi automated inflation pump 
(Hokanson, Inc). Strain gauge and pressure cuff signal were sampled at 1000Hz and stored for 
offline assessment of Kf.  
 
Muscle biopsy 
A resting muscle biopsy was taken from the lateral portion of the m. vastus lateralis using the 
percutaneous needle biopsy technique under local anaesthetic (1% lidocaine) as recently 
described (48). Excess blood and visible collagen or fat were removed before samples were 
embedded in Tissue-Tek OCT Compound (Sakura Finetek Europe, Zoeterwoude, 
Netherlands) and immediately frozen in liquid nitrogen cooled isopentane (Sigma-Aldrich, 
Dorset, UK). Samples were then stored at-80oC until analysis was performed.  
 
Oral glucose tolerance test and Matsuda insulin sensitivity index 
Following the insertion of a cannula into an antecubital vein, a resting 25ml blood sample was 
taken; participants then ingested a 25% glucose beverage containing 75g glucose made up in 
300ml of water. Further blood samples were collected at 30, 60, 90 and 120 minutes while 
participants rested. Plasma samples were separated by centrifugation (10 minutes at 1600g) 
and stored at -80oC until analysis. Plasma insulin concentrations were determined by enzyme 
linked immuno-sorbent assay (ELISA) using a commercially available kit (Invitrogen, UK).  
Plasma glucose concentrations were analysed using an automated analyzer (IL ILab 650 
Chemistry Analyzer, Diamond Diagnostics, USA).  
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Area under the curve (AUC) for insulin and glucose during the oral glucose tolerance test was 
calculated using the conventional trapezoid rule. The Matsuda index, a variable which is 
generally accepted and widely used as a non-invasive measure of whole body insulin 
sensitivity was calculated using the formula: 
 
 
Where FPG is fasting plasma glucose concentration (mg.dl-1), FPI is fasting plasma insulin 
concentration (µU.ml-1), and mean OGTT glucose and insulin is the mean plasma glucose 
(mg.dl-1) and insulin (µU.ml-1) concentration of all samples taken during the oral glucose 
tolerance test (0, 30, 60, 90 and 120 min).  
 
Body composition  
Percentage body fat was assessed by dual-energy X-ray absorptiometry (DXA-Hologic 
Discovery W with Hologic QDR software for windows XP version 12.4.2). 
 
Dietary control  
24 hours prior to both the pre and post training experimental trial participant’s diets were 
standardised. Diets were matched to participants average daily energy intake based on 3 day 
diet diaries analysed using a computer system (WISP) and composed of 50% carbohydrate, 
35% fat and 15% protein.  
 
Training  
Training was initiated ~48 hours after the muscle biopsy. Following a 2 minute warm up at 
50W participants performed repeated 30s high intensity cycling bouts at a workload 
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corresponding to 200% Wmax. High intensity bouts were interspersed with 120s of cycling at 
30W for recovery. Participants completed 4 intervals for the first 3 sessions; this was then 
increased by 1 repetition every 3 sessions, participants did 12 sessions in total, completing 7 
intervals during the final training session.  
 
We chose a workload corresponding to 200% Wmax as previous unpublished work by 
ourselves showed that Wingate based SIT elicited a mean power output of equivalent to 200% 
Wmax as determined by progressive exercise test to exhaustion.  Thus, to closely match the 
mean workload of Wingate based SIT we suggested 200% Wmax. We believe the alternative 
SIT protocol developed for this study maintains both the anaerobic nature and the time saving 
benefits of Wingate based SIT whilst avoiding the demanding nature of Wingate based SIT as 
discussed earlier.  
 
Cardiovascular risk profile 
An automatic analyzer (IL ILab 650 Chemistry Analyzer, Diamond Diagnostics, USA)  
was used to determine non-esterified fatty acid (NEFA), triglyceride and total cholesterol 
concentrations using commercially available kits (NEFA: Randox Laboratories Ltd, Co. 
Antrim, UK, triglyceride and cholesterol: Instrumentation Laboratory Ltd UK, Warrington, 
UK). 
 
Immunofluorescence  
Quantitative immunofluorescence 
NOX2 content in the skeletal muscle microvascular endothelium and membrane was assessed 
using the immunofluorescence staining protocol and quantification technique described 
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previously (Chapter 2). The immunofluorescence staining protocol and quantification 
technique used for eNOS content and eNOS ser1177 phosphorylation has been adapted from 
the method previously described in chapter 2 to allow for differentiation between skeletal 
muscle capillaries and arterioles.  
 
Serial 5μm transverse sections were cut and collected on to room temperature uncoated glass 
slides. Pre and post training samples from each participant were placed on the same slide, and 
slides were analysed in duplicate. 
 
Sections were fixed in acetone and ethanol (3:1). Sections were then incubated with 
antibodies against either eNOS (Transduction Laboratories, Lexington, KY), p-eNOS ser1177 
(Cell Signalling Technology, Beverly, MA) in combination with anti-α smooth muscle actin 
(SMA; abcam, Cambridge, UK) as a marker to differentiate between arterioles and capillaries. 
Sections were then incubated with appropriately labelled secondary antibodies (Invitrogen, 
Paisley, UK), in combination with Ulex Europaeus-FITC conjugated (UEA-I-FITC; Sigma-
Aldrich, UK) as a marker of the endothelium. Following staining coverslips were applied 
using a glycerol and mowiol 4-88 solution. 
 
Images were acquired with an inverted confocal microscope (Leica DMIRE2, Leica 
Microsystems) with a 40x oil immersion objective. FITC fluorescence was excited with a 488 
nm line of the argon laser and detected with 500-570 nm emission. Alexa fluor 546 and 633 
fluorophore were excited with 543 nm and 633 nm lines of the Helium-Neon laser and 550-
650 nm and 650-730 nm emission, respectively. Identical settings were used for all image 
capture within each participant. 
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Image analysis was performed using Image Pro Plus 5.1 software. Blood vessels were divided 
into either capillaries or arterioles using the αSMA image. The endothelial (UEA-I-FITC) 
outline was overlaid onto the corresponding eNOS or p-eNOS ser1177 image. Fluorescence 
intensity of the eNOS or p-eNOS ser1177 signal was quantified within the endothelial specific 
area. Arteriole diameter was also determined on calibrated images using Image Pro Plus 5.1 
software.  
 
Capillarization  
Muscle sections were incubated with anti-myosin type I (developed by Dr Blau DSHB) 
followed by goat anti-mouse IgM 350 (Invitrogen, Paisley, UK) to identify type I muscle 
fibres. This was performed in combination with UEA-I-FITC (Sigma-Aldrich, UK) and wheat 
germ agglutinin-350 (WGA-350; Invitrogen, UK) as markers of the endothelium and plasma 
membrane, respectively. 
 
For analysis, slides were viewed using a Nikon E600 microscope using a 40x 0.75 numerical 
aperture objective. Images were captured using a SPOT RT KE colour three shot camera 
(Diagnostic Instrument Inc., MI, USA). 
 
Capillaries were quantified in a fibre type specific manner manually using the UEA-I, WGA-
350 and myosin heavy chain images. The following indexes were measured (30): 1) number 
of capillaries around a fibre (capillary contacts (CC)), 2) capillary-to-fibre ratio on an 
individual-fibre basis (C/FI), the number of capillaries sharing a fibre (sharing factor (SF)), 4) 
capillary density (CD) and 5) capillary-fibre-perimeter exchange (CFPE) index. Fibre cross 
sectional area and perimeter were measured using ImagePro Plus 5.1 software. 
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Statistics 
Capillary contacts, capillary-to-fibre ratio on an individual-fibre basis, capillary-fibre-
perimeter exchange, fibre cross sectional area and perimeter were analyzed using a factorial 
ANOVA, with the factors ‘training’ (pre versus post) and ‘fiber type’ (type I versus type II). 
eNOS content and eNOS ser1177 phosphorylation in capillaries and arterioles were also 
analyzed using a factorial ANOVA, with the factors ‘training’ (pre versus post) and ‘vessel 
type’ (capillary versus arteriole). All other analysis was done using a paired samples t-test. All 
analyses were performed using statistical analysis software (SPSS for windows version 16.0 
(SPSS, Chicago, IL).  Significance was set at P ≤ 0.05. Data is presented as means ± S.E.M.  
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6.4 Results 
Training effect 
VO2peak and Wmax increased by 9% and 12%, respectively following training (P < 0.05), but 
there was no change in body weight (P = 0.846), BMI (P = 0.811) or percentage body fat (P 
= 0.190) following training. Resting heart rate was unchanged by training (P = 0.242), as 
were brachial artery MAP (P = 0.656), systolic blood pressure (P = 0.427) and diastolic 
blood pressure (P = 0.290; Table 1). 
 
Insulin sensitivity  
Both glucose and insulin AUC were reduced by training (P < 0.05; Table 1), resulting in a 
significant improvement in ISI Matsuda by 18 % (P < 0.05; Table 1). 
 
Cardiovascular risk profile 
Fasting NEFA concentration was significantly reduced following training by 38% (P < 0.05; 
Table 1). However, fasting plasma total triglyceride concentration and fasting cholesterol 
were not significantly reduced following SIT (plasma triglyceride P = 0.174, cholesterol P = 
0.173; Table 1). 
 
Basal eNOS content and phosphorylation  
 4 weeks of SIT significantly (P<0.05) increased eNOS content in arterioles (10%) and 
capillaries (13%), resulting in a significant main effect of training on skeletal muscle 
microvascular eNOS content (P < 0.05) (Fig. 1). eNOS content was significantly higher in 
skeletal muscle arterioles than capillaries (P < 0.05) both pre- and post-SIT. eNOS ser1177 
phosphorylation measured in the basal state was increased in arterioles and capillaries by 15% 
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and 7%, respectively following training, resulting in a main effect of training on eNOS ser1177 
phosphorylation (P < 0.05) (Fig. 2). Skeletal muscle eNOS ser1177 phosphorylation was 
significantly higher in skeletal muscle arterioles than capillaries (P < 0.05). Mean arteriole 
diameter for assessment of eNOS and eNOS ser1177 phosphorylation pre and post training was 
9.6±0.8µm and 8±1 arterioles were analysed for each condition. 
 
NOX2 
 Skeletal muscle total microvascular (capillaries and arterioles) endothelial NOX2 content was 
reduced by 15% following training (P < 0.05), but skeletal muscle membrane NOX2 was 
unchanged by training (P = 0.413) (Fig. 3). 
 
Microvascular filtration capacity and capillarization  
Microvascular filtration capacity was reduced following training (P < 0.05) (Fig. 4). Fibre 
cross sectional area and perimeter were not different in type I and II fibres (Fibre cross 
sectional area P = 0.436, perimeter P = 0.188) and were unaltered by training in either type I 
or II fibres (Fibre cross sectional area P = 0.513, perimeter P = 0.974). Capillary density was 
unchanged by training (P = 0.722). Capillary-fibre-perimeter exchange index was higher in 
type I than type II fibre (P < 0.05), but was unaffected by training (P = 0.454). Neither 
capillary contacts nor capillary-to-fibre ratio were different depending on fibre type (capillary 
contact P = 0.082, capillary-to-fibre ratio P = 0.083) and both were unaffected by training in 
either fibre type (capillary contact P = 0.329, capillary-to-fibre ratio P = 0.342) (table 2, Fig. 
5). 
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Arterial stiffness 
AIx @75bpm was significantly reduced following training (P < 0.05) (Fig. 6a). Aortic PWV 
was also significantly reduced by 11% following training (P < 0.05) (Fig. 6b) and peripheral 
PWV tended to decrease following training (P = 0.066) (Fig. 6c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
228 
 
Table 6.1. Subject characteristics, resting hemodynamics and peak oxygen uptake pre 
and post training. 
Variable Pre training Post training 
Age (yr) 23±3  
Height (cm) 176.6±3.3  
Weight (Kg) 111.1±6.1 111.3±5.7 
BMI (kg.m-2) 35.5±1.1 35.6±1.1 
% body fat (%) 31.8±2.3 31.4±2.5 
VO2peak (ml.Kg
-1.min-1) 35.9±2.8 39.3±2.3* 
Wmax (W) 239.7±11.4 267.7±13.8* 
ISI Matsuda 1.8±0.1 2.1±0.2* 
Glucose AUC (mmol.L-
1.120min-1) 
988±68 891±50* 
Insulin AUC 
(mmol.L-1.120min-1) 
13837±1453 11789±1601* 
Resting heart rate (bpm) 66±4 61±3 
Mean arterial pressure 
(mmHg) 
86±4 88±4 
Systolic blood pressure 
(mmHg) 
128±5 126±7 
Diastolic blood pressure 
(mmHg) 
66±5 69±4 
Triglycerides (mmol.L-1) 2.05±0.15 1.75±0.23 
Total cholesterol (mmol.L-1) 6.4±0.4 5.5±0.5 
NEFA (mmol.L-1) 0.52±0.06 0.32±0.03* 
 
Values are means ± S.E.M. * Significant change from pre training, P < 0.05 
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Figure 6.1. Effect of SIT on eNOS content in capillaries and arterioles. 
A. Confocal images of skeletal muscle pre (left) and post (right) SIT in capillaries and 
arterioles. The skeletal muscle microvascular endothelium was revealed using Ulex 
Europaeus-FITC conjugated lectin (green). Arterioles and capillaries were differentiated using 
anti smooth muscle actin in combination with Alexa-Fluror 633 conjugated secondary 
antibody (blue). Skeletal muscle eNOS expression was revealed using Alexa-Fluror 546 
conjugated secondary antibody (red). Bar = 50μm. B Mean fluorescence intensity of eNOS is 
summarized. The mean level of eNOS pre training in capillaries was assigned a value of 1, 
and the relative intensity of eNOS in arterioles and post training was calculated. * Main effect 
of training, P < 0.05. † Main effect of vessel type, P < 0.05. 
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Figure 6.2. Effect of SIT on eNOS ser1177 phosphorylation in capillaries and arterioles. 
A. Confocal images of skeletal muscle pre (left) and post (right) SIT in capillaries and 
arterioles. The skeletal muscle microvascular endothelium was revealed using Ulex 
Europaeus-FITC conjugated lectin (green). Arterioles and capillaries were differentiated using 
anti smooth muscle actin in combination with Alexa-Fluror 633 conjugated secondary 
antibody (blue). Skeletal muscle eNOS ser1177 phosphorylation was revealed using Alexa-
Fluror 546 conjugated secondary antibody (red). Bar = 50μm. B Mean fluorescence intensity 
of eNOS ser1177is summarized. The mean level of eNOS ser1177 pre training in capillaries was 
assigned a value of 1, and the relative intensity of eNOS in arterioles and post training was 
calculated. * Main effect of training, P < 0.05. † Main effect of vessel type, P < 0.05. 
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Figure 6.3. Effect of SIT on NOX2 content in capillaries and arterioles. 
Widefield microscopy images of skeletal muscle pre (left) and post (right) SIT. The skeletal 
muscle microvascular endothelium was revealed using Ulex Europaeus-FITC conjugated 
lectin (green), and skeletal muscle membrane was revealed using wheat germ agglutinin-350 
(WGA-350, blue). Skeletal muscle NOX2 content was revealed using Alexa-Fluror 594 
conjugated secondary antibody (red). Bar = 50μm. B Mean fluorescence intensity of NOX2 
within the endothelium is summarized. C Mean fluorescence intensity of sub-sarcolemma 
NOX2 is summarized. The mean level of NOX2 pre training was assigned a value of 1, and 
the relative intensity of NOX2 post training was calculated. * Significant change from pre 
training, P < 0.05. 
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Figure 6.4. Calf microvascular filtration capacity pre and post training. 
Calf microvascular Kf  measured using venous occlusion plethysmography. Fluid filtration 
(Jv) was measured over the final 2 minutes of five 5 minute cumulative pressure steps 
(10mmHg). Jv was then plotted against pressure and the resulting slope of the line gave a 
measure of Kf. Kf is a functional measure proportional to the capillary surface area available 
for transendothelial transport of insulin and glucose. * Significant change from pre training, P 
< 0.05. 
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Figure 6.5. Effect of training on skeletal muscle capillarization. 
Widefield microscopy images of skeletal muscle pre (left) and post (right) SIT. Skeletal 
muscle capillarization was revealed using Ulex Europaeus-FITC conjugated lectin (UEA-I, 
green), the skeletal muscle membrane was revealed using wheat germ agglutinin-350 (WGA-
350, blue) and fibre type was revealed using anti-myosin type I (red). Composite image shows 
a combination of the UEA-I and WGA-350 images. Bar = 50μm. 
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Table 6.2. Capillarization pre and post training. 
Variable Pre training Post training 
Overall FA (mm2) 3761±385 4134±300 
Type I FA (mm2) 3493±376 4142±419 
Type II FA (mm2) 4037±499 4207±309 
Overall Perimeter (mm2) 267.3±23.0 267.6±9.8 
Type I Perimeter (mm2) 242.4±13.7 264.5±13.2 
Type II Perimeter (mm2) 293.8±39.6 273.8±10.5 
Overall CC 5.03±0.45 5.56±0.32 
Type I CC 5.29±0.59 5.88±0.39 
Type II CC 4.85±0.38 5.31±0.27 
Overall C/FI 1.90±0.19 2.12±0.12 
Type I C/FI 2.01±0.25 2.26±0.18 
Type II C/FI 1.82±0.16 2.00±0.12 
Overall CFPE 7.43±0.58 8.01±0.47 
Type I CFPE 8.14±0.75 8.62±0.45 
Type II CFPE 6.88±0.56 7.37±0.47 
SF 2.71±0.04 2.69±0.02 
CD (caps/ mm2) 845.0±76.9 868.5±42.5 
 
Values are means ± S.E.M. P <0.05. FA, fibre cross sectional area, SF, sharing factor, CD, 
capillary density, CC, capillary contacts, C/FI, capillary-to-fibre ratio on an individual-fibre 
basis, CFPE, capillary- fibre-perimeter exchange. 
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Figure 6.6. Measures of systemic wave reflections and arterial stiffness pre and post 
training. 
A. Augmentation index normalised to 75 beats per minute pre and post SIT. B. Central pulse 
wave velocity pre and post SIT. C. Peripheral pulse wave velocity pre and post SIT. Values 
are means ± S.E.M. * Significant change from pre training, P < 0.05. 
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6.5 Discussion 
The most important novel findings of the present study are that 4 weeks of constant workload 
SIT in young previously sedentary obese males: 1) increased both skeletal muscle arteriole 
and capillary endothelial eNOS content and ser1177 phosphorylation in the basal state; 2) 
decreased microvascular NOX2 content and 3) increased microvascular Kf a measure of the 
capillary surface area available for transendothelial transport of insulin and glucose. As 
hypothesised these microvascular adaptations were paralleled by improvements in maximum 
aerobic capacity and whole body insulin sensitivity. Finally our results also show that 
constant workload SIT is effective at decreasing cardiovascular risk factors and arterial 
stiffness in obese participants.  These results suggest that constant workload SIT is an 
effective, time efficient training mode for changing most of the measured variables in a 
direction consistent with health benefits in young obese males.    
  
Time efficient training stimulus 
We and others have previously shown that “all out” SIT based on repeated Wingate’s is an 
effective way of improving aerobic exercise capacity and insulin sensitivity in previously 
sedentary individuals (3, 11, 17). However these “all out sprint” protocols have been criticised 
for the demanding nature and high levels of motivation required to complete these 
interventions. Also the specialised equipment required to perform Wingate’s prevent it from 
being implemented in community interventions (25). These criticisms have led to the 
suggestion that SIT may not be a suitable method of training in obese individuals and those 
with exercise limitations (19). We therefore developed a method of SIT which would 
maintain the anaerobic nature of “all out” SIT, but would be within the physical abilities of 
obese individuals. The current study has shown that 4 wk of this new constant workload SIT 
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method was effective at increasing VO2peak in obese individuals with similar improvements 
observed as after 6 weeks of ‘all out’ SIT in lean sedentary individuals (9% current study 
versus 8% lean sedentary; (17). As aerobic capacity has been shown to be a more powerful 
predictor of mortality than established clinical risk factors such as hypertension and type II 
diabetes (43), this improvement in VO2peak may have long-term health benefits if maintained 
over the rest of the lifespan. The new method of training was also effective at increasing 
insulin sensitivity in the obese group studied. As the insulin resistance in obesity is strongly 
associated with the development of type II diabetes (26), the improvement in insulin 
sensitivity may ultimately result in reduced progression to type II diabetes.  . The increase in 
VO2peak and insulin sensitivity observed following training are probably the consequence of 
increases in mitochondrial density, improved lipid metabolism (28) and the increase in 
microvascular NO bioavailability and function, that is likely to result from the observed 
changes in eNOS and NAD(P)Hox. 
 
 
Microvascular function  
The technique used in the current study to investigate eNOS content and ser1177 
phosphorylation is an adaptation of the previous technique outlined by Cocks et al. (18) 
allowing differentiation between arterioles and capillaries. As mean arteriole diameter 
measured 9.6±0.8 µM we suggest that mainly 2nd order and terminal arterioles (TA) are 
analysed by the technique (38). We believe that this is a significant improvement on the 
previously described method (18) as it specifically provides information on terminal 
arterioles. Insulin and exercise induced vasodilation of terminal arterioles has been proposed 
to control capillary recruitment, microvascular blood volume, capillary surface available for 
transport of insulin and glucose and microvascular blood flow. Therefore, knowledge of 
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arteriole specific enzyme content and eNOS ser1177 phosphorylation will help to provide 
mechanistic information on the control of microvascular perfusion in response to a number of 
important stimuli such as, exercise, insulin and VEGF and on the blunting of these signals in 
sedentary and obese individuals and patients with type II diabetes and cardiovascular disease.  
 
Both eNOS protein content and ser1177 phosphorylation were increased following SIT in 
skeletal muscle 2A and TA arterioles. Neither skeletal muscle eNOS content or 
phosphorylation have been previously investigated in arterioles and capillaries specifically 
following any form of training, in man or animal models, in the healthy nor in the obese state. 
However the finding of increased eNOS content following SIT is similar to previous work in 
young sedentary males where mixed skeletal muscle microvascular (arterioles, capillaries and 
venules) eNOS content was increased following 6wk of SIT (17). 
 
The findings do however suggest that eNOS ser1177 phosphorylation may respond differently 
to SIT in the obese than in lean sedentary individuals, with an increase in both capillary and 
arteriole specific eNOS ser1177phosphorylation in obesity after 4 weeks of SIT and a reduction 
in the sedentary young men following 6wk of SIT (mixed skeletal muscle microvasculature). 
It is difficult to draw comparisons between the two studies due to the different exercise mode 
and duration of training however; as the increases in VO2peak are comparable the training 
stimuli appear to induce similar adaptations. However, the difference in response of eNOS 
ser1177 could be due to a number of reasons. Firstly, the reduced eNOS ser1177 phosphorylation 
in sedentary lean individuals was proposed to be due to a reduction in basal shear stress as a 
result of the increase in capillary density seen after 6wk SIT (17); while in the current study 
no change in capillary density was observed. However, such differences in the angiogenic 
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response are unlikely to explain the increase in eNOS ser1177 phosphorylation post-training 
shown in the present study. Basal eNOS ser1177phosphorylation has been shown to be 
impaired following high fat feeding in rats (8), as such, it is possible that basal eNOS1177 
phosphorylation is inhibited in obesity. Therefore, the increase in eNOS 
ser1177phosphorylation in the present study may be the result of reduced inhibition of basal 
eNOS ser1177 phosphorylation following SIT.  
 
Skeletal muscle microvascular NAD(P)Hox content was reduced following SIT in obese 
participants. This decrease in NADP(H)ox following 4 wk of SIT is therefore important as it 
will reduce NO quenching and increase NO bioavailability, thus better supporting the insulin, 
exercise and VEGF induced activation of eNOS and the angiogenic effect of exercise. The 
findings of the current study suggest that adaptations to skeletal muscle microvascular 
NAD(P)Hox content may differ between lean sedentary and obese sedentary men as skeletal 
muscle microvascular NOX2 content was not reduced after 6 weeks of SIT in sedentary males 
(17). We previously suggested that this might be the consequence of the amount of 
NAD(P)Hox expression being minimal in the lean sedentary young males before training, 
who despite of being sedentary are in a healthy state probably without significant 
microvascular pathology (17).  
 
The increase in arteriolar eNOS content and ser1177 phosphorylation and reduction in 
microvascular NOX2 content, both enzymes responsible for NO bioavailability, may 
contribute to the improved insulin sensitivity observed in the current study. Insulin mediated 
increases in skeletal muscle microvascular blood flow have been reported to be inhibited in 
obesity (15) and contribute to the impaired glucose disposal. Insulin dependent elevations in 
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microvascular blood flow are thought to be mediated by dilation of terminal arterioles (5), 
through insulin induced eNOS ser1177 phosphorylation (45, 51). In addition to eNOS mediated 
production of NO, quenching of NO by O2- generated by NAD(P)Hox may further reduce NO 
bioavailability impairing insulin dependent increases in microvascular blood flow (52).  
Therefore the improved protein content of eNOS and NAD(P)Hox and increased ser1177 
phosphorylation of eNOS following SIT could have beneficial effects on insulin mediated 
vasodilatation in obesity contributing to the observed improved insulin sensitivity.  
 
Previous studies have shown that an adequate NO bioavailability is required to support the 
angiogenic effect of exercise training (simulated by electrical stimulation in rats), as 
treatments of rats with L-NMMA prevented angiogenesis in skeletal muscle (40). However, 
despite the improvement in enzymes responsible for NO bioavailability no change was 
observed in any of the measures of angiogenesis used in the current study. We suggest the 
absence of an increase in angiogenesis may be the result of high NAD(P)Hox protein 
expression in the obese leading to substantial quenching of the produced NO and therefore to 
too low an NO bioavailability to support the angiogenic affect of VEGF.  While the young 
sedentary men investigated previously following SIT (17) had lower NAD(P)Hox at the start 
of the training and therefore achieved significant increases in capillary density.   
 
Although there was no change in capillarization following SIT there was an increase in 
skeletal muscle Kf. The increase in Kf is of functional relevance as Kf  is associated with 
insulin sensitivity (16). The primary determinant of Kf has been suggested to be 
microvascular surface area for exchange mediated by an increase in capillary density (10, 13). 
The increase in Kf without increases in capillary density was therefore not expected, but 
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changes in Kf have previously been reported using an electrical stimulation protocol designed 
to induce minimal capillary growth (10). The increases in Kf in the present study may 
therefore, be due to other factors, such as, an increase in permeability of the microvasculature 
increasing fluid exchange (23),  and/ or an increase in the perfused surface area of the 
microvasculature. As discussed above it may be possible that not all the microvasculature is 
perfused at rest (14) and that the elevation in Kf is the result of an increased ability to dilate 
terminal arterioles, increasing perfusion of skeletal muscle. If true the changes in enzymes 
responsible for NO bioavailability discussed above may have an important role in this 
functional change.  
 
Cardiovascular risk factors 
The improvements in microvascular function were paralleled by a significant reduction in 
fasting plasma fatty acid (FA) concentration. In cultured endothelial cells incubation with a 
high concentration of FA inhibits NO production in a dose dependent fashion (47) and insulin 
mediated elevations in skeletal muscle microvascular volume are severely blunted following 
acute intralipid/heparin exposure (37). High levels of plasma FA are assumed to contribute to 
the insulin resistance in obese individuals (7). As a result this reduction in plasma FA 
concentrations after 4 weeks of SIT may contribute to both the improved microvascular 
function and increase in whole body insulin sensitivity.  In addition, there was also a trend for 
a reduced fasting plasma TG and cholesterol. As plasma TG and plasma cholesterol are 
recognised as strong risk factors for cardiovascular disease and these decreases are seen after 
only 4 weeks, constant workload SIT in future long-term interventions in larger groups may 
well prove to be a powerful means to lower these cardiovascular risk factors.   
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Arterial stiffness 
In the present study 4 weeks of constant workload SIT significantly reduced central artery 
stiffness and produced a strong trend for reduced peripheral artery stiffness in young healthy 
obese males. To the authors knowledge this is the first study to investigate arterial stiffness 
following SIT in an obese group and only the second to study training of any form on arterial 
stiffness in obesity. In line with the current study, Arena et al. (2) showed that 10 wks of 
aerobic training reduced aortic pulse wave velocity in obese individuals. The reduced central 
artery stiffness observed in the present study is of clinical relevance  as obesity is related to 
increased central artery stiffness even in young individuals (54) and is associated with 
negative cardiovascular outcomes (12). Therefore, the finding that SIT can reduce central 
artery stiffness is of significant importance in this young otherwise healthy obese group.  
 
Previous studies using SIT (17) or endurance training (29) have shown no change in 
peripheral artery stiffness in sedentary young non-obese individuals. However peripheral 
artery stiffness in response to training has not been investigated in an obese group, who are 
known to exhibit, elevated peripheral artery stiffness (41, 54). This elevation in peripheral 
artery stiffness observed in obesity may explain the strong trend for reduced peripheral artery 
stiffness following SIT in the obese group studied. Future studies in larger groups will be 
required to investigate the clinical relevance of this observation.  
 
As well as decreasing arterial stiffness SIT caused a reduction in systemic wave reflections 
measured through AIx. AIx has been shown to be of independent predictive value for all 
cause mortality (35), and provides additional information than that of PWV alone, as AIx is 
determined by changes in small artery tone and structure as well as central artery stiffness 
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(31). The reduction in AIx following SIT in obesity is therefore of potential clinical interest as 
well. 
 
Conclusion 
In conclusion this study provides novel information that constant workload SIT is an effective 
training mode to increase skeletal muscle eNOS content and basal ser1177 phosphorylation 
while reducing NOX2 content in young obese males. In addition SIT also increased 
microvascular Kf. The study shows that these changes in microvascular function and enzymes 
involved in NO bioavailability were paralleled by improvements in maximal aerobic capacity 
and insulin sensitivity suggesting that microvascular changes may contribute to the functional 
improvements observed. The SIT intervention used in this study involved a maximum time 
commitment of 1 h per week leading to the conclusion that constant workload SIT is a time 
efficient alternative to achieve metabolic effects that are likely to lead to long-term health 
benefits in young previously sedentary obese males. 
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7.1 Overview 
Dramatic changes in lifestyle over the latter half of the 20th century have led many to develop 
a sedentary lifestyle which does not fit the genetic makeup of Homo sapiens (11). In 
combination with an abundant supply of food and unhealthy food choices and eating habits 
this has led to the current global obesity epidemic, which is threatening the world. Both 
inactivity and obesity elevate the risk for development of cardiovascular and metabolic 
disease (7, 47). In addition to direct health implications and reductions in quality of life, the 
economic cost of a sedentary lifestyle and obesity warrants urgent action (1, 2). Reductions in 
aerobic exercise capacity and impairments in  glycaemic control are among the key 
maladaptation’s from the optimally trained healthy phenotype and play important roles in the 
development of the chronic diseases that are associated with inactivity, obesity and ageing. 
An inability to match perfusion of skeletal muscle to metabolic demand, likely contributes to 
both the reduced aerobic exercise capacity and impaired glycaemic control often progressing 
in skeletal muscle insulin resistance in many sedentary and obese individuals (chapter 1). 
Capillary rarefaction leading to a reduction in the surface area available for exchange of 
insulin, nutrients and oxygen and an impaired ability to recruit capillaries in response to 
insulin and exercise are the primary reasons for this skeletal muscle underperfusion (chapter 
1), although suggestions have been made that a reduced bulk blood flow to the skeletal 
muscle due to impaired feed artery dilation may contribute as well.  As insulin and exercise 
(shear-stress) induced vasodilatation and the exercise-induced increase in angiogenesis are all 
nitric oxide (NO)-dependent, often in synergy with other mechanisms, reductions in NO 
bioavailability at the start of this PhD project were hypothesised to be responsible for the 
impaired perfusion of skeletal muscle in inactivity and obesity (chapter 1). 
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Endurance training (ET) has long been known to increase aerobic capacity (31) and insulin 
sensitivity (26) and therefore is part of the ACSM guidelines for physical activity and health 
promotion (25). One of the established effects of ET is that it increases eNOS expression and 
protein content at all levels of the arterial tree and improves NO dependent vasodilatory 
functions such as flow mediated dilation (FMD) (chapter 1). As such, improved perfusion of 
skeletal muscle likely contributes to the improvements in aerobic exercise capacity and 
insulin sensitivity observed in sedentary and obese individuals following ET (chapter 1). 
However many people do not meet current activity guidelines and as the most common cited 
reason for this is a lack of time (49), there is a need to develop alternative time efficient 
training strategies. High intensity interval training (HIT) and sprint interval training (SIT) has 
received great interest due to its ability to mirror a number of the metabolic adaptations of ET, 
but with a massive reduction in time commitment (20). In addition to ET and SIT, resistance 
training (RT) is an important training method due to its effects on muscle mass, strength and 
insulin sensitivity (25, 30). However its effect on the vasculature is understudied. The few 
studies to investigate RT’s effect on macrovascular health suggest that it has either no or a 
negative effect (chapter 1). Despite the important role that all three modes of exercise 
training may have on cardiovascular and metabolic health, their effect on the skeletal muscle 
microvasculature and in particular the enzymes that control NO bioavailability has not been 
investigated. Therefore, the aims of this thesis were 1) develop a reliable method to measure 
the protein content and phosphorylation state of enzymes that determine NO production 
(eNOS) and NO quenching (NADP(H)oxidase) specifically in the microvasculature of human 
skeletal muscle, 2) investigate the effect of ET, SIT and RT in lean sedentary individuals on 
these endothelial microvascular enzymes and on capillary density, 3) investigate the effect of 
an adapted SIT protocol on muscle capillary density and these endothelial microvascular 
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enzymes in terminal arterioles and capillaries in obese males , and 4) use the indicated 
immunofluorescence methods in obese Zucker rats (OZR) to investigate the molecular 
mechanisms that lead to impaired microvascular dilation and insulin resistance during a 
hyperinsulinemic euglycemic clamp.  
 
7.2 The use of immunofluorescence microscopy to investigate skeletal 
muscle microvascular enzymes 
Previous studies investigating vascular enzymes responsible for NO bioavailability in human 
skeletal muscle have either used Western blots or sandwich enzyme immunoassay techniques 
applied to extracts of whole muscle homogenates (27, 28). Techniques using whole muscle 
homogenates have obvious disadvantages if the aim is to measure their content in the 
endothelial layer of specific blood vessels. These are discussed at length in chapter 2. In 
animal models enzymes responsible for NO bioavailability have also been investigated using 
Western blots applied to whole muscle homogenates (18) and through isolation of first to fifth 
(terminal) order skeletal muscle arterioles (34, 37, 38) followed by homogenisation and 
Western blots. However, apart from being technically challenging requiring skilled hands and 
large muscle samples this technique does not allow for the measurement of the protein content 
of enzymes as they occur in situ in the endothelial layer of terminal arterioles and capillaries, 
which as discussed in chapter 1 play key roles in the upregulation of skeletal muscle 
perfusion in response to insulin and exercise. The underlying mechanism has been proposed 
to involve dilation of terminal arterioles leading to recruitment of previously underperfused 
capillaries and enlargement of the capillary surface area available for transendothelial 
transport of insulin, glucose, other nutrients and oxygen. Therefore, in chapter 2 a description 
is given of the development of an immunofluorescence microscopy technique which allows 
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the visualisation and subsequent quantitation of skeletal muscle microvascular eNOS content 
and ser1177 phosphorylation and NAD(P)Hoxidase subunit NOX2 content, without the 
confounding factors associated with techniques using whole muscle homogenates. The 
primary objective of chapter 2 was to establish if the adapted immunofluorescence 
microscopy techniques could be used reliably. The secondary objective was to use the 
techniques developed to investigate the effect of 1 h of moderate intensity endurance exercise 
on eNOS ser1177 phosphorylation to investigate whether these newly developed methods were 
able to measure changes in the physiological range. The final objective (method development 
and applications described in chapters 3 and 6) was to adapt the technique to allow for 
independent analysis of capillaries and arterioles in human and rat skeletal muscle. 
 
Evidence is provided in chapter 2 that quantitative immunofluorescence microscopy can be 
used reliably to investigate skeletal muscle endothelial enzymes specifically in the endothelial 
layer of skeletal muscle microvessels (assessed as a mixture of capillaries and 4th and 5th order 
arterioles and venules). Subsequently, quantitative immunofluorescence microscopy showed 
that eNOS ser1177 phosphorylation is elevated in the human skeletal muscle microvasculature 
following acute exercise. This has led to the hypothesis that the observed activation of eNOS 
suggests that increases in skeletal muscle microvascular NO production may play a role in the 
microvascular dilation and functional hyperaemia during endurance exercise, although the full 
extent of its involvement is difficult to speculate on due to the large number of vasodilatory 
mechanisms and the previously observed redundancy of the often complementary systems, 
with some being major regulation systems and other playing a role in fine-tuning (15).  
 
259 
 
In addition in chapters 3 and 6 the technique was successfully adapted to allow for 
investigation of arterioles and capillaries independently of each other. As explained in chapter 
1 both insulin and exercise have been hypothesized to lead to the recruitment of previously 
underperfused capillaries via their vasodilatory effect on the terminal arterioles. It, therefore, 
is crucially important that eNOS ser1177 phosphorylation is measured specifically in the 
terminal arterioles. This was achieved with the addition of a vascular smooth muscle stain in 
chapter 3 and 6. This will allow us in future studies to investigate if there are reductions in 
eNOS content and/ or impairments in eNOS ser1177 phosphorylation in skeletal muscle 
arterioles, which explain the blunting of the vasodilatory response to insulin and exercise in 
sedentary compared to trained individuals, in obese compared to lean, and in old compared to 
young. If these differences exist then insulin and exercise stimulated eNOS ser1177 
phosphorylation will also be used as future outcome measure in exercise training 
interventions. 
 
7.3 Sprint interval training: a time efficient training mode to increase 
vascular function in sedentary and obese individuals 
Previous studies into the effectiveness of low volume sprint interval training (SIT) have 
focused on SIT’s ability to improve markers of skeletal muscle adaptation and potential 
molecular mechanisms behind these adaptations (20). However, only one previous study has 
compared SIT’s effect on the vasculature to that of ET (44) and this study did not look at the 
skeletal muscle microvasculature and the enzymes in its endothelial layer that control NO 
bioavailability. Therefore in chapter 4 the immunofluorescence techniques developed in 
chapter 2 were used to investigate the effect of ET and SIT in young sedentary males on 
skeletal muscle microvascular density, eNOS and NOX2 contents and eNOS ser1177 
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phosphorylation in the basal state and following acute exercise pre and post training. In 
addition the effect of ET and SIT on arterial stiffness was investigated.  
 
The results showed that: 1) 6 weeks of ET and SIT in young previously sedentary adult males 
increased skeletal muscle capillarization to a similar extent, 2)  SIT induced greater increases 
in skeletal muscle microvascular eNOS content than ET, 3) Acute exercise caused an increase 
in skeletal muscle eNOS ser1177 phosphorylation irrespective of training status with a reduced 
post training eNOS ser1177 phosphorylation in both the basal and post exercise state, 4) Neither 
ET nor SIT had an effect on NOX2 content in the young sedentary healthy males in this 
study. Finally ET and SIT produced similar changes in central (measured using aortic pulse 
wave velocity) and systemic (systemic wave reflections measured through augmentation 
index) indexes of vascular stiffness. 
 
As previously observed for aerobic capacity and fat use during exercise, SIT was as effective 
as ET in this study at increasing microvascular density and more effective at increasing eNOS 
content in the skeletal muscle microvascular endothelium. Numerous exercise related signals 
may increase eNOS gene expression and protein content, but two stimuli may be particularly 
important in the difference observed between ET and SIT (16). Firstly, studies in cultured 
endothelial cells and intact arteries have shown that the elevation in shear stress is an 
important signal for the upregulation of eNOS mRNA and eNOS protein expression (4). As 
exercise intensity during the 30 second bouts of SIT are much higher than during cycling at 
65% VO2max the blood shear stress seen by the endothelial layer of the muscle 
microvasculature is most likely to be much higher as well. This increased shear stress may be 
a potential reason for the elevated increase in eNOS content after SIT. Secondly, small 
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increases in vascular oxidative stress in a range which does not lead to NO quenching or 
oxidative damage are known to accompany exercise and have been shown to also stimulate 
eNOS expression (4). In particular hydrogen peroxide (H2O2) has been shown to elevate 
eNOS expression, and in transgenic rats over expressing catalase (responsible for 
decomposition of H2O2 to water and oxygen) increases in eNOS expression were not evident 
following exercise training (33). As oxidative stress is elevated more following high intensity 
than moderate intensity exercise (22) this could be a second mechanism leading to a larger 
increase in eNOS protein expression following SIT.            
 
A limitation of the study conducted in chapter 4 and other chapters within this thesis is that 
no measure of microvascular dilation in response to insulin or exercise has been made. This 
makes it difficult to speculate on the physiological relevance of the changes in eNOS content 
and ser1177 phosphorylation. As such, discussion of potential methods that could be used in 
future studies to make parallel microvascular function measurements will be discussed at 
length in the subsection future research of this chapter.           
     
Following the success of the SIT protocol used in chapter 4, chapter 6 aimed to investigate 
the effect of SIT on microvascular function in obesity. However following the experience 
from chapter 4, and suggestions from others regarding the feasibility of ‘all out’ SIT using 
repeated Wingate’s (14, 20) in individuals and populations with exercise limitations, we chose 
to use an adapted SIT protocol involving constant load cycling, as a more realistic alternative 
in the obese group that was investigated in this study. Using the data collected from chapter 4 
which suggested the mean workload during repeated Wingate’s to be approximately 200% 
Wmax, we designed a protocol using a constant load of 200% Wmax for 30s with 2 minutes 
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rest between the exercise bouts. Using this protocol a pilot study was performed to investigate 
the feasibility (adherence) and effectiveness of 4 weeks of this new constant workload SIT 
protocol on microvascular structure and the enzymes controlling NO bioavailability in obese 
sedentary males. It also investigated whether the 4 week constant workload SIT led to 
measurable increases in aerobic capacity and insulin sensitivity. As the clinical effects of 
exercise training are important for the obese population measurements of variables that 
determine cardiovascular risk were also made.  
 
The results showed that the constant workload SIT protocol was effective at increasing both 
skeletal muscle arteriole and capillary endothelial eNOS content and ser1177 phosphorylation 
in young previously sedentary obese males. SIT also led to decreased microvascular NOX2 
content. All these enzyme changes are expected to increase NO production and 
bioavailability. SIT increased microvascular Kf (filtration capacity), which is a recognised 
functional measure of the capillary surface area in skeletal muscle available for transport of 
insulin, glucose and oxygen and for net transport of plasma water at increased venous 
pressures. The principle of the Kf measurement is based on the latter variable (19). These 
microvascular adaptations were paralleled by improvements in maximum aerobic capacity 
and whole body insulin sensitivity. However, surprisingly microvascular density was not 
improved by 4 weeks constant workload SIT. These improvements in microvascular function 
and structure coincided with improvements in aerobic capacity, insulin sensitivity and a better 
cardiovascular risk profile. Finally our results also indicated that constant workload SIT was 
effective at reducing arterial stiffness in obesity. As such the SIT protocol used proved to be 
an effective and extremely time efficient method of training to improve aerobic capacity, 
insulin sensitivity and vascular function. The adapted SIT protocol was more time efficient 
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than the repeated Wingate based SIT used in chapter 4 with a maximum session length of 
only 19.5  min (3.5 min exercise, 12 min recovery, 2 min warm-up and 2 min cool down) 
compared to 30 minutes for the Wingate based SIT in chapter 4. Although it would be useful 
to compare the effect of the new SIT method to repeated Wingate’s, this would require a 
comparison in the same group with exactly the same training duration. Future research in 
larger groups will be required to answer the question which of the two methods achieves the 
largest changes and is most acceptable to achieve a chronic change in lifestyle and physical 
activity levels.  
 
Following this successful pilot the study should be expanded to include more participants, 
reducing possible statistically errors, and compared with an ET group as was conducted in 
chapter 4. As in Chapter 4, this ET group would provide a control allowing for comparison 
of the different training modes to fully elucidate the effectiveness and efficiency of constant 
workload SIT in obesity.   
 
7.4 Resistance training (RT) to improve microvascular function 
Although ET is the primary mode of exercise recommended to achieve improvements in 
fitness and health by authorities, recently RT has been included in American College of 
Sports Medicine (ACSM) exercise guidelines due to its effects on muscle mass, strength and 
insulin sensitivity (25). As previously discussed microvascular adaptations play a role in the 
improvement in insulin sensitivity observed following ET and SIT in previously sedentary 
men. However, there is a paucity of data regarding the effect of RT on the microvasculature, 
and if such adaptations could contribute to the elevation in insulin sensitivity which is known 
to occur following RT. As such, chapter 5 aimed to investigate the effect of RT on muscle 
264 
 
microvascular density and microvascular enzyme contents to establish whether such changes 
occur following RT and could be part of the mechanism that leads to increases in insulin 
sensitivity following RT in previously sedentary men.  
 
As observed in many earlier studies, the study showed that RT significantly improved insulin 
sensitivity and muscle strength. However the increase in insulin sensitivity was not 
accompanied by an increase in capillary density, eNOS content or ser1177 phosphorylation or 
decreased NOX2 content. These data provide evidence that the increases in insulin sensitivity 
following RT are not mediated by improvements in microvascular density and/ or eNOS 
content. The results of this thesis therefore suggest that the mechanisms leading to 
improvements in insulin sensitivity are different for RT than for ET or SIT. It is my 
suggestion, therefore, that a combination of ET (or SIT) with RT may prove to be the most 
effective training approach as it may increase muscle insulin sensitivity via multiple 
mechanisms. In addition to the potential benefits on insulin sensitivity combined training 
would maintain the unique beneficial effects of RT on muscle mass and strength, which are 
critical to maintaining a lifelong mobility and independency in the growing elderly 
population. 
 
Finally our results also indicated that unlike previous suggestions (39) RT did not increase 
central artery stiffness. Although this adds to a number of publications suggesting that RT 
performed according to the recommendations of the ACSM (2-3 set of 12 repetitions at 80% 1 
repetition maximum) does not cause elevations in arterial stiffness (10, 42, 43), future studies 
should investigate the discrepancy between effects and other studies using different RT 
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protocols (concentric lifting protocols, high volume RT or high intensity super sets) (3, 13, 
41, 42) and reports of increased arterial stiffness in strength trained athletes (40). 
 
7.5 The effect of metabolic syndrome on eNOS signalling following insulin 
stimulation 
Previous work using contrast enhanced ultrasound (CEU) in rat and man and leg 1-
methylxanthine (1-MX) extraction in rats has led to the hypothesis that insulin-induced NO 
dependent dilatation of terminal arterioles leads to an increase in microvascular blood volume 
and capillary recruitment in healthy rats and humans, which is instrumental to the insulin-
induced increase in skeletal muscle glucose uptake during an hyperinsulinemic-euglycemic 
clamp, oral glucose tolerance test or ingestion of a mixed carbohydrate containing meal (5, 6, 
12, 45). However it is suggested that impairments in this mechanism are partly responsible for 
the reduced glucose uptake in response to insulin observed in obesity and the metabolic 
syndrome (5, 6, 12, 45). No studies so far have investigated the in vivo eNOS signalling 
mechanisms behind the insulin induced increase in  microvascular blood volume/capillary 
recruitment in lean individuals and potential mechanisms of impairment in the metabolic 
syndrome. As such, the aim of the study in Chapter 3 was to investigate the effect of the 
metabolic syndrome on eNOS content and ser1176 phosphorylation in terminal arterioles and 
capillaries using the obese Zucker rat (OZR) as a model of the metabolic syndrome.  
 
The results show that there was no difference between the eNOS content and fasted eNOS 
ser1176 phosphorylation in the endothelium of terminal arterioles of lean Zucker rats (LZR) 
and OZR, but during a hyperinsulinemic-euglycemic (HE-) clamp insulin stimulated eNOS 
ser1176 phosphorylation was significantly impaired in the OZR, even resulting in a reduction in 
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eNOS ser1176 phosphorylation during the HE-clamp. In addition the results showed that eNOS 
content and fasted ser1176 phosphorylation were also not different between LZR and OZR in 
the endothelium of capillaries. Unlike terminal arterioles, insulin stimulation during the HE-
clamp did not increase eNOS ser1176 phopshorylation in LZR, but did result in a significant 
reduction in eNOS ser1176 phopshorylation in OZR. These impairments in insulin stimulated 
eNOS ser1176 phosphorylation were accompanied by a substantial reduction in whole body 
glucose clearance during the first 21 minutes of HE-clamp and reduced whole insulin 
sensitivity. This study, therefore, suggests that impairments in insulin mediated eNOS ser1176 
phosphorylation lead to the previously observed blunting of insulin mediated increases in 
muscle microvascular volume (54) and that this molecular mechanism is instrumental to the 
reduced insulin sensitivity in OZR. 
 
7.6 Future research        
7.6.1 Microvascular function 
As discussed earlier a limitation of the work in this thesis is that we were not able to relate the 
observed changes in endothelial enzymes to measurements of the vasodilation of terminal 
arteries, recruitment of previously underperfused capillaries and increases in muscle 
microvascular blood volume and muscle microvascular blood flow. This would have provided 
more insight into the functional relevance of the observed changes in these enzymes on the 
impairments seen in obesity and metabolic syndrome, and in the beneficial training 
adaptations seen in sedentary and obese individuals.  
 
A number of techniques are purported to measure relevant aspects of microvascular perfusion 
or function. However many of these techniques have a number of limitations (discussed in 
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detail by Clark et al.), or do not measure microvascular perfusion within the skeletal muscle, 
which is an essential condition for the coupling of the enzyme data obtained from the skeletal 
muscle microvascular endothelium with functional measures.  
 
Intramuscular microdialysis in combination with the forearm model and blood flow 
measurements provides a direct measurement of capillary permeability-surface area product 
(24) and could therefore be regarded as the “gold standard” method for simultaneously 
assessing changes in transendothelial transport of insulin and glucose and the capillary surface 
area available for transport of insulin, glucose, other nutrients and oxygen. The method has 
previously shown that increases in capillary permeability-surface area product in healthy 
individuals occur during an oral glucose tolerance test and an HE- clamp at very low 
physiological blood insulin concentrations (24). Further increases in insulin infusion during a 
clamp to levels traditionally used in clinical research aiming to measure insulin resistance, did 
not further increase the capillary surface area product. A second publication has shown that 
increases in capillary permeability surface area during a HE- clamp are even smaller in type 2 
diabetics than in obese individuals (23). Despite the analytical power of this method it is 
complex, technically challenging and the invasive nature of the method have prevented a 
widespread use so far.  
 
Contrast enhanced ultrasound (CEU) is an indirect method which can be used to measure 
microvascular blood volume (MBV) and microvascular flow velocity (MFV) in skeletal 
muscle with the product of  these variables giving muscle microvascular blood flow (MBF)  
(50-53, 55). This implies that all functional consequences of dilation of terminal arterioles 
leading to increases in muscle microvascular blood volume and the local muscle 
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microvascular blood flow can be measured. The disadvantage of the method is that it requires 
the infusion of microspheres and is therefore invasive, a high level of ultrasound knowledge 
and skills, expensive ultrasound equipment able to use linear probes are required, and finally, 
CEU cannot be used on moving or contracting muscles. Adaptations to the original CEU 
technique to allow for continuous real-time imaging have shown that physiological levels of 
insulin (75 µU/ml) lead to an increase in MBV resulting in elevated glucose uptake without 
increases in MFV (46). The same is true for measurements taken immediately after light 
exercise, while higher exercise intensities lead to increases in both MBV and MFV.  
 
CEU involves the infusion of microspheres (the size of red blood cells and filled with contrast 
agent) visualised by ultrasound in the tissue of interest (most publication in human skeletal 
muscle and heart).  The acoustic intensity of the image obtained is proportional to the 
concentration of microspheres within the volume of tissue being imaged.  A single pulse of 
high-energy ultrasound is administered to destroy all the microspheres within the ultrasound 
beam.  Subsequently, the rate of microsphere replenishment can be measured and reflects 
MFV while the plateau level of microspheres reached after destruction reflects MBV.  As 
larger vessels fill more quickly, background subtraction of the average acoustic intensity 
generated within 1 second after the high-energy pulse is applied, thus eliminating larger 
vessels from the analysis, providing assessment of MBV and MFV in terminal arterioles, 
capillaries (major contribution), and 4th and 5th order venules. As a result I believe this 
technique would allow us to relate changes in microvascular eNOS content and insulin and 
exercise induced increases in ser1177 phosphorylation to increases in muscle microvascular 
perfusion and muscle microvascular blood volume (MBV) as a measure of increases in 
capillary surface area in future studies.   
269 
 
 
Following introduction of these methods, it would be of great interest to combine these 
techniques with similar methods to investigate macrovascular function, as this would allow 
for integrated assessment of vascular adaptations at multiple vascular levels. As such, flow 
mediated dilation (FMD) and/or total limb blood flow assessed with plethysmography and/or 
Doppler ultrasound in response to insulin or exercise could be used in conjunction with the 
quantitative immunofluorescence from endothelial scrapings of arteries to provide assessment 
of the endothelial enzymes determining NO production and NO quenching in feed arteries. 
Such an integrated approach simultaneously examining the muscle microvasculature and the 
macrovasculature would allow us to investigate differences in time course of response to 
inactivity or training interventions within these discrete vascular beds, to thus identify the 
most important early targets for future interventions involving diet, exercise and pharmaca. 
This is important as it has been suggested that microvascular and macrovascular adaptations 
interact to elevate cardiovascular and metabolic disease risk and that muscle microvascular 
adaptations in fact precede macrovascular impairments (32). In addition, it has been suggested 
that the time course of adaptations to inactivity and exercise training may differ between 
vascular beds (48). For example within conduit arteries it is suggested that functional changes 
following inactivity may precede structural changes, however this is not the case within the 
resistance vasculature (48). It is also highly likely that there are differences between arms and 
legs due to the inherent difference in usage of these limbs in day to day life in sedentary 
individuals. As such investigation of both the muscle microvasculature and the 
macrovasculature taking into account functional adaptations and changes in signalling 
mechanisms and endothelial enzyme changes would provide more information on the effect 
that inactivity and training interventions have on the potential mechanisms behind any 
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differences between vascular beds. This information may have the potential to inform and 
impact therapeutic interventions in that it indicates the best possible targets and best possible 
timing for implementation of such interventions.  
      
A second area that could be investigated with the use of this integrated approach is the 
contribution that impaired limb blood flow and microvascular perfusion, respectively, play in 
the reduced aerobic capacity of older adults. This is a heavily investigated but poorly 
understood research topic with a large clinical relevance as reductions in leg and muscle 
microvascular blood flow have large implications for exercise capacity (determining mobility 
and independence and therefore quality of life) and the development of chronic metabolic 
diseases as explained in this thesis. Using this integrated approach it would be possible to 
examine whether reductions in NO bioavailability through impaired NO production or 
increased NO quenching lead to impairments in the response to exercise both at the muscle 
microvascular and the macrovascular level and to provide evidence that distinct mechanisms 
are responsible for the impaired exercise hyperemia of elderly adults within different vascular 
beds as suggested by Frisbee et al. in OZR (17).      
 
Finally, the observation in chapter 6 that capillary density does not change following 4 weeks 
of SIT, may suggest the possibility that functional adaptations such as increases in 
angiogenesis are delayed in obesity.  This raises the question of whether the efficiency of 
vascular adaptations to training in an obese group may be impaired. As NO bioavailability is 
important for exercise induced angiogenesis and many other vascular adaptations (for 
example, increases in FMD and insulin-mediated increases in MBV), it is possible that high 
levels of NO quenching by O2
- produced by NAD(P)Hox may be responsible for a blunting of 
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the adaptive response to training in the first weeks. It may therefore be that a second block of 
training following the increases in eNOS content and reduction in NOX2 content may be 
more efficient at inducing angiogenesis and other functional adaptations, due to gradual 
increases in NO production and reductions in NO quenching increasing NO bioavailability.  
As such, it would be interesting to investigate a longer training intervention (3 months) with 
measurements of vascular enzymes responsible for NO bioavailability and functional 
outcomes at regular intervals (2, 4, 6, 8, and 12 weeks), to investigate whether elevated 
oxidative stress through increased NAD(P)Hox needs to be cleared, and increased NO 
production through increased eNOS content and phosphorylation occur to maximise the 
benefits of training interventions.  
 
7.6.2 High intensity interval training 
The work contained within this thesis (chapter 4 and 6) and previously by others (8, 44) 
suggests that low volume SIT is an effective method of training which appears to result in 
similar adaptations to ET despite substantial time savings. However it is my belief that much 
more research is needed into all forms of SIT and/or HIT as exercise training modes.   
   
Current SIT protocols use either the original ‘all out’ repeated Wingate SIT method developed 
by Gibala et al. (9), Chapter 4), or various constant workload protocols based on power 
outputs obtained from these original Wingate studies (constant load SIT and HIT) (Chapter 
4,(29, 35, 36)). These constant workload HIT protocols have been developed due to the highly 
demanding nature of “all out” SIT, which requires high levels of motivation and specialised 
equipment (chapter 6) (14, 20, 21). However this has resulted in a large range of workloads 
and time interval encompassed by the HIT title. It is my belief that the wide range of 
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workloads and interval durations likely result in different adaptations. As such it would seem 
essential to perform a study or series of studies investigating various different HIT and SIT 
protocols, evaluating their effectiveness against each other based on physiological and clinical 
variables such as aerobic capacity, insulin sensitivity and cardiovascular risk factors, but also 
time efficiency and psychological aspects such as enjoyment and motivation which are 
extremely important aspects of an effective training programme, especially for its 
implementation in the community. It is the current researcher’s belief that such studies would 
show substantial differences in the adaptations and mechanisms of adaptation between 
different HIT and SIT protocols and therefore would inform expert consensus reports and 
future authorative public health statements and guidelines on the efficiency and feasibility of 
HIT and SIT.   
 
In addition to work optimising HIT and SIT protocols, future studies should begin to evaluate 
the long term health benefits of HIT and SIT as we know very little about it in comparison 
with what is known about the health benefits of endurance training. Current studies vary from 
only 2-6 weeks (20, 21). As such the similar effects of SIT compared to ET which manifest 
after short term training may not be observed over a period of many months. Gibala et al. (21) 
have speculated that the time course for physiological changes may differ between ET and 
SIT and the very high intensity nature of SIT may result in rapid adaptations whereas 
adaptations induced by lower intensity ET may be slower to occur but progress further. 
Therefore it would seem essential to investigate the effects of ET and SIT over longer time 
periods to see if the comparable adaptations are maintained before definitive conclusions 
about SIT’s efficiency can be drawn. Finally, long term studies are also necessary to establish 
the potential effects of SIT on health, the risk for development of chronic disease and 
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premature mortality. If these effects are as impressive as the results in this thesis suggest then 
successful implementation of SIT into the lifestyle of sedentary, obese and elderly population 
in the long-term would also reduce the prevalence of chronic disease in these at risk 
populations and limit the use of the relevant treatments, thus, leading to massive savings in 
health care costs.         
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